id	sid	tid	token	lemma	pos
iajs-3311	1	1	254	254	NUM
iajs-3311	1	2	©	©	ADP
iajs-3311	1	3	published	publish	VERB
iajs-3311	1	4	by	by	ADP
iajs-3311	1	5	college	college	NOUN
iajs-3311	1	6	of	of	ADP
iajs-3311	1	7	education	education	NOUN
iajs-3311	1	8	for	for	ADP
iajs-3311	1	9	pure	pure	ADJ
iajs-3311	1	10	science	science	NOUN
iajs-3311	1	11	(	(	PUNCT
iajs-3311	1	12	ibn	ibn	PROPN
iajs-3311	1	13	al	al	PROPN
iajs-3311	1	14	-	-	PUNCT
iajs-3311	1	15	haitham	haitham	PROPN
iajs-3311	1	16	)	)	PUNCT
iajs-3311	1	17	,	,	PUNCT
iajs-3311	1	18	university	university	NOUN
iajs-3311	1	19	of	of	ADP
iajs-3311	1	20	baghdad	baghdad	PROPN
iajs-3311	1	21	.	.	PUNCT
iajs-3311	2	1	this	this	PRON
iajs-3311	2	2	is	be	AUX
iajs-3311	2	3	an	an	DET
iajs-3311	2	4	open	open	ADJ
iajs-3311	2	5	-	-	PUNCT
iajs-3311	2	6	access	access	NOUN
iajs-3311	2	7	article	article	NOUN
iajs-3311	2	8	distributed	distribute	VERB
iajs-3311	2	9	under	under	ADP
iajs-3311	2	10	the	the	DET
iajs-3311	2	11	terms	term	NOUN
iajs-3311	2	12	of	of	ADP
iajs-3311	2	13	the	the	DET
iajs-3311	2	14	creative	creative	ADJ
iajs-3311	2	15	commons	common	NOUN
iajs-3311	2	16	attribution	attribution	NOUN
iajs-3311	2	17	4.0	4.0	NUM
iajs-3311	2	18	international	international	ADJ
iajs-3311	2	19	license	license	NOUN
iajs-3311	2	20	evaluation	evaluation	NOUN
iajs-3311	2	21	of	of	ADP
iajs-3311	2	22	slc16a11	slc16a11	NOUN
iajs-3311	2	23	gene	gene	NOUN
iajs-3311	2	24	polymorphisms	polymorphism	NOUN
iajs-3311	2	25	in	in	ADP
iajs-3311	2	26	type	type	NOUN
iajs-3311	2	27	2	2	NUM
iajs-3311	2	28	diabetes	diabetes	NOUN
iajs-3311	2	29	mellitus	mellitus	NOUN
iajs-3311	2	30	patients	patient	NOUN
iajs-3311	2	31	narjes	narjes	PROPN
iajs-3311	2	32	majed	majed	PROPN
iajs-3311	2	33	jassim1	jassim1	PROPN
iajs-3311	2	34	*	*	PUNCT
iajs-3311	2	35	and	and	CCONJ
iajs-3311	2	36	aliaa	aliaa	PROPN
iajs-3311	2	37	saadoon	saadoon	NOUN
iajs-3311	2	38	abdul	abdul	PROPN
iajs-3311	2	39	-	-	PUNCT
iajs-3311	2	40	razaq2	razaq2	PROPN
iajs-3311	2	41	1department	1department	NUM
iajs-3311	2	42	of	of	ADP
iajs-3311	2	43	chemistry	chemistry	NOUN
iajs-3311	2	44	,	,	PUNCT
iajs-3311	2	45	collegeof	collegeof	ADJ
iajs-3311	2	46	science	science	NOUN
iajs-3311	2	47	,	,	PUNCT
iajs-3311	2	48	university	university	NOUN
iajs-3311	2	49	of	of	ADP
iajs-3311	2	50	baghdad	baghdad	PROPN
iajs-3311	2	51	,	,	PUNCT
iajs-3311	2	52	baghdad	baghdad	PROPN
iajs-3311	2	53	,	,	PUNCT
iajs-3311	2	54	iraq	iraq	PROPN
iajs-3311	2	55	.	.	PUNCT
iajs-3311	3	1	2market	2market	NUM
iajs-3311	3	2	research	research	NOUN
iajs-3311	3	3	and	and	CCONJ
iajs-3311	3	4	consumer	consumer	NOUN
iajs-3311	3	5	protection	protection	NOUN
iajs-3311	3	6	,	,	PUNCT
iajs-3311	3	7	university	university	NOUN
iajs-3311	3	8	of	of	ADP
iajs-3311	3	9	baghdad	baghdad	PROPN
iajs-3311	3	10	,	,	PUNCT
iajs-3311	3	11	baghdad	baghdad	PROPN
iajs-3311	3	12	,	,	PUNCT
iajs-3311	3	13	iraq	iraq	PROPN
iajs-3311	3	14	.	.	PUNCT
iajs-3311	4	1	*	*	PUNCT
iajs-3311	4	2	corresponding	correspond	VERB
iajs-3311	4	3	author	author	NOUN
iajs-3311	4	4	.	.	PUNCT
iajs-3311	5	1	received	receive	VERB
iajs-3311	5	2	:	:	PUNCT
iajs-3311	5	3	5	5	NUM
iajs-3311	5	4	march	march	NOUN
iajs-3311	5	5	2023	2023	NUM
iajs-3311	5	6	accepted	accept	VERB
iajs-3311	5	7	:	:	PUNCT
iajs-3311	5	8	18	18	NUM
iajs-3311	5	9	may	may	PROPN
iajs-3311	5	10	2023	2023	NUM
iajs-3311	5	11	published	publish	VERB
iajs-3311	5	12	:	:	PUNCT
iajs-3311	5	13	20	20	NUM
iajs-3311	5	14	july	july	PROPN
iajs-3311	5	15	2024	2024	NUM
iajs-3311	5	16	doi.org/10.30526/37.3.3311	doi.org/10.30526/37.3.3311	NOUN
iajs-3311	5	17	abstract	abstract	ADP
iajs-3311	5	18	the	the	DET
iajs-3311	5	19	most	most	ADV
iajs-3311	5	20	prevalent	prevalent	ADJ
iajs-3311	5	21	form	form	NOUN
iajs-3311	5	22	of	of	ADP
iajs-3311	5	23	diabetes	diabetes	NOUN
iajs-3311	5	24	,	,	PUNCT
iajs-3311	5	25	type	type	NOUN
iajs-3311	5	26	2	2	NUM
iajs-3311	5	27	diabetes	diabetes	NOUN
iajs-3311	5	28	mellitus	mellitus	NOUN
iajs-3311	5	29	(	(	PUNCT
iajs-3311	5	30	t2	t2	NOUN
iajs-3311	5	31	dm	dm	PROPN
iajs-3311	5	32	)	)	PUNCT
iajs-3311	5	33	,	,	PUNCT
iajs-3311	5	34	is	be	AUX
iajs-3311	5	35	defined	define	VERB
iajs-3311	5	36	by	by	ADP
iajs-3311	5	37	hyperglycemia	hyperglycemia	NOUN
iajs-3311	5	38	in	in	ADP
iajs-3311	5	39	the	the	DET
iajs-3311	5	40	presence	presence	NOUN
iajs-3311	5	41	of	of	ADP
iajs-3311	5	42	hyperinsulinemia	hyperinsulinemia	NOUN
iajs-3311	5	43	,	,	PUNCT
iajs-3311	5	44	which	which	PRON
iajs-3311	5	45	is	be	AUX
iajs-3311	5	46	brought	bring	VERB
iajs-3311	5	47	on	on	ADP
iajs-3311	5	48	by	by	ADP
iajs-3311	5	49	insulin	insulin	NOUN
iajs-3311	5	50	resistance	resistance	NOUN
iajs-3311	5	51	and	and	CCONJ
iajs-3311	5	52	β	β	NOUN
iajs-3311	5	53	-	-	ADJ
iajs-3311	5	54	cell	cell	NOUN
iajs-3311	5	55	functional	functional	ADJ
iajs-3311	5	56	abnormalities	abnormality	NOUN
iajs-3311	5	57	of	of	ADP
iajs-3311	5	58	insulin	insulin	NOUN
iajs-3311	5	59	secretion	secretion	NOUN
iajs-3311	5	60	.	.	PUNCT
iajs-3311	6	1	the	the	DET
iajs-3311	6	2	work	work	NOUN
iajs-3311	6	3	aims	aim	VERB
iajs-3311	6	4	to	to	PART
iajs-3311	6	5	study	study	VERB
iajs-3311	6	6	the	the	DET
iajs-3311	6	7	association	association	NOUN
iajs-3311	6	8	of	of	ADP
iajs-3311	6	9	the	the	DET
iajs-3311	6	10	slc16a11	slc16a11	PROPN
iajs-3311	6	11	gene	gene	NOUN
iajs-3311	6	12	with	with	ADP
iajs-3311	6	13	t2	t2	NOUN
iajs-3311	6	14	dm	dm	NOUN
iajs-3311	6	15	;	;	PUNCT
iajs-3311	6	16	besides	besides	SCONJ
iajs-3311	6	17	the	the	DET
iajs-3311	6	18	50	50	NUM
iajs-3311	6	19	healthy	healthy	ADJ
iajs-3311	6	20	individuals	individual	NOUN
iajs-3311	6	21	who	who	PRON
iajs-3311	6	22	served	serve	VERB
iajs-3311	6	23	as	as	ADP
iajs-3311	6	24	the	the	DET
iajs-3311	6	25	control	control	NOUN
iajs-3311	6	26	group	group	NOUN
iajs-3311	6	27	,	,	PUNCT
iajs-3311	6	28	50	50	NUM
iajs-3311	6	29	diabetic	diabetic	ADJ
iajs-3311	6	30	patients	patient	NOUN
iajs-3311	6	31	also	also	ADV
iajs-3311	6	32	had	have	VERB
iajs-3311	6	33	their	their	PRON
iajs-3311	6	34	blood	blood	NOUN
iajs-3311	6	35	drawn	draw	VERB
iajs-3311	6	36	.	.	PUNCT
iajs-3311	7	1	participants	participant	NOUN
iajs-3311	7	2	were	be	AUX
iajs-3311	7	3	divided	divide	VERB
iajs-3311	7	4	into	into	ADP
iajs-3311	7	5	two	two	NUM
iajs-3311	7	6	groups	group	NOUN
iajs-3311	7	7	based	base	VERB
iajs-3311	7	8	on	on	ADP
iajs-3311	7	9	the	the	DET
iajs-3311	7	10	following	follow	VERB
iajs-3311	7	11	criteria	criterion	NOUN
iajs-3311	7	12	:	:	PUNCT
iajs-3311	7	13	a	a	DET
iajs-3311	7	14	control	control	NOUN
iajs-3311	7	15	group	group	NOUN
iajs-3311	7	16	consists	consist	VERB
iajs-3311	7	17	of	of	ADP
iajs-3311	7	18	50	50	NUM
iajs-3311	7	19	healthy	healthy	ADJ
iajs-3311	7	20	participants	participant	NOUN
iajs-3311	7	21	between	between	ADP
iajs-3311	7	22	the	the	DET
iajs-3311	7	23	ages	age	NOUN
iajs-3311	7	24	of	of	ADP
iajs-3311	7	25	20	20	NUM
iajs-3311	7	26	and	and	CCONJ
iajs-3311	7	27	70	70	NUM
iajs-3311	7	28	,	,	PUNCT
iajs-3311	7	29	while	while	SCONJ
iajs-3311	7	30	the	the	DET
iajs-3311	7	31	patient	patient	ADJ
iajs-3311	7	32	group	group	NOUN
iajs-3311	7	33	consists	consist	VERB
iajs-3311	7	34	of	of	ADP
iajs-3311	7	35	50	50	NUM
iajs-3311	7	36	participants	participant	NOUN
iajs-3311	7	37	who	who	PRON
iajs-3311	7	38	were	be	AUX
iajs-3311	7	39	diagnosed	diagnose	VERB
iajs-3311	7	40	with	with	ADP
iajs-3311	7	41	diabetes	diabetes	NOUN
iajs-3311	7	42	.	.	PUNCT
iajs-3311	8	1	the	the	DET
iajs-3311	8	2	patient	patient	ADJ
iajs-3311	8	3	group	group	NOUN
iajs-3311	8	4	had	have	VERB
iajs-3311	8	5	58	58	NUM
iajs-3311	8	6	%	%	NOUN
iajs-3311	8	7	male	male	NOUN
iajs-3311	8	8	and	and	CCONJ
iajs-3311	8	9	42	42	NUM
iajs-3311	8	10	%	%	NOUN
iajs-3311	8	11	female	female	ADJ
iajs-3311	8	12	participants	participant	NOUN
iajs-3311	8	13	,	,	PUNCT
iajs-3311	8	14	whereas	whereas	SCONJ
iajs-3311	8	15	the	the	DET
iajs-3311	8	16	control	control	NOUN
iajs-3311	8	17	group	group	NOUN
iajs-3311	8	18	had	have	VERB
iajs-3311	8	19	52	52	NUM
iajs-3311	8	20	%	%	NOUN
iajs-3311	8	21	male	male	NOUN
iajs-3311	8	22	and	and	CCONJ
iajs-3311	8	23	48	48	NUM
iajs-3311	8	24	%	%	NOUN
iajs-3311	8	25	female	female	ADJ
iajs-3311	8	26	participants	participant	NOUN
iajs-3311	8	27	.	.	PUNCT
iajs-3311	9	1	despite	despite	SCONJ
iajs-3311	9	2	the	the	DET
iajs-3311	9	3	fact	fact	NOUN
iajs-3311	9	4	that	that	SCONJ
iajs-3311	9	5	many	many	ADJ
iajs-3311	9	6	genetic	genetic	ADJ
iajs-3311	9	7	discoveries	discovery	NOUN
iajs-3311	9	8	are	be	AUX
iajs-3311	9	9	relatively	relatively	ADV
iajs-3311	9	10	recent	recent	ADJ
iajs-3311	9	11	and	and	CCONJ
iajs-3311	9	12	have	have	AUX
iajs-3311	9	13	not	not	PART
iajs-3311	9	14	yet	yet	ADV
iajs-3311	9	15	had	have	VERB
iajs-3311	9	16	a	a	DET
iajs-3311	9	17	significant	significant	ADJ
iajs-3311	9	18	impact	impact	NOUN
iajs-3311	9	19	on	on	ADP
iajs-3311	9	20	our	our	PRON
iajs-3311	9	21	understanding	understanding	NOUN
iajs-3311	9	22	of	of	ADP
iajs-3311	9	23	the	the	DET
iajs-3311	9	24	pathogenesis	pathogenesis	NOUN
iajs-3311	9	25	of	of	ADP
iajs-3311	9	26	diabetes	diabetes	NOUN
iajs-3311	9	27	,	,	PUNCT
iajs-3311	9	28	they	they	PRON
iajs-3311	9	29	have	have	AUX
iajs-3311	9	30	already	already	ADV
iajs-3311	9	31	made	make	VERB
iajs-3311	9	32	a	a	DET
iajs-3311	9	33	substantial	substantial	ADJ
iajs-3311	9	34	contribution	contribution	NOUN
iajs-3311	9	35	by	by	ADP
iajs-3311	9	36	revealing	reveal	VERB
iajs-3311	9	37	pathways	pathway	NOUN
iajs-3311	9	38	that	that	PRON
iajs-3311	9	39	could	could	AUX
iajs-3311	9	40	not	not	PART
iajs-3311	9	41	have	have	AUX
iajs-3311	9	42	been	be	AUX
iajs-3311	9	43	connected	connect	VERB
iajs-3311	9	44	to	to	ADP
iajs-3311	9	45	diabetes	diabetes	NOUN
iajs-3311	9	46	by	by	ADP
iajs-3311	9	47	presumptive	presumptive	ADJ
iajs-3311	9	48	models	model	NOUN
iajs-3311	9	49	that	that	PRON
iajs-3311	9	50	already	already	ADV
iajs-3311	9	51	exist	exist	VERB
iajs-3311	9	52	.	.	PUNCT
iajs-3311	10	1	nevertheless	nevertheless	ADV
iajs-3311	10	2	,	,	PUNCT
iajs-3311	10	3	it	it	PRON
iajs-3311	10	4	's	be	AUX
iajs-3311	10	5	critical	critical	ADJ
iajs-3311	10	6	to	to	PART
iajs-3311	10	7	remember	remember	VERB
iajs-3311	10	8	that	that	SCONJ
iajs-3311	10	9	diabetes	diabetes	NOUN
iajs-3311	10	10	is	be	AUX
iajs-3311	10	11	probably	probably	ADV
iajs-3311	10	12	a	a	DET
iajs-3311	10	13	far	far	ADV
iajs-3311	10	14	more	more	ADV
iajs-3311	10	15	complex	complex	ADJ
iajs-3311	10	16	condition	condition	NOUN
iajs-3311	10	17	than	than	ADP
iajs-3311	10	18	the	the	DET
iajs-3311	10	19	distinction	distinction	NOUN
iajs-3311	10	20	between	between	ADP
iajs-3311	10	21	t1	t1	PROPN
iajs-3311	10	22	dm	dm	NOUN
iajs-3311	10	23	and	and	CCONJ
iajs-3311	10	24	t2	t2	NOUN
iajs-3311	10	25	dm	dm	PROPN
iajs-3311	10	26	suggests	suggest	VERB
iajs-3311	10	27	.	.	PUNCT
iajs-3311	11	1	keywords	keyword	NOUN
iajs-3311	11	2	:	:	PUNCT
iajs-3311	11	3	slc16a11	slc16a11	NOUN
iajs-3311	11	4	,	,	PUNCT
iajs-3311	11	5	type	type	NOUN
iajs-3311	11	6	1	1	NUM
iajs-3311	11	7	diabetes	diabetes	NOUN
iajs-3311	11	8	mellitus	mellitus	NOUN
iajs-3311	11	9	,	,	PUNCT
iajs-3311	11	10	typs	typs	PROPN
iajs-3311	11	11	2	2	NUM
iajs-3311	11	12	diabetes	diabetes	NOUN
iajs-3311	11	13	mellitus	mellitus	NOUN
iajs-3311	11	14	,	,	PUNCT
iajs-3311	11	15	polymerase	polymerase	NOUN
iajs-3311	11	16	chain	chain	NOUN
iajs-3311	11	17	reaction	reaction	NOUN
iajs-3311	11	18	.	.	PUNCT
iajs-3311	12	1	1	1	X
iajs-3311	12	2	.	.	X
iajs-3311	12	3	introduction	introduction	NOUN
iajs-3311	12	4	diabetes	diabetes	NOUN
iajs-3311	12	5	mellitus	mellitus	NOUN
iajs-3311	12	6	(	(	PUNCT
iajs-3311	12	7	dm	dm	PROPN
iajs-3311	12	8	)	)	PUNCT
iajs-3311	12	9	,	,	PUNCT
iajs-3311	12	10	sometimes	sometimes	ADV
iajs-3311	12	11	known	know	VERB
iajs-3311	12	12	as	as	ADP
iajs-3311	12	13	diabetes	diabete	NOUN
iajs-3311	12	14	,	,	PUNCT
iajs-3311	12	15	is	be	AUX
iajs-3311	12	16	a	a	DET
iajs-3311	12	17	set	set	NOUN
iajs-3311	12	18	of	of	ADP
iajs-3311	12	19	metabolic	metabolic	NOUN
iajs-3311	12	20	illnesses	illness	NOUN
iajs-3311	12	21	characterized	characterize	VERB
iajs-3311	12	22	by	by	ADP
iajs-3311	12	23	excessive	excessive	ADJ
iajs-3311	12	24	blood	blood	NOUN
iajs-3311	12	25	sugar	sugar	NOUN
iajs-3311	12	26	levels	level	NOUN
iajs-3311	12	27	[	[	X
iajs-3311	12	28	1	1	NUM
iajs-3311	12	29	]	]	PUNCT
iajs-3311	12	30	.	.	PUNCT
iajs-3311	13	1	according	accord	VERB
iajs-3311	13	2	to	to	ADP
iajs-3311	13	3	the	the	DET
iajs-3311	13	4	world	world	PROPN
iajs-3311	13	5	health	health	NOUN
iajs-3311	13	6	organization	organization	NOUN
iajs-3311	13	7	(	(	PUNCT
iajs-3311	13	8	who	who	PRON
iajs-3311	13	9	,	,	PUNCT
iajs-3311	13	10	2021	2021	NUM
iajs-3311	13	11	)	)	PUNCT
iajs-3311	13	12	,	,	PUNCT
iajs-3311	13	13	dm	dm	PROPN
iajs-3311	13	14	is	be	AUX
iajs-3311	13	15	a	a	DET
iajs-3311	13	16	chronic	chronic	ADJ
iajs-3311	13	17	condition	condition	NOUN
iajs-3311	13	18	that	that	PRON
iajs-3311	13	19	occurs	occur	VERB
iajs-3311	13	20	when	when	SCONJ
iajs-3311	13	21	the	the	DET
iajs-3311	13	22	body	body	NOUN
iajs-3311	13	23	either	either	CCONJ
iajs-3311	13	24	produces	produce	VERB
iajs-3311	13	25	inadequate	inadequate	ADJ
iajs-3311	13	26	quantities	quantity	NOUN
iajs-3311	13	27	of	of	ADP
iajs-3311	13	28	insulin	insulin	NOUN
iajs-3311	13	29	or	or	CCONJ
iajs-3311	13	30	is	be	AUX
iajs-3311	13	31	unable	unable	ADJ
iajs-3311	13	32	to	to	PART
iajs-3311	13	33	use	use	VERB
iajs-3311	13	34	insulin	insulin	NOUN
iajs-3311	13	35	effectively	effectively	ADV
iajs-3311	13	36	.	.	PUNCT
iajs-3311	14	1	diabetes	diabetes	NOUN
iajs-3311	14	2	affects	affect	VERB
iajs-3311	14	3	metabolism	metabolism	NOUN
iajs-3311	14	4	by	by	ADP
iajs-3311	14	5	reducing	reduce	VERB
iajs-3311	14	6	glucose	glucose	NOUN
iajs-3311	14	7	levels	level	NOUN
iajs-3311	14	8	or	or	CCONJ
iajs-3311	14	9	impairing	impair	VERB
iajs-3311	14	10	the	the	DET
iajs-3311	14	11	body	body	NOUN
iajs-3311	14	12	's	's	PART
iajs-3311	14	13	ability	ability	NOUN
iajs-3311	14	14	to	to	PART
iajs-3311	14	15	regulate	regulate	VERB
iajs-3311	14	16	blood	blood	NOUN
iajs-3311	14	17	sugar	sugar	NOUN
iajs-3311	14	18	levels	level	NOUN
iajs-3311	14	19	owing	owe	VERB
iajs-3311	14	20	to	to	ADP
iajs-3311	14	21	inadequate	inadequate	ADJ
iajs-3311	14	22	insulin	insulin	NOUN
iajs-3311	14	23	secretion	secretion	NOUN
iajs-3311	14	24	or	or	CCONJ
iajs-3311	14	25	activity	activity	NOUN
iajs-3311	14	26	.	.	PUNCT
iajs-3311	15	1	amino	amino	ADJ
iajs-3311	15	2	acids	acid	NOUN
iajs-3311	15	3	,	,	PUNCT
iajs-3311	15	4	or	or	CCONJ
iajs-3311	15	5	carbohydrates	carbohydrate	NOUN
iajs-3311	15	6	,	,	PUNCT
iajs-3311	15	7	can	can	AUX
iajs-3311	15	8	be	be	AUX
iajs-3311	15	9	used	use	VERB
iajs-3311	15	10	to	to	PART
iajs-3311	15	11	make	make	VERB
iajs-3311	15	12	triglycerides	triglyceride	NOUN
iajs-3311	15	13	and	and	CCONJ
iajs-3311	15	14	fatty	fatty	NOUN
iajs-3311	15	15	acids	acid	NOUN
iajs-3311	15	16	.	.	PUNCT
iajs-3311	16	1	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3311	16	2	https://orcid.org/0000-0003-0697-7114	https://orcid.org/0000-0003-0697-7114	PROPN
iajs-3311	16	3	mailto:narjes.maged1205m@sc.uobaghdad.edu.iq	mailto:narjes.maged1205m@sc.uobaghdad.edu.iq	PROPN
iajs-3311	16	4	https://orcid.org/0000-0003-4315-5611	https://orcid.org/0000-0003-4315-5611	PROPN
iajs-3311	16	5	mailto:alia.sadon@yahoo.com	mailto:alia.sadon@yahoo.com	PROPN
iajs-3311	16	6	ihjpas	ihjpas	PROPN
iajs-3311	16	7	.	.	PUNCT
iajs-3311	17	1	2024	2024	NUM
iajs-3311	17	2	,	,	PUNCT
iajs-3311	17	3	37	37	NUM
iajs-3311	17	4	(	(	PUNCT
iajs-3311	17	5	3	3	NUM
iajs-3311	17	6	)	)	PUNCT
iajs-3311	17	7	255	255	NUM
iajs-3311	17	8	due	due	ADP
iajs-3311	17	9	to	to	ADP
iajs-3311	17	10	non	non	ADJ
iajs-3311	17	11	-	-	ADJ
iajs-3311	17	12	diabetic	diabetic	ADJ
iajs-3311	17	13	cells	cell	NOUN
iajs-3311	17	14	'	'	PART
iajs-3311	17	15	failure	failure	NOUN
iajs-3311	17	16	to	to	PART
iajs-3311	17	17	identify	identify	VERB
iajs-3311	17	18	blood	blood	NOUN
iajs-3311	17	19	glucose	glucose	NOUN
iajs-3311	17	20	absorption	absorption	NOUN
iajs-3311	17	21	,	,	PUNCT
iajs-3311	17	22	enzymes	enzyme	NOUN
iajs-3311	17	23	in	in	ADP
iajs-3311	17	24	the	the	DET
iajs-3311	17	25	pentose	pentose	NOUN
iajs-3311	17	26	phosphate	phosphate	NOUN
iajs-3311	17	27	,	,	PUNCT
iajs-3311	17	28	glycolytic	glycolytic	ADJ
iajs-3311	17	29	,	,	PUNCT
iajs-3311	17	30	and	and	CCONJ
iajs-3311	17	31	lipogenic	lipogenic	ADJ
iajs-3311	17	32	pathways	pathway	NOUN
iajs-3311	17	33	(	(	PUNCT
iajs-3311	17	34	ppp	ppp	NOUN
iajs-3311	17	35	)	)	PUNCT
iajs-3311	17	36	are	be	AUX
iajs-3311	17	37	blocked	block	VERB
iajs-3311	17	38	,	,	PUNCT
iajs-3311	17	39	with	with	ADP
iajs-3311	17	40	increased	increase	VERB
iajs-3311	17	41	gluconeogenic	gluconeogenic	ADJ
iajs-3311	17	42	,	,	PUNCT
iajs-3311	17	43	glycogenolytic	glycogenolytic	ADJ
iajs-3311	17	44	,	,	PUNCT
iajs-3311	17	45	and	and	CCONJ
iajs-3311	17	46	lipolytic	lipolytic	ADJ
iajs-3311	17	47	activity	activity	NOUN
iajs-3311	17	48	[	[	X
iajs-3311	17	49	2	2	NUM
iajs-3311	17	50	]	]	PUNCT
iajs-3311	17	51	.	.	PUNCT
iajs-3311	18	1	the	the	DET
iajs-3311	18	2	most	most	ADV
iajs-3311	18	3	common	common	ADJ
iajs-3311	18	4	form	form	NOUN
iajs-3311	18	5	of	of	ADP
iajs-3311	18	6	diabetes	diabetes	NOUN
iajs-3311	18	7	is	be	AUX
iajs-3311	18	8	type	type	NOUN
iajs-3311	18	9	2	2	NUM
iajs-3311	18	10	diabetes	diabetes	NOUN
iajs-3311	18	11	(	(	PUNCT
iajs-3311	18	12	t2	t2	NOUN
iajs-3311	18	13	dm	dm	PROPN
iajs-3311	18	14	)	)	PUNCT
iajs-3311	18	15	,	,	PUNCT
iajs-3311	18	16	called	call	VERB
iajs-3311	18	17	non	non	ADJ
iajs-3311	18	18	-	-	ADJ
iajs-3311	18	19	insulin	insulin	ADJ
iajs-3311	18	20	-	-	PUNCT
iajs-3311	18	21	dependent	dependent	ADJ
iajs-3311	18	22	diabetes	diabetes	NOUN
iajs-3311	18	23	mellitus	mellitus	NOUN
iajs-3311	18	24	or	or	CCONJ
iajs-3311	18	25	"	"	PUNCT
iajs-3311	18	26	adult	adult	NOUN
iajs-3311	18	27	-	-	PUNCT
iajs-3311	18	28	onset	onset	NOUN
iajs-3311	18	29	"	"	PUNCT
iajs-3311	18	30	diabetes	diabetes	NOUN
iajs-3311	18	31	,	,	PUNCT
iajs-3311	18	32	so	so	ADV
iajs-3311	18	33	-	-	PUNCT
iajs-3311	18	34	called	call	VERB
iajs-3311	18	35	because	because	SCONJ
iajs-3311	18	36	it	it	PRON
iajs-3311	18	37	typically	typically	ADV
iajs-3311	18	38	develops	develop	VERB
iajs-3311	18	39	in	in	ADP
iajs-3311	18	40	adults	adult	NOUN
iajs-3311	18	41	over	over	ADP
iajs-3311	18	42	age	age	NOUN
iajs-3311	18	43	35	35	NUM
iajs-3311	18	44	.	.	PUNCT
iajs-3311	19	1	however	however	ADV
iajs-3311	19	2	,	,	PUNCT
iajs-3311	19	3	it	it	PRON
iajs-3311	19	4	can	can	AUX
iajs-3311	19	5	develop	develop	VERB
iajs-3311	19	6	at	at	ADP
iajs-3311	19	7	any	any	DET
iajs-3311	19	8	age	age	NOUN
iajs-3311	19	9	[	[	X
iajs-3311	19	10	3	3	NUM
iajs-3311	19	11	]	]	PUNCT
iajs-3311	19	12	.	.	PUNCT
iajs-3311	20	1	t2	t2	PROPN
iajs-3311	20	2	dm	dm	PROPN
iajs-3311	20	3	is	be	AUX
iajs-3311	20	4	caused	cause	VERB
iajs-3311	20	5	by	by	ADP
iajs-3311	20	6	islet	islet	NOUN
iajs-3311	20	7	cell	cell	NOUN
iajs-3311	20	8	dysfunction	dysfunction	NOUN
iajs-3311	20	9	,	,	PUNCT
iajs-3311	20	10	which	which	PRON
iajs-3311	20	11	is	be	AUX
iajs-3311	20	12	caused	cause	VERB
iajs-3311	20	13	by	by	ADP
iajs-3311	20	14	a	a	DET
iajs-3311	20	15	combination	combination	NOUN
iajs-3311	20	16	of	of	ADP
iajs-3311	20	17	two	two	NUM
iajs-3311	20	18	primary	primary	ADJ
iajs-3311	20	19	factors	factor	NOUN
iajs-3311	20	20	:	:	PUNCT
iajs-3311	20	21	the	the	DET
iajs-3311	20	22	failure	failure	NOUN
iajs-3311	20	23	of	of	ADP
iajs-3311	20	24	insulin	insulin	NOUN
iajs-3311	20	25	-	-	PUNCT
iajs-3311	20	26	sensitive	sensitive	ADJ
iajs-3311	20	27	organs	organ	NOUN
iajs-3311	20	28	to	to	PART
iajs-3311	20	29	respond	respond	VERB
iajs-3311	20	30	to	to	ADP
iajs-3311	20	31	insulin	insulin	NOUN
iajs-3311	20	32	and	and	CCONJ
iajs-3311	20	33	defective	defective	ADJ
iajs-3311	20	34	insulin	insulin	NOUN
iajs-3311	20	35	production	production	NOUN
iajs-3311	20	36	by	by	ADP
iajs-3311	20	37	pancreatic	pancreatic	ADJ
iajs-3311	20	38	islet	islet	NOUN
iajs-3311	20	39	cells	cell	NOUN
iajs-3311	20	40	.	.	PUNCT
iajs-3311	21	1	a	a	DET
iajs-3311	21	2	persistent	persistent	ADJ
iajs-3311	21	3	dysregulation	dysregulation	NOUN
iajs-3311	21	4	of	of	ADP
iajs-3311	21	5	the	the	DET
iajs-3311	21	6	hyperglycemia	hyperglycemia	NOUN
iajs-3311	21	7	state	state	NOUN
iajs-3311	21	8	caused	cause	VERB
iajs-3311	21	9	by	by	ADP
iajs-3311	21	10	an	an	DET
iajs-3311	21	11	insufficient	insufficient	ADJ
iajs-3311	21	12	compensatory	compensatory	ADJ
iajs-3311	21	13	insulin	insulin	NOUN
iajs-3311	21	14	secretory	secretory	ADJ
iajs-3311	21	15	system	system	NOUN
iajs-3311	21	16	may	may	AUX
iajs-3311	21	17	increase	increase	VERB
iajs-3311	21	18	the	the	DET
iajs-3311	21	19	risk	risk	NOUN
iajs-3311	21	20	of	of	ADP
iajs-3311	21	21	heart	heart	NOUN
iajs-3311	21	22	,	,	PUNCT
iajs-3311	21	23	vasculature	vasculature	NOUN
iajs-3311	21	24	,	,	PUNCT
iajs-3311	21	25	eyes	eye	NOUN
iajs-3311	21	26	,	,	PUNCT
iajs-3311	21	27	kidneys	kidney	NOUN
iajs-3311	21	28	,	,	PUNCT
iajs-3311	21	29	and	and	CCONJ
iajs-3311	21	30	nerve	nerve	NOUN
iajs-3311	21	31	diseases	disease	NOUN
iajs-3311	21	32	[	[	X
iajs-3311	21	33	4	4	NUM
iajs-3311	21	34	]	]	PUNCT
iajs-3311	21	35	.	.	PUNCT
iajs-3311	22	1	genetic	genetic	ADJ
iajs-3311	22	2	and	and	CCONJ
iajs-3311	22	3	environmental	environmental	ADJ
iajs-3311	22	4	factors	factor	NOUN
iajs-3311	22	5	can	can	AUX
iajs-3311	22	6	contribute	contribute	VERB
iajs-3311	22	7	to	to	ADP
iajs-3311	22	8	the	the	DET
iajs-3311	22	9	clinical	clinical	ADJ
iajs-3311	22	10	picture	picture	NOUN
iajs-3311	22	11	of	of	ADP
iajs-3311	22	12	t2	t2	NOUN
iajs-3311	22	13	dm	dm	X
iajs-3311	23	1	[	[	X
iajs-3311	23	2	5	5	NUM
iajs-3311	23	3	]	]	PUNCT
iajs-3311	23	4	.	.	PUNCT
iajs-3311	24	1	changes	change	NOUN
iajs-3311	24	2	in	in	ADP
iajs-3311	24	3	specific	specific	ADJ
iajs-3311	24	4	substrates	substrate	NOUN
iajs-3311	24	5	of	of	ADP
iajs-3311	24	6	particular	particular	ADJ
iajs-3311	24	7	proteins	protein	NOUN
iajs-3311	24	8	and	and	CCONJ
iajs-3311	24	9	transports	transport	NOUN
iajs-3311	24	10	,	,	PUNCT
iajs-3311	24	11	such	such	ADJ
iajs-3311	24	12	as	as	ADP
iajs-3311	24	13	the	the	DET
iajs-3311	24	14	14	14	NUM
iajs-3311	24	15	-	-	PUNCT
iajs-3311	24	16	membered	membere	VERB
iajs-3311	24	17	monocarboxylate	monocarboxylate	ADJ
iajs-3311	24	18	transporter	transporter	NOUN
iajs-3311	24	19	(	(	PUNCT
iajs-3311	24	20	mct	mct	PROPN
iajs-3311	24	21	)	)	PUNCT
iajs-3311	24	22	family	family	NOUN
iajs-3311	24	23	,	,	PUNCT
iajs-3311	24	24	which	which	PRON
iajs-3311	24	25	is	be	AUX
iajs-3311	24	26	defined	define	VERB
iajs-3311	24	27	by	by	ADP
iajs-3311	24	28	two	two	NUM
iajs-3311	24	29	highly	highly	ADV
iajs-3311	24	30	conserved	conserved	ADJ
iajs-3311	24	31	sequences	sequence	NOUN
iajs-3311	24	32	,	,	PUNCT
iajs-3311	24	33	can	can	AUX
iajs-3311	24	34	play	play	VERB
iajs-3311	24	35	vital	vital	ADJ
iajs-3311	24	36	roles	role	NOUN
iajs-3311	24	37	in	in	ADP
iajs-3311	24	38	most	most	ADJ
iajs-3311	24	39	cellular	cellular	ADJ
iajs-3311	24	40	functions	function	NOUN
iajs-3311	24	41	in	in	ADP
iajs-3311	24	42	the	the	DET
iajs-3311	24	43	pathophysiology	pathophysiology	NOUN
iajs-3311	24	44	of	of	ADP
iajs-3311	24	45	diabetes	diabetes	NOUN
iajs-3311	24	46	and	and	CCONJ
iajs-3311	24	47	cancer	cancer	NOUN
iajs-3311	25	1	[	[	X
iajs-3311	25	2	6	6	NUM
iajs-3311	25	3	]	]	PUNCT
iajs-3311	25	4	.	.	PUNCT
iajs-3311	26	1	members	member	NOUN
iajs-3311	26	2	of	of	ADP
iajs-3311	26	3	that	that	DET
iajs-3311	26	4	family	family	NOUN
iajs-3311	26	5	include	include	VERB
iajs-3311	26	6	mct1	mct1	PROPN
iajs-3311	26	7	(	(	PUNCT
iajs-3311	26	8	slc16a1	slc16a1	PROPN
iajs-3311	26	9	)	)	PUNCT
iajs-3311	26	10	,	,	PUNCT
iajs-3311	26	11	mct4	mct4	PROPN
iajs-3311	26	12	(	(	PUNCT
iajs-3311	26	13	slc16a3	slc16a3	PROPN
iajs-3311	26	14	)	)	PUNCT
iajs-3311	26	15	,	,	PUNCT
iajs-3311	26	16	and	and	CCONJ
iajs-3311	26	17	mct11	mct11	PROPN
iajs-3311	26	18	(	(	PUNCT
iajs-3311	26	19	slc16a11	slc16a11	NOUN
iajs-3311	26	20	)	)	PUNCT
iajs-3311	26	21	.	.	PUNCT
iajs-3311	27	1	despite	despite	SCONJ
iajs-3311	27	2	their	their	PRON
iajs-3311	27	3	structural	structural	ADJ
iajs-3311	27	4	similarity	similarity	NOUN
iajs-3311	27	5	,	,	PUNCT
iajs-3311	27	6	members	member	NOUN
iajs-3311	27	7	of	of	ADP
iajs-3311	27	8	the	the	DET
iajs-3311	27	9	slc16	slc16	PROPN
iajs-3311	27	10	family	family	NOUN
iajs-3311	27	11	mediate	mediate	VERB
iajs-3311	27	12	the	the	DET
iajs-3311	27	13	transport	transport	NOUN
iajs-3311	27	14	of	of	ADP
iajs-3311	27	15	various	various	ADJ
iajs-3311	27	16	substances	substance	NOUN
iajs-3311	27	17	through	through	ADP
iajs-3311	27	18	two	two	NUM
iajs-3311	27	19	separate	separate	ADJ
iajs-3311	27	20	active	active	ADJ
iajs-3311	27	21	methods	method	NOUN
iajs-3311	27	22	based	base	VERB
iajs-3311	27	23	on	on	ADP
iajs-3311	27	24	their	their	PRON
iajs-3311	27	25	function	function	NOUN
iajs-3311	27	26	.	.	PUNCT
iajs-3311	28	1	slc16a11	slc16a11	PROPN
iajs-3311	28	2	can	can	AUX
iajs-3311	28	3	be	be	AUX
iajs-3311	28	4	expressed	express	VERB
iajs-3311	28	5	in	in	ADP
iajs-3311	28	6	a	a	DET
iajs-3311	28	7	small	small	ADJ
iajs-3311	28	8	amount	amount	NOUN
iajs-3311	28	9	of	of	ADP
iajs-3311	28	10	human	human	ADJ
iajs-3311	28	11	tissue	tissue	NOUN
iajs-3311	28	12	,	,	PUNCT
iajs-3311	28	13	whereas	whereas	SCONJ
iajs-3311	28	14	the	the	DET
iajs-3311	28	15	highest	high	ADJ
iajs-3311	28	16	levels	level	NOUN
iajs-3311	28	17	can	can	AUX
iajs-3311	28	18	be	be	AUX
iajs-3311	28	19	found	find	VERB
iajs-3311	28	20	in	in	ADP
iajs-3311	28	21	the	the	DET
iajs-3311	28	22	thyroid	thyroid	NOUN
iajs-3311	28	23	,	,	PUNCT
iajs-3311	28	24	liver	liver	NOUN
iajs-3311	28	25	,	,	PUNCT
iajs-3311	28	26	and	and	CCONJ
iajs-3311	28	27	salivary	salivary	ADJ
iajs-3311	28	28	glands	gland	NOUN
iajs-3311	28	29	.	.	PUNCT
iajs-3311	29	1	it	it	PRON
iajs-3311	29	2	is	be	AUX
iajs-3311	29	3	a	a	DET
iajs-3311	29	4	member	member	NOUN
iajs-3311	29	5	of	of	ADP
iajs-3311	29	6	the	the	DET
iajs-3311	29	7	first	first	ADJ
iajs-3311	29	8	class	class	NOUN
iajs-3311	29	9	of	of	ADP
iajs-3311	29	10	slc16	slc16	PROPN
iajs-3311	29	11	participants	participant	NOUN
iajs-3311	29	12	(	(	PUNCT
iajs-3311	29	13	category	category	NOUN
iajs-3311	29	14	i	i	NOUN
iajs-3311	29	15	:	:	PUNCT
iajs-3311	29	16	mct1	mct1	PROPN
iajs-3311	29	17	and	and	CCONJ
iajs-3311	29	18	mct4	mct4	PROPN
iajs-3311	29	19	)	)	PUNCT
iajs-3311	29	20	,	,	PUNCT
iajs-3311	29	21	which	which	PRON
iajs-3311	29	22	use	use	VERB
iajs-3311	29	23	a	a	DET
iajs-3311	29	24	proton	proton	NOUN
iajs-3311	29	25	(	(	PUNCT
iajs-3311	29	26	h+)-coupled	h+)-couple	VERB
iajs-3311	29	27	mechanism	mechanism	NOUN
iajs-3311	29	28	to	to	PART
iajs-3311	29	29	transport	transport	VERB
iajs-3311	29	30	essential	essential	ADJ
iajs-3311	29	31	monocarboxylic	monocarboxylic	ADJ
iajs-3311	29	32	acids	acid	NOUN
iajs-3311	29	33	,	,	PUNCT
iajs-3311	29	34	including	include	VERB
iajs-3311	29	35	lactate	lactate	NOUN
iajs-3311	29	36	,	,	PUNCT
iajs-3311	29	37	pyruvate	pyruvate	NOUN
iajs-3311	29	38	,	,	PUNCT
iajs-3311	29	39	and	and	CCONJ
iajs-3311	29	40	ketone	ketone	NOUN
iajs-3311	29	41	bodies	body	NOUN
iajs-3311	29	42	.	.	PUNCT
iajs-3311	30	1	additionally	additionally	ADV
iajs-3311	30	2	,	,	PUNCT
iajs-3311	30	3	mct11	mct11	PROPN
iajs-3311	30	4	may	may	AUX
iajs-3311	30	5	function	function	VERB
iajs-3311	30	6	as	as	ADP
iajs-3311	30	7	a	a	DET
iajs-3311	30	8	monocarboxylate	monocarboxylate	ADJ
iajs-3311	30	9	transporter	transporter	NOUN
iajs-3311	30	10	linked	link	VERB
iajs-3311	30	11	to	to	ADP
iajs-3311	30	12	the	the	DET
iajs-3311	30	13	proton	proton	NOUN
iajs-3311	30	14	[	[	X
iajs-3311	30	15	7	7	NUM
iajs-3311	30	16	]	]	PUNCT
iajs-3311	30	17	.	.	PUNCT
iajs-3311	31	1	a	a	DET
iajs-3311	31	2	positive	positive	ADJ
iajs-3311	31	3	genetic	genetic	ADJ
iajs-3311	31	4	correlation	correlation	NOUN
iajs-3311	31	5	between	between	ADP
iajs-3311	31	6	t2	t2	PROPN
iajs-3311	31	7	dm	dm	PROPN
iajs-3311	31	8	and	and	CCONJ
iajs-3311	31	9	dna	dna	PROPN
iajs-3311	31	10	polymorphisms	polymorphism	NOUN
iajs-3311	31	11	was	be	AUX
iajs-3311	31	12	observed	observe	VERB
iajs-3311	31	13	in	in	ADP
iajs-3311	31	14	the	the	DET
iajs-3311	31	15	slc16a11	slc16a11	NOUN
iajs-3311	31	16	coding	code	VERB
iajs-3311	31	17	area	area	NOUN
iajs-3311	31	18	.	.	PUNCT
iajs-3311	32	1	it	it	PRON
iajs-3311	32	2	is	be	AUX
iajs-3311	32	3	debatable	debatable	ADJ
iajs-3311	32	4	,	,	PUNCT
iajs-3311	32	5	nonetheless	nonetheless	ADV
iajs-3311	32	6	,	,	PUNCT
iajs-3311	32	7	how	how	SCONJ
iajs-3311	32	8	these	these	DET
iajs-3311	32	9	t2	t2	NOUN
iajs-3311	32	10	dm	dm	PROPN
iajs-3311	32	11	variations	variation	NOUN
iajs-3311	32	12	impact	impact	NOUN
iajs-3311	32	13	slc16a11	slc16a11	PROPN
iajs-3311	32	14	's	's	PART
iajs-3311	32	15	functionality	functionality	NOUN
iajs-3311	33	1	[	[	X
iajs-3311	33	2	8	8	NUM
iajs-3311	33	3	]	]	PUNCT
iajs-3311	33	4	.	.	PUNCT
iajs-3311	34	1	solute	solute	ADJ
iajs-3311	34	2	carrier	carrier	NOUN
iajs-3311	34	3	(	(	PUNCT
iajs-3311	34	4	slc	slc	PROPN
iajs-3311	34	5	)	)	PUNCT
iajs-3311	34	6	16a11	16a11	NOUN
iajs-3311	34	7	has	have	AUX
iajs-3311	34	8	been	be	AUX
iajs-3311	34	9	identified	identify	VERB
iajs-3311	34	10	as	as	ADP
iajs-3311	34	11	a	a	DET
iajs-3311	34	12	t2	t2	NOUN
iajs-3311	34	13	dm	dm	NOUN
iajs-3311	34	14	risk	risk	NOUN
iajs-3311	34	15	gene	gene	NOUN
iajs-3311	34	16	.	.	PUNCT
iajs-3311	35	1	slc16a11	slc16a11	NOUN
iajs-3311	35	2	's	's	PART
iajs-3311	35	3	physiological	physiological	ADJ
iajs-3311	35	4	role	role	NOUN
iajs-3311	35	5	has	have	AUX
iajs-3311	35	6	not	not	PART
iajs-3311	35	7	yet	yet	ADV
iajs-3311	35	8	been	be	AUX
iajs-3311	35	9	determined	determine	VERB
iajs-3311	35	10	.	.	PUNCT
iajs-3311	36	1	however	however	ADV
iajs-3311	36	2	,	,	PUNCT
iajs-3311	36	3	how	how	SCONJ
iajs-3311	36	4	these	these	DET
iajs-3311	36	5	slc16a11	slc16a11	NOUN
iajs-3311	36	6	variants	variant	NOUN
iajs-3311	36	7	affect	affect	VERB
iajs-3311	36	8	people	people	NOUN
iajs-3311	36	9	with	with	ADP
iajs-3311	36	10	t2	t2	NOUN
iajs-3311	36	11	dm	dm	PROPN
iajs-3311	36	12	remains	remain	VERB
iajs-3311	36	13	unknown	unknown	ADJ
iajs-3311	36	14	.	.	PUNCT
iajs-3311	37	1	the	the	DET
iajs-3311	37	2	blood	blood	NOUN
iajs-3311	37	3	lipids	lipid	NOUN
iajs-3311	37	4	were	be	AUX
iajs-3311	37	5	particularly	particularly	ADV
iajs-3311	37	6	impacted	impact	VERB
iajs-3311	37	7	by	by	ADP
iajs-3311	37	8	the	the	DET
iajs-3311	37	9	slc16a11	slc16a11	PROPN
iajs-3311	37	10	genotype	genotype	NOUN
iajs-3311	37	11	when	when	SCONJ
iajs-3311	37	12	it	it	PRON
iajs-3311	37	13	came	come	VERB
iajs-3311	37	14	to	to	ADP
iajs-3311	37	15	t2	t2	NOUN
iajs-3311	37	16	dm	dm	PROPN
iajs-3311	37	17	laboratory	laboratory	NOUN
iajs-3311	37	18	parameter	parameter	NOUN
iajs-3311	37	19	values	value	NOUN
iajs-3311	37	20	.	.	PUNCT
iajs-3311	38	1	lipid	lipid	ADJ
iajs-3311	38	2	metabolism	metabolism	NOUN
iajs-3311	38	3	may	may	AUX
iajs-3311	38	4	be	be	AUX
iajs-3311	38	5	involved	involve	VERB
iajs-3311	38	6	in	in	ADP
iajs-3311	38	7	slc16a11	slc16a11	NOUN
iajs-3311	38	8	's	's	PART
iajs-3311	38	9	function	function	NOUN
iajs-3311	38	10	[	[	X
iajs-3311	38	11	9	9	NUM
iajs-3311	38	12	]	]	PUNCT
iajs-3311	38	13	.	.	PUNCT
iajs-3311	39	1	this	this	DET
iajs-3311	39	2	study	study	NOUN
iajs-3311	39	3	was	be	AUX
iajs-3311	39	4	designed	design	VERB
iajs-3311	39	5	to	to	PART
iajs-3311	39	6	look	look	VERB
iajs-3311	39	7	at	at	ADP
iajs-3311	39	8	the	the	DET
iajs-3311	39	9	relationship	relationship	NOUN
iajs-3311	39	10	between	between	ADP
iajs-3311	39	11	the	the	DET
iajs-3311	39	12	slc16a11	slc16a11	NOUN
iajs-3311	39	13	gene	gene	NOUN
iajs-3311	39	14	and	and	CCONJ
iajs-3311	39	15	t2	t2	NOUN
iajs-3311	39	16	dm	dm	PROPN
iajs-3311	39	17	.	.	PROPN
iajs-3311	39	18	2	2	NUM
iajs-3311	39	19	.	.	X
iajs-3311	39	20	materials	material	NOUN
iajs-3311	39	21	and	and	CCONJ
iajs-3311	39	22	methods	method	NOUN
iajs-3311	39	23	2.1	2.1	NUM
iajs-3311	39	24	study	study	NOUN
iajs-3311	39	25	design	design	NOUN
iajs-3311	39	26	in	in	ADP
iajs-3311	39	27	this	this	DET
iajs-3311	39	28	study	study	NOUN
iajs-3311	39	29	,	,	PUNCT
iajs-3311	39	30	it	it	PRON
iajs-3311	39	31	has	have	AUX
iajs-3311	39	32	been	be	AUX
iajs-3311	39	33	selected	select	VERB
iajs-3311	39	34	two	two	NUM
iajs-3311	39	35	groups	group	NOUN
iajs-3311	39	36	of	of	ADP
iajs-3311	39	37	participants	participant	NOUN
iajs-3311	39	38	.	.	PUNCT
iajs-3311	40	1	the	the	DET
iajs-3311	40	2	first	first	ADJ
iajs-3311	40	3	group	group	NOUN
iajs-3311	40	4	includes	include	VERB
iajs-3311	40	5	t2	t2	NOUN
iajs-3311	40	6	dm	dm	NOUN
iajs-3311	40	7	patients	patient	NOUN
iajs-3311	40	8	,	,	PUNCT
iajs-3311	40	9	and	and	CCONJ
iajs-3311	40	10	the	the	DET
iajs-3311	40	11	control	control	NOUN
iajs-3311	40	12	group	group	NOUN
iajs-3311	40	13	comprises	comprise	VERB
iajs-3311	40	14	healthy	healthy	ADJ
iajs-3311	40	15	people	people	NOUN
iajs-3311	40	16	.	.	PUNCT
iajs-3311	41	1	the	the	DET
iajs-3311	41	2	current	current	ADJ
iajs-3311	41	3	work	work	NOUN
iajs-3311	41	4	was	be	AUX
iajs-3311	41	5	completed	complete	VERB
iajs-3311	41	6	in	in	ADP
iajs-3311	41	7	the	the	DET
iajs-3311	41	8	biochemistry	biochemistry	NOUN
iajs-3311	41	9	department	department	NOUN
iajs-3311	41	10	lab	lab	NOUN
iajs-3311	41	11	at	at	ADP
iajs-3311	41	12	the	the	DET
iajs-3311	41	13	college	college	NOUN
iajs-3311	41	14	of	of	ADP
iajs-3311	41	15	sciences	sciences	PROPN
iajs-3311	41	16	,	,	PUNCT
iajs-3311	41	17	university	university	NOUN
iajs-3311	41	18	of	of	ADP
iajs-3311	41	19	baghdad	baghdad	PROPN
iajs-3311	41	20	.	.	PUNCT
iajs-3311	42	1	it	it	PRON
iajs-3311	42	2	was	be	AUX
iajs-3311	42	3	intended	intend	VERB
iajs-3311	42	4	for	for	SCONJ
iajs-3311	42	5	sample	sample	NOUN
iajs-3311	42	6	collection	collection	NOUN
iajs-3311	42	7	to	to	PART
iajs-3311	42	8	happen	happen	VERB
iajs-3311	42	9	between	between	ADP
iajs-3311	42	10	september	september	PROPN
iajs-3311	42	11	2021	2021	NUM
iajs-3311	42	12	and	and	CCONJ
iajs-3311	42	13	january	january	PROPN
iajs-3311	42	14	2022	2022	NUM
iajs-3311	42	15	.	.	PUNCT
iajs-3311	43	1	patients	patient	NOUN
iajs-3311	43	2	group	group	NOUN
iajs-3311	43	3	;	;	PUNCT
iajs-3311	43	4	at	at	ADP
iajs-3311	43	5	the	the	DET
iajs-3311	43	6	diabetes	diabetes	NOUN
iajs-3311	43	7	and	and	CCONJ
iajs-3311	43	8	endocrinology	endocrinology	NOUN
iajs-3311	43	9	center	center	NOUN
iajs-3311	43	10	in	in	ADP
iajs-3311	43	11	baghdad	baghdad	PROPN
iajs-3311	43	12	,	,	PUNCT
iajs-3311	43	13	iraq	iraq	PROPN
iajs-3311	43	14	,	,	PUNCT
iajs-3311	43	15	50	50	NUM
iajs-3311	43	16	individuals	individual	NOUN
iajs-3311	43	17	with	with	ADP
iajs-3311	43	18	t2	t2	NOUN
iajs-3311	43	19	dm	dm	PROPN
iajs-3311	43	20	were	be	AUX
iajs-3311	43	21	hospitalized	hospitalize	VERB
iajs-3311	43	22	.	.	PUNCT
iajs-3311	44	1	the	the	DET
iajs-3311	44	2	control	control	PROPN
iajs-3311	44	3	group	group	NOUN
iajs-3311	44	4	consisted	consist	VERB
iajs-3311	44	5	of	of	ADP
iajs-3311	44	6	50	50	NUM
iajs-3311	44	7	people	people	NOUN
iajs-3311	44	8	who	who	PRON
iajs-3311	44	9	appeared	appear	VERB
iajs-3311	44	10	to	to	PART
iajs-3311	44	11	be	be	AUX
iajs-3311	44	12	in	in	ADP
iajs-3311	44	13	good	good	ADJ
iajs-3311	44	14	health	health	NOUN
iajs-3311	44	15	.	.	PUNCT
iajs-3311	45	1	both	both	CCONJ
iajs-3311	45	2	the	the	DET
iajs-3311	45	3	patient	patient	ADJ
iajs-3311	45	4	and	and	CCONJ
iajs-3311	45	5	control	control	NOUN
iajs-3311	45	6	groups	group	NOUN
iajs-3311	45	7	included	include	VERB
iajs-3311	45	8	members	member	NOUN
iajs-3311	45	9	of	of	ADP
iajs-3311	45	10	the	the	DET
iajs-3311	45	11	same	same	ADJ
iajs-3311	45	12	ethnic	ethnic	ADJ
iajs-3311	45	13	group	group	NOUN
iajs-3311	45	14	.	.	PUNCT
iajs-3311	46	1	ihjpas	ihjpas	PROPN
iajs-3311	46	2	.	.	PUNCT
iajs-3311	47	1	2024	2024	NUM
iajs-3311	47	2	,	,	PUNCT
iajs-3311	47	3	37	37	NUM
iajs-3311	47	4	(	(	PUNCT
iajs-3311	47	5	3	3	NUM
iajs-3311	47	6	)	)	PUNCT
iajs-3311	47	7	256	256	NUM
iajs-3311	47	8	2.2	2.2	NUM
iajs-3311	47	9	exclusion	exclusion	NOUN
iajs-3311	47	10	criteria	criterion	NOUN
iajs-3311	47	11	t1	t1	NOUN
iajs-3311	47	12	dm	dm	NOUN
iajs-3311	47	13	,	,	PUNCT
iajs-3311	47	14	diabetes	diabetes	NOUN
iajs-3311	47	15	with	with	ADP
iajs-3311	47	16	a	a	DET
iajs-3311	47	17	duration	duration	NOUN
iajs-3311	47	18	of	of	ADP
iajs-3311	47	19	>	>	DET
iajs-3311	47	20	20	20	NUM
iajs-3311	47	21	and	and	CCONJ
iajs-3311	47	22	5	5	NUM
iajs-3311	47	23	,	,	PUNCT
iajs-3311	47	24	age	age	NOUN
iajs-3311	47	25	>	>	X
iajs-3311	47	26	60	60	NUM
iajs-3311	47	27	and	and	CCONJ
iajs-3311	47	28	40	40	NUM
iajs-3311	47	29	,	,	PUNCT
iajs-3311	47	30	smoking	smoking	NOUN
iajs-3311	47	31	,	,	PUNCT
iajs-3311	47	32	renal	renal	ADJ
iajs-3311	47	33	failure	failure	NOUN
iajs-3311	47	34	,	,	PUNCT
iajs-3311	47	35	thyroid	thyroid	NOUN
iajs-3311	47	36	illness	illness	NOUN
iajs-3311	47	37	,	,	PUNCT
iajs-3311	47	38	malignant	malignant	ADJ
iajs-3311	47	39	disease	disease	NOUN
iajs-3311	47	40	,	,	PUNCT
iajs-3311	47	41	hepatic	hepatic	ADJ
iajs-3311	47	42	disease	disease	NOUN
iajs-3311	47	43	,	,	PUNCT
iajs-3311	47	44	pregnant	pregnant	ADJ
iajs-3311	47	45	women	woman	NOUN
iajs-3311	47	46	,	,	PUNCT
iajs-3311	47	47	and	and	CCONJ
iajs-3311	47	48	medications	medication	NOUN
iajs-3311	47	49	with	with	ADP
iajs-3311	47	50	a	a	DET
iajs-3311	47	51	proven	proven	ADJ
iajs-3311	47	52	effect	effect	NOUN
iajs-3311	47	53	on	on	ADP
iajs-3311	47	54	bone	bone	NOUN
iajs-3311	47	55	metabolism	metabolism	NOUN
iajs-3311	47	56	such	such	ADJ
iajs-3311	47	57	as	as	ADP
iajs-3311	47	58	anticonvulsants	anticonvulsant	NOUN
iajs-3311	47	59	,	,	PUNCT
iajs-3311	47	60	heparin	heparin	ADJ
iajs-3311	47	61	sodium	sodium	NOUN
iajs-3311	47	62	,	,	PUNCT
iajs-3311	47	63	and	and	CCONJ
iajs-3311	47	64	corticosteroids	corticosteroid	NOUN
iajs-3311	47	65	,	,	PUNCT
iajs-3311	47	66	were	be	AUX
iajs-3311	47	67	excluded	exclude	VERB
iajs-3311	47	68	.	.	PUNCT
iajs-3311	48	1	2.3	2.3	NUM
iajs-3311	48	2	definition	definition	NOUN
iajs-3311	48	3	of	of	ADP
iajs-3311	48	4	diabetic	diabetic	ADJ
iajs-3311	48	5	status	status	NOUN
iajs-3311	48	6	according	accord	VERB
iajs-3311	48	7	to	to	ADP
iajs-3311	48	8	the	the	DET
iajs-3311	48	9	american	american	ADJ
iajs-3311	48	10	diabetes	diabetes	PROPN
iajs-3311	48	11	association	association	PROPN
iajs-3311	48	12	(	(	PUNCT
iajs-3311	48	13	ada	ada	PROPN
iajs-3311	48	14	)	)	PUNCT
iajs-3311	49	1	[	[	X
iajs-3311	49	2	10	10	NUM
iajs-3311	49	3	]	]	PUNCT
iajs-3311	49	4	,	,	PUNCT
iajs-3311	49	5	for	for	ADP
iajs-3311	49	6	people	people	NOUN
iajs-3311	49	7	with	with	ADP
iajs-3311	49	8	diabetes	diabetes	NOUN
iajs-3311	49	9	,	,	PUNCT
iajs-3311	49	10	the	the	DET
iajs-3311	49	11	range	range	NOUN
iajs-3311	49	12	for	for	ADP
iajs-3311	49	13	the	the	DET
iajs-3311	49	14	hemoglobin	hemoglobin	NOUN
iajs-3311	49	15	a1c	a1c	PROPN
iajs-3311	49	16	(	(	PUNCT
iajs-3311	49	17	hba1c	hba1c	ADJ
iajs-3311	49	18	)	)	PUNCT
iajs-3311	49	19	level	level	NOUN
iajs-3311	49	20	is	be	AUX
iajs-3311	49	21	below	below	ADP
iajs-3311	49	22	6.5	6.5	NUM
iajs-3311	49	23	%	%	NOUN
iajs-3311	49	24	.	.	PUNCT
iajs-3311	50	1	these	these	DET
iajs-3311	50	2	people	people	NOUN
iajs-3311	50	3	have	have	VERB
iajs-3311	50	4	a	a	DET
iajs-3311	50	5	fasting	fast	VERB
iajs-3311	50	6	glucose	glucose	NOUN
iajs-3311	50	7	test	test	NOUN
iajs-3311	50	8	below	below	ADP
iajs-3311	50	9	126	126	NUM
iajs-3311	50	10	mg	mg	PROPN
iajs-3311	50	11	/	/	SYM
iajs-3311	50	12	dl	dl	PROPN
iajs-3311	50	13	or	or	CCONJ
iajs-3311	50	14	200	200	NUM
iajs-3311	50	15	mg	mg	PROPN
iajs-3311	50	16	/	/	SYM
iajs-3311	50	17	dl	dl	PROPN
iajs-3311	50	18	after	after	ADP
iajs-3311	50	19	fasting	fast	VERB
iajs-3311	50	20	for	for	ADP
iajs-3311	50	21	at	at	ADV
iajs-3311	50	22	least	least	ADV
iajs-3311	50	23	eight	eight	NUM
iajs-3311	50	24	hours	hour	NOUN
iajs-3311	50	25	.	.	PUNCT
iajs-3311	51	1	for	for	ADP
iajs-3311	51	2	people	people	NOUN
iajs-3311	51	3	without	without	ADP
iajs-3311	51	4	diabetes	diabetes	NOUN
iajs-3311	51	5	,	,	PUNCT
iajs-3311	51	6	the	the	DET
iajs-3311	51	7	normal	normal	ADJ
iajs-3311	51	8	range	range	NOUN
iajs-3311	51	9	for	for	ADP
iajs-3311	51	10	the	the	DET
iajs-3311	51	11	hba1c	hba1c	ADJ
iajs-3311	51	12	level	level	NOUN
iajs-3311	51	13	is	be	AUX
iajs-3311	51	14	below	below	ADP
iajs-3311	51	15	5.6	5.6	NUM
iajs-3311	51	16	%	%	NOUN
iajs-3311	51	17	,	,	PUNCT
iajs-3311	51	18	with	with	ADP
iajs-3311	51	19	a	a	DET
iajs-3311	51	20	fasting	fasting	NOUN
iajs-3311	51	21	length	length	NOUN
iajs-3311	51	22	of	of	ADP
iajs-3311	51	23	more	more	ADJ
iajs-3311	51	24	than	than	ADP
iajs-3311	51	25	eight	eight	NUM
iajs-3311	51	26	hours	hour	NOUN
iajs-3311	51	27	.	.	PUNCT
iajs-3311	52	1	these	these	DET
iajs-3311	52	2	people	people	NOUN
iajs-3311	52	3	have	have	VERB
iajs-3311	52	4	a	a	DET
iajs-3311	52	5	fasting	fast	VERB
iajs-3311	52	6	glucose	glucose	NOUN
iajs-3311	52	7	test	test	NOUN
iajs-3311	52	8	below	below	ADP
iajs-3311	52	9	100	100	NUM
iajs-3311	52	10	mg	mg	PROPN
iajs-3311	52	11	/	/	SYM
iajs-3311	52	12	dl	dl	PROPN
iajs-3311	52	13	and	and	CCONJ
iajs-3311	52	14	post	post	ADJ
iajs-3311	52	15	-	-	ADJ
iajs-3311	52	16	ogtt	ogtt	ADJ
iajs-3311	52	17	glucose	glucose	NOUN
iajs-3311	52	18	levels	level	NOUN
iajs-3311	52	19	under	under	ADP
iajs-3311	52	20	140	140	NUM
iajs-3311	52	21	mg	mg	PROPN
iajs-3311	52	22	/	/	SYM
iajs-3311	52	23	dl	dl	PROPN
iajs-3311	52	24	.	.	PUNCT
iajs-3311	53	1	the	the	DET
iajs-3311	53	2	statistical	statistical	ADJ
iajs-3311	53	3	analysis	analysis	NOUN
iajs-3311	53	4	did	do	AUX
iajs-3311	53	5	n't	not	PART
iajs-3311	53	6	include	include	VERB
iajs-3311	53	7	people	people	NOUN
iajs-3311	53	8	with	with	ADP
iajs-3311	53	9	pre	pre	ADJ
iajs-3311	53	10	-	-	ADJ
iajs-3311	53	11	diabetes	diabetes	ADJ
iajs-3311	53	12	intermediate	intermediate	ADJ
iajs-3311	53	13	phenotypes	phenotype	NOUN
iajs-3311	53	14	.	.	PUNCT
iajs-3311	54	1	because	because	SCONJ
iajs-3311	54	2	at	at	ADV
iajs-3311	54	3	least	least	ADV
iajs-3311	54	4	one	one	NUM
iajs-3311	54	5	diabetic	diabetic	ADJ
iajs-3311	54	6	autoantibody	autoantibody	NOUN
iajs-3311	54	7	characterizes	characterize	VERB
iajs-3311	54	8	t1	t1	PROPN
iajs-3311	54	9	dm	dm	PROPN
iajs-3311	54	10	,	,	PUNCT
iajs-3311	54	11	which	which	PRON
iajs-3311	54	12	is	be	AUX
iajs-3311	54	13	primarily	primarily	ADV
iajs-3311	54	14	an	an	DET
iajs-3311	54	15	autoimmune	autoimmune	ADJ
iajs-3311	54	16	condition	condition	NOUN
iajs-3311	54	17	(	(	PUNCT
iajs-3311	54	18	glutamic	glutamic	ADJ
iajs-3311	54	19	acid	acid	NOUN
iajs-3311	54	20	decarboxylase	decarboxylase	NOUN
iajs-3311	54	21	or	or	CCONJ
iajs-3311	54	22	insulinoma	insulinoma	NOUN
iajs-3311	54	23	-	-	PUNCT
iajs-3311	54	24	associated	associate	VERB
iajs-3311	54	25	antibody	antibody	NOUN
iajs-3311	54	26	)	)	PUNCT
iajs-3311	55	1	[	[	X
iajs-3311	55	2	11	11	NUM
iajs-3311	55	3	]	]	X
iajs-3311	55	4	;	;	PUNCT
iajs-3311	55	5	however	however	ADV
iajs-3311	55	6	,	,	PUNCT
iajs-3311	55	7	in	in	ADP
iajs-3311	55	8	the	the	DET
iajs-3311	55	9	current	current	ADJ
iajs-3311	55	10	literature	literature	NOUN
iajs-3311	55	11	,	,	PUNCT
iajs-3311	55	12	these	these	DET
iajs-3311	55	13	measures	measure	NOUN
iajs-3311	55	14	have	have	AUX
iajs-3311	55	15	not	not	PART
iajs-3311	55	16	been	be	AUX
iajs-3311	55	17	investigated	investigate	VERB
iajs-3311	55	18	in	in	ADP
iajs-3311	55	19	hchs	hchs	PROPN
iajs-3311	55	20	/	/	SYM
iajs-3311	55	21	sol	sol	NOUN
iajs-3311	55	22	.	.	PUNCT
iajs-3311	56	1	for	for	ADP
iajs-3311	56	2	the	the	DET
iajs-3311	56	3	sample	sample	NOUN
iajs-3311	56	4	employed	employ	VERB
iajs-3311	56	5	in	in	ADP
iajs-3311	56	6	the	the	DET
iajs-3311	56	7	same	same	ADJ
iajs-3311	56	8	study	study	NOUN
iajs-3311	56	9	,	,	PUNCT
iajs-3311	56	10	we	we	PRON
iajs-3311	56	11	were	be	AUX
iajs-3311	56	12	unable	unable	ADJ
iajs-3311	56	13	to	to	PART
iajs-3311	56	14	distinguish	distinguish	VERB
iajs-3311	56	15	t2	t2	NOUN
iajs-3311	56	16	dm	dm	NOUN
iajs-3311	56	17	from	from	ADP
iajs-3311	56	18	t1	t1	PROPN
iajs-3311	56	19	dm	dm	PROPN
iajs-3311	56	20	.	.	PUNCT
iajs-3311	57	1	furthermore	furthermore	ADV
iajs-3311	57	2	,	,	PUNCT
iajs-3311	57	3	research	research	NOUN
iajs-3311	57	4	indicates	indicate	VERB
iajs-3311	57	5	that	that	SCONJ
iajs-3311	57	6	the	the	DET
iajs-3311	57	7	age	age	NOUN
iajs-3311	57	8	at	at	ADP
iajs-3311	57	9	which	which	PRON
iajs-3311	57	10	t2	t2	NOUN
iajs-3311	57	11	dm	dm	PRON
iajs-3311	57	12	initially	initially	ADV
iajs-3311	57	13	appears	appear	VERB
iajs-3311	57	14	has	have	AUX
iajs-3311	57	15	lately	lately	ADV
iajs-3311	57	16	fallen	fall	VERB
iajs-3311	57	17	significantly	significantly	ADV
iajs-3311	57	18	,	,	PUNCT
iajs-3311	57	19	making	make	VERB
iajs-3311	57	20	it	it	PRON
iajs-3311	57	21	impossible	impossible	ADJ
iajs-3311	57	22	to	to	PART
iajs-3311	57	23	differentiate	differentiate	VERB
iajs-3311	57	24	between	between	ADP
iajs-3311	57	25	different	different	ADJ
iajs-3311	57	26	forms	form	NOUN
iajs-3311	57	27	of	of	ADP
iajs-3311	57	28	diabetes	diabetes	NOUN
iajs-3311	57	29	based	base	VERB
iajs-3311	57	30	on	on	ADP
iajs-3311	57	31	diagnosis	diagnosis	NOUN
iajs-3311	57	32	age	age	NOUN
iajs-3311	57	33	.	.	PUNCT
iajs-3311	58	1	in	in	ADP
iajs-3311	58	2	any	any	DET
iajs-3311	58	3	event	event	NOUN
iajs-3311	58	4	,	,	PUNCT
iajs-3311	58	5	given	give	VERB
iajs-3311	58	6	that	that	SCONJ
iajs-3311	58	7	only	only	ADV
iajs-3311	58	8	one	one	NUM
iajs-3311	58	9	of	of	ADP
iajs-3311	58	10	these	these	DET
iajs-3311	58	11	sample	sample	NOUN
iajs-3311	58	12	's	's	PART
iajs-3311	58	13	20	20	NUM
iajs-3311	58	14	–	–	PUNCT
iajs-3311	58	15	70	70	NUM
iajs-3311	58	16	-	-	PUNCT
iajs-3311	58	17	year	year	NOUN
iajs-3311	58	18	-	-	PUNCT
iajs-3311	58	19	old	old	ADJ
iajs-3311	58	20	participants	participant	NOUN
iajs-3311	58	21	could	could	AUX
iajs-3311	58	22	potentially	potentially	ADV
iajs-3311	58	23	have	have	AUX
iajs-3311	58	24	t1	t1	PROPN
iajs-3311	58	25	dm	dm	NUM
iajs-3311	58	26	based	base	VERB
iajs-3311	58	27	on	on	ADP
iajs-3311	58	28	the	the	DET
iajs-3311	58	29	use	use	NOUN
iajs-3311	58	30	of	of	ADP
iajs-3311	58	31	insulin	insulin	NOUN
iajs-3311	58	32	and	and	CCONJ
iajs-3311	58	33	that	that	SCONJ
iajs-3311	58	34	they	they	PRON
iajs-3311	58	35	were	be	AUX
iajs-3311	58	36	all	all	PRON
iajs-3311	58	37	included	include	VERB
iajs-3311	58	38	in	in	ADP
iajs-3311	58	39	our	our	PRON
iajs-3311	58	40	hchs	hchs	PROPN
iajs-3311	58	41	/	/	SYM
iajs-3311	58	42	sol	sol	NOUN
iajs-3311	58	43	sample	sample	NOUN
iajs-3311	58	44	,	,	PUNCT
iajs-3311	58	45	it	it	PRON
iajs-3311	58	46	does	do	AUX
iajs-3311	58	47	n't	not	PART
iajs-3311	58	48	seem	seem	VERB
iajs-3311	58	49	likely	likely	ADJ
iajs-3311	58	50	that	that	SCONJ
iajs-3311	58	51	removing	remove	VERB
iajs-3311	58	52	t1	t1	NOUN
iajs-3311	58	53	dm	dm	NOUN
iajs-3311	58	54	and	and	CCONJ
iajs-3311	58	55	t2	t2	NOUN
iajs-3311	58	56	dm	dm	PROPN
iajs-3311	58	57	will	will	AUX
iajs-3311	58	58	have	have	VERB
iajs-3311	58	59	a	a	DET
iajs-3311	58	60	significant	significant	ADJ
iajs-3311	58	61	impact	impact	NOUN
iajs-3311	58	62	on	on	ADP
iajs-3311	58	63	the	the	DET
iajs-3311	58	64	results	result	NOUN
iajs-3311	58	65	.	.	PUNCT
iajs-3311	59	1	2.4	2.4	NUM
iajs-3311	59	2	methods	method	NOUN
iajs-3311	59	3	when	when	SCONJ
iajs-3311	59	4	it	it	PRON
iajs-3311	59	5	is	be	AUX
iajs-3311	59	6	necessary	necessary	ADJ
iajs-3311	59	7	to	to	PART
iajs-3311	59	8	boost	boost	VERB
iajs-3311	59	9	the	the	DET
iajs-3311	59	10	sensitivity	sensitivity	NOUN
iajs-3311	59	11	and	and	CCONJ
iajs-3311	59	12	specificity	specificity	NOUN
iajs-3311	59	13	of	of	ADP
iajs-3311	59	14	pcr	pcr	NOUN
iajs-3311	59	15	,	,	PUNCT
iajs-3311	59	16	such	such	ADJ
iajs-3311	59	17	as	as	ADP
iajs-3311	59	18	when	when	SCONJ
iajs-3311	59	19	amplifying	amplify	VERB
iajs-3311	59	20	a	a	DET
iajs-3311	59	21	particular	particular	ADJ
iajs-3311	59	22	member	member	NOUN
iajs-3311	59	23	of	of	ADP
iajs-3311	59	24	a	a	DET
iajs-3311	59	25	polymorphic	polymorphic	ADJ
iajs-3311	59	26	gene	gene	NOUN
iajs-3311	59	27	family	family	NOUN
iajs-3311	59	28	or	or	CCONJ
iajs-3311	59	29	when	when	SCONJ
iajs-3311	59	30	creating	create	VERB
iajs-3311	59	31	a	a	DET
iajs-3311	59	32	cdna	cdna	PROPN
iajs-3311	59	33	copy	copy	NOUN
iajs-3311	59	34	of	of	ADP
iajs-3311	59	35	an	an	DET
iajs-3311	59	36	mrna	mrna	NOUN
iajs-3311	59	37	present	present	NOUN
iajs-3311	59	38	at	at	ADP
iajs-3311	59	39	extremely	extremely	ADV
iajs-3311	59	40	low	low	ADJ
iajs-3311	59	41	abundance	abundance	NOUN
iajs-3311	59	42	in	in	ADP
iajs-3311	59	43	clinical	clinical	ADJ
iajs-3311	59	44	material	material	NOUN
iajs-3311	59	45	containing	contain	VERB
iajs-3311	59	46	dna	dna	NOUN
iajs-3311	59	47	,	,	PUNCT
iajs-3311	59	48	polymerase	polymerase	NOUN
iajs-3311	59	49	chain	chain	NOUN
iajs-3311	59	50	reaction	reaction	NOUN
iajs-3311	59	51	(	(	PUNCT
iajs-3311	59	52	pcr	pcr	NOUN
iajs-3311	59	53	)	)	PUNCT
iajs-3311	59	54	is	be	AUX
iajs-3311	59	55	performed	perform	VERB
iajs-3311	59	56	,	,	PUNCT
iajs-3311	59	57	agarose	agarose	NOUN
iajs-3311	59	58	gel	gel	NOUN
iajs-3311	59	59	electrophoresis	electrophoresis	NOUN
iajs-3311	59	60	was	be	AUX
iajs-3311	59	61	used	use	VERB
iajs-3311	59	62	to	to	PART
iajs-3311	59	63	assess	assess	VERB
iajs-3311	59	64	the	the	DET
iajs-3311	59	65	dna	dna	NOUN
iajs-3311	59	66	's	's	PART
iajs-3311	59	67	concentration	concentration	NOUN
iajs-3311	59	68	and	and	CCONJ
iajs-3311	59	69	purity	purity	NOUN
iajs-3311	59	70	.	.	PUNCT
iajs-3311	60	1	in	in	ADP
iajs-3311	60	2	pcr	pcr	PROPN
iajs-3311	60	3	,	,	PUNCT
iajs-3311	60	4	two	two	NUM
iajs-3311	60	5	separate	separate	ADJ
iajs-3311	60	6	amplification	amplification	NOUN
iajs-3311	60	7	procedures	procedure	NOUN
iajs-3311	60	8	using	use	VERB
iajs-3311	60	9	a	a	DET
iajs-3311	60	10	unique	unique	ADJ
iajs-3311	60	11	pair	pair	NOUN
iajs-3311	60	12	of	of	ADP
iajs-3311	60	13	primers	primer	NOUN
iajs-3311	60	14	are	be	AUX
iajs-3311	60	15	usually	usually	ADV
iajs-3311	60	16	performed	perform	VERB
iajs-3311	60	17	.	.	PUNCT
iajs-3311	61	1	for	for	ADP
iajs-3311	61	2	the	the	DET
iajs-3311	61	3	second	second	ADJ
iajs-3311	61	4	pcr	pcr	NOUN
iajs-3311	61	5	,	,	PUNCT
iajs-3311	61	6	which	which	PRON
iajs-3311	61	7	is	be	AUX
iajs-3311	61	8	primed	prime	VERB
iajs-3311	61	9	by	by	ADP
iajs-3311	61	10	oligonucleotides	oligonucleotide	NOUN
iajs-3311	61	11	placed	place	VERB
iajs-3311	61	12	between	between	ADP
iajs-3311	61	13	the	the	DET
iajs-3311	61	14	primers	primer	NOUN
iajs-3311	61	15	of	of	ADP
iajs-3311	61	16	the	the	DET
iajs-3311	61	17	first	first	ADJ
iajs-3311	61	18	pcr	pcr	NOUN
iajs-3311	61	19	,	,	PUNCT
iajs-3311	61	20	the	the	DET
iajs-3311	61	21	product	product	NOUN
iajs-3311	61	22	of	of	ADP
iajs-3311	61	23	the	the	DET
iajs-3311	61	24	first	first	ADJ
iajs-3311	61	25	amplification	amplification	NOUN
iajs-3311	61	26	reaction	reaction	NOUN
iajs-3311	61	27	acts	act	VERB
iajs-3311	61	28	as	as	ADP
iajs-3311	61	29	the	the	DET
iajs-3311	61	30	template	template	NOUN
iajs-3311	61	31	.	.	PUNCT
iajs-3311	62	1	using	use	VERB
iajs-3311	62	2	two	two	NUM
iajs-3311	62	3	sets	set	NOUN
iajs-3311	62	4	of	of	ADP
iajs-3311	62	5	oligonucleotides	oligonucleotide	NOUN
iajs-3311	62	6	increases	increase	VERB
iajs-3311	62	7	the	the	DET
iajs-3311	62	8	pcr	pcr	NOUN
iajs-3311	62	9	's	's	PART
iajs-3311	62	10	sensitivity	sensitivity	NOUN
iajs-3311	62	11	because	because	SCONJ
iajs-3311	62	12	more	more	ADJ
iajs-3311	62	13	cycles	cycle	NOUN
iajs-3311	62	14	may	may	AUX
iajs-3311	62	15	be	be	AUX
iajs-3311	62	16	done	do	VERB
iajs-3311	62	17	.	.	PUNCT
iajs-3311	63	1	the	the	DET
iajs-3311	63	2	specificity	specificity	NOUN
iajs-3311	63	3	of	of	ADP
iajs-3311	63	4	the	the	DET
iajs-3311	63	5	response	response	NOUN
iajs-3311	63	6	has	have	AUX
iajs-3311	63	7	been	be	AUX
iajs-3311	63	8	improved	improve	VERB
iajs-3311	63	9	by	by	ADP
iajs-3311	63	10	the	the	DET
iajs-3311	63	11	binding	binding	NOUN
iajs-3311	63	12	of	of	ADP
iajs-3311	63	13	two	two	NUM
iajs-3311	63	14	distinct	distinct	ADJ
iajs-3311	63	15	sets	set	NOUN
iajs-3311	63	16	of	of	ADP
iajs-3311	63	17	primers	primer	NOUN
iajs-3311	63	18	to	to	ADP
iajs-3311	63	19	the	the	DET
iajs-3311	63	20	same	same	ADJ
iajs-3311	63	21	target	target	NOUN
iajs-3311	63	22	template	template	NOUN
iajs-3311	63	23	.	.	PUNCT
iajs-3311	64	1	while	while	SCONJ
iajs-3311	64	2	nested	nested	ADJ
iajs-3311	64	3	pcr	pcr	PROPN
iajs-3311	64	4	is	be	AUX
iajs-3311	64	5	a	a	DET
iajs-3311	64	6	valuable	valuable	ADJ
iajs-3311	64	7	method	method	NOUN
iajs-3311	64	8	for	for	ADP
iajs-3311	64	9	amplifying	amplifying	ADJ
iajs-3311	64	10	sections	section	NOUN
iajs-3311	64	11	of	of	ADP
iajs-3311	64	12	long	long	ADJ
iajs-3311	64	13	templates	template	NOUN
iajs-3311	64	14	,	,	PUNCT
iajs-3311	64	15	it	it	PRON
iajs-3311	64	16	requires	require	VERB
iajs-3311	64	17	knowledge	knowledge	NOUN
iajs-3311	64	18	of	of	ADP
iajs-3311	64	19	the	the	DET
iajs-3311	64	20	target	target	NOUN
iajs-3311	64	21	sequence	sequence	NOUN
iajs-3311	64	22	.	.	PUNCT
iajs-3311	65	1	hot	hot	ADJ
iajs-3311	65	2	start	start	NOUN
iajs-3311	65	3	pcr	pcr	PROPN
iajs-3311	65	4	should	should	AUX
iajs-3311	65	5	be	be	AUX
iajs-3311	65	6	performed	perform	VERB
iajs-3311	65	7	on	on	ADP
iajs-3311	65	8	the	the	DET
iajs-3311	65	9	tubes	tube	NOUN
iajs-3311	65	10	or	or	CCONJ
iajs-3311	65	11	microtiter	microtiter	NOUN
iajs-3311	65	12	plate	plate	NOUN
iajs-3311	65	13	after	after	ADP
iajs-3311	65	14	placing	place	VERB
iajs-3311	65	15	them	they	PRON
iajs-3311	65	16	in	in	ADP
iajs-3311	65	17	the	the	DET
iajs-3311	65	18	thermal	thermal	ADJ
iajs-3311	65	19	cycler	cycler	NOUN
iajs-3311	65	20	.	.	PUNCT
iajs-3311	66	1	for	for	ADP
iajs-3311	66	2	the	the	DET
iajs-3311	66	3	initial	initial	ADJ
iajs-3311	66	4	round	round	NOUN
iajs-3311	66	5	of	of	ADP
iajs-3311	66	6	amplification	amplification	NOUN
iajs-3311	66	7	,	,	PUNCT
iajs-3311	66	8	use	use	VERB
iajs-3311	66	9	the	the	DET
iajs-3311	66	10	denaturation	denaturation	NOUN
iajs-3311	66	11	,	,	PUNCT
iajs-3311	66	12	annealing	annealing	NOUN
iajs-3311	66	13	,	,	PUNCT
iajs-3311	66	14	and	and	CCONJ
iajs-3311	66	15	polymerization	polymerization	NOUN
iajs-3311	66	16	durations	duration	NOUN
iajs-3311	66	17	and	and	CCONJ
iajs-3311	66	18	temperatures	temperature	NOUN
iajs-3311	66	19	listed	list	VERB
iajs-3311	66	20	in	in	ADP
iajs-3311	66	21	the	the	DET
iajs-3311	66	22	following	follow	VERB
iajs-3311	66	23	table	table	NOUN
iajs-3311	66	24	1	1	NUM
iajs-3311	66	25	.	.	PUNCT
iajs-3311	66	26	ihjpas	ihjpas	PROPN
iajs-3311	66	27	.	.	PUNCT
iajs-3311	67	1	2024	2024	NUM
iajs-3311	67	2	,	,	PUNCT
iajs-3311	67	3	37	37	NUM
iajs-3311	67	4	(	(	PUNCT
iajs-3311	67	5	3	3	NUM
iajs-3311	67	6	)	)	PUNCT
iajs-3311	67	7	257	257	NUM
iajs-3311	67	8	table	table	NOUN
iajs-3311	67	9	1	1	NUM
iajs-3311	67	10	.	.	PUNCT
iajs-3311	68	1	the	the	DET
iajs-3311	68	2	pcr	pcr	PROPN
iajs-3311	68	3	cycling	cycling	NOUN
iajs-3311	68	4	program	program	NOUN
iajs-3311	68	5	.	.	PUNCT
iajs-3311	69	1	steps	step	NOUN
iajs-3311	69	2	temp	temp	NOUN
iajs-3311	69	3	.	.	PUNCT
iajs-3311	70	1	(	(	PUNCT
iajs-3311	70	2	°	°	ADP
iajs-3311	70	3	c	c	NOUN
iajs-3311	70	4	)	)	PUNCT
iajs-3311	70	5	time	time	NOUN
iajs-3311	70	6	cycle	cycle	NOUN
iajs-3311	70	7	initial	initial	ADJ
iajs-3311	70	8	denaturation	denaturation	NOUN
iajs-3311	70	9	95	95	NUM
iajs-3311	70	10	3	3	NUM
iajs-3311	70	11	min	min	NOUN
iajs-3311	70	12	1	1	NUM
iajs-3311	70	13	dna	dna	NOUN
iajs-3311	70	14	denaturation	denaturation	NOUN
iajs-3311	70	15	95	95	NUM
iajs-3311	70	16	30	30	NUM
iajs-3311	70	17	sec	sec	PROPN
iajs-3311	70	18	35	35	NUM
iajs-3311	70	19	annealing	anneal	VERB
iajs-3311	70	20	51	51	NUM
iajs-3311	70	21	45	45	NUM
iajs-3311	70	22	sec	sec	PROPN
iajs-3311	70	23	35	35	NUM
iajs-3311	70	24	extension	extension	NOUN
iajs-3311	70	25	72	72	NUM
iajs-3311	70	26	30	30	NUM
iajs-3311	70	27	sec	sec	PROPN
iajs-3311	70	28	35	35	NUM
iajs-3311	70	29	final	final	ADJ
iajs-3311	70	30	extension	extension	NOUN
iajs-3311	70	31	72	72	NUM
iajs-3311	70	32	7	7	NUM
iajs-3311	70	33	min	min	NOUN
iajs-3311	70	34	1	1	NUM
iajs-3311	70	35	3	3	NUM
iajs-3311	70	36	.	.	PUNCT
iajs-3311	70	37	results	result	NOUN
iajs-3311	70	38	this	this	DET
iajs-3311	70	39	result	result	NOUN
iajs-3311	70	40	is	be	AUX
iajs-3311	70	41	explained	explain	VERB
iajs-3311	70	42	by	by	ADP
iajs-3311	70	43	the	the	DET
iajs-3311	70	44	fact	fact	NOUN
iajs-3311	70	45	that	that	SCONJ
iajs-3311	70	46	this	this	DET
iajs-3311	70	47	mutation	mutation	NOUN
iajs-3311	70	48	is	be	AUX
iajs-3311	70	49	rare	rare	ADJ
iajs-3311	70	50	in	in	ADP
iajs-3311	70	51	the	the	DET
iajs-3311	70	52	population	population	NOUN
iajs-3311	70	53	.	.	PUNCT
iajs-3311	71	1	so	so	ADV
iajs-3311	71	2	,	,	PUNCT
iajs-3311	71	3	no	no	DET
iajs-3311	71	4	mutation	mutation	NOUN
iajs-3311	71	5	appeared	appear	VERB
iajs-3311	71	6	in	in	ADP
iajs-3311	71	7	100	100	NUM
iajs-3311	71	8	iraqi	iraqi	ADJ
iajs-3311	71	9	(	(	PUNCT
iajs-3311	71	10	50	50	NUM
iajs-3311	71	11	patients	patient	NOUN
iajs-3311	71	12	and	and	CCONJ
iajs-3311	71	13	50	50	NUM
iajs-3311	71	14	controls	control	NOUN
iajs-3311	71	15	)	)	PUNCT
iajs-3311	71	16	.	.	PUNCT
iajs-3311	72	1	the	the	DET
iajs-3311	72	2	frequency	frequency	NOUN
iajs-3311	72	3	of	of	ADP
iajs-3311	72	4	the	the	DET
iajs-3311	72	5	snp	snp	NOUN
iajs-3311	72	6	is	be	AUX
iajs-3311	72	7	c=0.00004	c=0.00004	NOUN
iajs-3311	72	8	(	(	PUNCT
iajs-3311	72	9	1/248500	1/248500	NUM
iajs-3311	72	10	,	,	PUNCT
iajs-3311	72	11	gnomed_exome	gnomed_exome	NOUN
iajs-3311	72	12	)	)	PUNCT
iajs-3311	72	13	,	,	PUNCT
iajs-3311	72	14	as	as	SCONJ
iajs-3311	72	15	shown	show	VERB
iajs-3311	72	16	in	in	ADP
iajs-3311	72	17	table	table	NOUN
iajs-3311	72	18	2	2	NUM
iajs-3311	72	19	.	.	PUNCT
iajs-3311	72	20	table	table	NOUN
iajs-3311	72	21	2	2	NUM
iajs-3311	72	22	.	.	PUNCT
iajs-3311	73	1	the	the	DET
iajs-3311	73	2	rs	rs	NOUN
iajs-3311	73	3	747934148	747934148	NUM
iajs-3311	73	4	.	.	PUNCT
iajs-3311	74	1	the	the	DET
iajs-3311	74	2	explanation	explanation	NOUN
iajs-3311	74	3	for	for	ADP
iajs-3311	74	4	this	this	DET
iajs-3311	74	5	result	result	NOUN
iajs-3311	74	6	is	be	AUX
iajs-3311	74	7	that	that	SCONJ
iajs-3311	74	8	this	this	DET
iajs-3311	74	9	mutation	mutation	NOUN
iajs-3311	74	10	is	be	AUX
iajs-3311	74	11	rare	rare	ADJ
iajs-3311	74	12	in	in	ADP
iajs-3311	74	13	the	the	DET
iajs-3311	74	14	population	population	NOUN
iajs-3311	74	15	.	.	PUNCT
iajs-3311	75	1	so	so	ADV
iajs-3311	75	2	,	,	PUNCT
iajs-3311	75	3	no	no	DET
iajs-3311	75	4	mutation	mutation	NOUN
iajs-3311	75	5	appears	appear	VERB
iajs-3311	75	6	in	in	ADP
iajs-3311	75	7	100	100	NUM
iajs-3311	75	8	iraqis	iraqis	PROPN
iajs-3311	75	9	(	(	PUNCT
iajs-3311	75	10	50	50	NUM
iajs-3311	75	11	patients	patient	NOUN
iajs-3311	75	12	and	and	CCONJ
iajs-3311	75	13	50	50	NUM
iajs-3311	75	14	control	control	NOUN
iajs-3311	75	15	)	)	PUNCT
iajs-3311	75	16	.	.	PUNCT
iajs-3311	76	1	the	the	DET
iajs-3311	76	2	frequency	frequency	NOUN
iajs-3311	76	3	of	of	ADP
iajs-3311	76	4	the	the	DET
iajs-3311	76	5	snp	snp	NOUN
iajs-3311	76	6	is	be	AUX
iajs-3311	76	7	c=	c=	NOUN
iajs-3311	76	8	0.00008	0.00008	NUM
iajs-3311	76	9	(	(	PUNCT
iajs-3311	76	10	2/242038	2/242038	NOUN
iajs-3311	76	11	,	,	PUNCT
iajs-3311	76	12	gnomed_exome	gnomed_exome	PROPN
iajs-3311	76	13	)	)	PUNCT
iajs-3311	76	14	,	,	PUNCT
iajs-3311	76	15	as	as	SCONJ
iajs-3311	76	16	shown	show	VERB
iajs-3311	76	17	in	in	ADP
iajs-3311	76	18	table	table	NOUN
iajs-3311	76	19	3	3	NUM
iajs-3311	76	20	.	.	PUNCT
iajs-3311	76	21	table	table	NOUN
iajs-3311	76	22	3	3	NUM
iajs-3311	76	23	.	.	PUNCT
iajs-3311	77	1	the	the	DET
iajs-3311	77	2	rs149434738	rs149434738	NOUN
iajs-3311	77	3	.	.	PUNCT
iajs-3311	78	1	this	this	DET
iajs-3311	78	2	result	result	NOUN
iajs-3311	78	3	is	be	AUX
iajs-3311	78	4	explained	explain	VERB
iajs-3311	78	5	by	by	ADP
iajs-3311	78	6	the	the	DET
iajs-3311	78	7	fact	fact	NOUN
iajs-3311	78	8	that	that	SCONJ
iajs-3311	78	9	this	this	DET
iajs-3311	78	10	mutation	mutation	NOUN
iajs-3311	78	11	is	be	AUX
iajs-3311	78	12	rare	rare	ADJ
iajs-3311	78	13	in	in	ADP
iajs-3311	78	14	the	the	DET
iajs-3311	78	15	population	population	NOUN
iajs-3311	78	16	.	.	PUNCT
iajs-3311	79	1	so	so	ADV
iajs-3311	79	2	,	,	PUNCT
iajs-3311	79	3	no	no	DET
iajs-3311	79	4	mutation	mutation	NOUN
iajs-3311	79	5	appeared	appear	VERB
iajs-3311	79	6	in	in	ADP
iajs-3311	79	7	120	120	NUM
iajs-3311	79	8	iraqis	iraqi	NOUN
iajs-3311	79	9	(	(	PUNCT
iajs-3311	79	10	50	50	NUM
iajs-3311	79	11	patients	patient	NOUN
iajs-3311	79	12	and	and	CCONJ
iajs-3311	79	13	50	50	NUM
iajs-3311	79	14	controls	control	NOUN
iajs-3311	79	15	)	)	PUNCT
iajs-3311	79	16	.	.	PUNCT
iajs-3311	80	1	the	the	DET
iajs-3311	80	2	frequency	frequency	NOUN
iajs-3311	80	3	of	of	ADP
iajs-3311	80	4	the	the	DET
iajs-3311	80	5	snp	snp	NOUN
iajs-3311	80	6	is	be	AUX
iajs-3311	80	7	c=0.00008(2/242038	c=0.00008(2/242038	NOUN
iajs-3311	80	8	,	,	PUNCT
iajs-3311	80	9	gnomed_exome	gnomed_exome	NOUN
iajs-3311	80	10	)	)	PUNCT
iajs-3311	80	11	,	,	PUNCT
iajs-3311	80	12	as	as	SCONJ
iajs-3311	80	13	shown	show	VERB
iajs-3311	80	14	in	in	ADP
iajs-3311	80	15	table	table	NOUN
iajs-3311	80	16	4	4	NUM
iajs-3311	80	17	.	.	PUNCT
iajs-3311	80	18	ihjpas	ihjpas	PROPN
iajs-3311	80	19	.	.	PUNCT
iajs-3311	81	1	2024	2024	NUM
iajs-3311	81	2	,	,	PUNCT
iajs-3311	81	3	37	37	NUM
iajs-3311	81	4	(	(	PUNCT
iajs-3311	81	5	3	3	NUM
iajs-3311	81	6	)	)	PUNCT
iajs-3311	81	7	258	258	NUM
iajs-3311	81	8	table	table	NOUN
iajs-3311	81	9	4	4	NUM
iajs-3311	81	10	.	.	PUNCT
iajs-3311	82	1	the	the	DET
iajs-3311	82	2	rs767615781	rs767615781	PROPN
iajs-3311	82	3	.	.	PROPN
iajs-3311	83	1	4	4	X
iajs-3311	83	2	.	.	X
iajs-3311	83	3	discussion	discussion	NOUN
iajs-3311	83	4	diabetes	diabetes	NOUN
iajs-3311	83	5	is	be	AUX
iajs-3311	83	6	a	a	DET
iajs-3311	83	7	chronic	chronic	ADJ
iajs-3311	83	8	health	health	NOUN
iajs-3311	83	9	condition	condition	NOUN
iajs-3311	83	10	that	that	PRON
iajs-3311	83	11	affects	affect	VERB
iajs-3311	83	12	how	how	SCONJ
iajs-3311	83	13	the	the	DET
iajs-3311	83	14	body	body	NOUN
iajs-3311	83	15	is	be	AUX
iajs-3311	83	16	unable	unable	ADJ
iajs-3311	83	17	to	to	PART
iajs-3311	83	18	maintain	maintain	VERB
iajs-3311	83	19	glucose	glucose	NOUN
iajs-3311	83	20	homeostasis	homeostasis	NOUN
iajs-3311	83	21	through	through	ADP
iajs-3311	83	22	adequate	adequate	ADJ
iajs-3311	83	23	absorption	absorption	NOUN
iajs-3311	83	24	.	.	PUNCT
iajs-3311	84	1	t1	t1	NOUN
iajs-3311	84	2	dm	dm	PROPN
iajs-3311	84	3	and	and	CCONJ
iajs-3311	84	4	t2	t2	NOUN
iajs-3311	84	5	dm	dm	NUM
iajs-3311	84	6	are	be	AUX
iajs-3311	84	7	the	the	DET
iajs-3311	84	8	two	two	NUM
iajs-3311	84	9	categories	category	NOUN
iajs-3311	84	10	into	into	ADP
iajs-3311	84	11	which	which	PRON
iajs-3311	84	12	diabetes	diabetes	NOUN
iajs-3311	84	13	has	have	AUX
iajs-3311	84	14	historically	historically	ADV
iajs-3311	84	15	been	be	AUX
iajs-3311	84	16	categorized	categorize	VERB
iajs-3311	84	17	.	.	PUNCT
iajs-3311	85	1	both	both	DET
iajs-3311	85	2	types	type	NOUN
iajs-3311	85	3	of	of	ADP
iajs-3311	85	4	diabetes	diabetes	NOUN
iajs-3311	85	5	can	can	AUX
iajs-3311	85	6	lead	lead	VERB
iajs-3311	85	7	to	to	ADP
iajs-3311	85	8	chronically	chronically	ADV
iajs-3311	85	9	high	high	ADJ
iajs-3311	85	10	blood	blood	NOUN
iajs-3311	85	11	sugar	sugar	NOUN
iajs-3311	85	12	levels	level	NOUN
iajs-3311	85	13	.	.	PUNCT
iajs-3311	86	1	that	that	PRON
iajs-3311	86	2	increases	increase	VERB
iajs-3311	86	3	the	the	DET
iajs-3311	86	4	risk	risk	NOUN
iajs-3311	86	5	of	of	ADP
iajs-3311	86	6	diabetes	diabetes	NOUN
iajs-3311	86	7	complications	complication	NOUN
iajs-3311	86	8	.	.	PUNCT
iajs-3311	87	1	over	over	ADP
iajs-3311	87	2	the	the	DET
iajs-3311	87	3	past	past	ADJ
iajs-3311	87	4	few	few	ADJ
iajs-3311	87	5	decades	decade	NOUN
iajs-3311	87	6	,	,	PUNCT
iajs-3311	87	7	the	the	DET
iajs-3311	87	8	knowledge	knowledge	NOUN
iajs-3311	87	9	of	of	ADP
iajs-3311	87	10	diabetes	diabetes	NOUN
iajs-3311	87	11	has	have	AUX
iajs-3311	87	12	expanded	expand	VERB
iajs-3311	87	13	to	to	PART
iajs-3311	87	14	incorporate	incorporate	VERB
iajs-3311	87	15	the	the	DET
iajs-3311	87	16	potential	potential	NOUN
iajs-3311	87	17	that	that	SCONJ
iajs-3311	87	18	a	a	DET
iajs-3311	87	19	number	number	NOUN
iajs-3311	87	20	of	of	ADP
iajs-3311	87	21	overlapping	overlap	VERB
iajs-3311	87	22	environmental	environmental	ADJ
iajs-3311	87	23	and	and	CCONJ
iajs-3311	87	24	inherited	inherit	VERB
iajs-3311	87	25	factors	factor	NOUN
iajs-3311	87	26	may	may	AUX
iajs-3311	87	27	contribute	contribute	VERB
iajs-3311	87	28	to	to	ADP
iajs-3311	87	29	various	various	ADJ
iajs-3311	87	30	disease	disease	NOUN
iajs-3311	87	31	presentations	presentation	NOUN
iajs-3311	87	32	.	.	PUNCT
iajs-3311	88	1	though	though	SCONJ
iajs-3311	88	2	they	they	PRON
iajs-3311	88	3	are	be	AUX
iajs-3311	88	4	two	two	NUM
iajs-3311	88	5	distinct	distinct	ADJ
iajs-3311	88	6	conditions	condition	NOUN
iajs-3311	88	7	,	,	PUNCT
iajs-3311	88	8	t1	t1	NOUN
iajs-3311	88	9	dm	dm	PROPN
iajs-3311	88	10	and	and	CCONJ
iajs-3311	88	11	t2	t2	NOUN
iajs-3311	88	12	dm	dm	PROPN
iajs-3311	88	13	represent	represent	VERB
iajs-3311	88	14	the	the	DET
iajs-3311	88	15	two	two	NUM
iajs-3311	88	16	ends	end	NOUN
iajs-3311	88	17	of	of	ADP
iajs-3311	88	18	a	a	DET
iajs-3311	88	19	diabetic	diabetic	ADJ
iajs-3311	88	20	spectrum	spectrum	NOUN
iajs-3311	88	21	.	.	PUNCT
iajs-3311	89	1	there	there	PRON
iajs-3311	89	2	are	be	VERB
iajs-3311	89	3	several	several	ADJ
iajs-3311	89	4	subgroups	subgroup	NOUN
iajs-3311	89	5	in	in	ADP
iajs-3311	89	6	the	the	DET
iajs-3311	89	7	intermediates	intermediate	NOUN
iajs-3311	89	8	,	,	PUNCT
iajs-3311	89	9	including	include	VERB
iajs-3311	89	10	maturity	maturity	NOUN
iajs-3311	89	11	-	-	PUNCT
iajs-3311	89	12	onset	onset	NOUN
iajs-3311	89	13	diabetes	diabetes	NOUN
iajs-3311	89	14	in	in	ADP
iajs-3311	89	15	the	the	DET
iajs-3311	89	16	young	young	ADJ
iajs-3311	89	17	(	(	PUNCT
iajs-3311	89	18	mody	mody	NOUN
iajs-3311	89	19	)	)	PUNCT
iajs-3311	89	20	and	and	CCONJ
iajs-3311	89	21	latent	latent	ADJ
iajs-3311	89	22	autoimmune	autoimmune	ADJ
iajs-3311	89	23	diabetes	diabetes	NOUN
iajs-3311	89	24	in	in	ADP
iajs-3311	89	25	adulthood	adulthood	PROPN
iajs-3311	89	26	(	(	PUNCT
iajs-3311	89	27	lada	lada	PROPN
iajs-3311	89	28	)	)	PUNCT
iajs-3311	89	29	.	.	PUNCT
iajs-3311	90	1	t1	t1	PROPN
iajs-3311	90	2	dm	dm	PROPN
iajs-3311	90	3	,	,	PUNCT
iajs-3311	90	4	commonly	commonly	ADV
iajs-3311	90	5	referred	refer	VERB
iajs-3311	90	6	to	to	ADP
iajs-3311	90	7	as	as	ADP
iajs-3311	90	8	juvenile	juvenile	ADJ
iajs-3311	90	9	diabetes	diabetes	NOUN
iajs-3311	90	10	or	or	CCONJ
iajs-3311	90	11	insulindependent	insulindependent	NOUN
iajs-3311	90	12	diabetes	diabetes	NOUN
iajs-3311	90	13	,	,	PUNCT
iajs-3311	90	14	is	be	AUX
iajs-3311	90	15	caused	cause	VERB
iajs-3311	90	16	by	by	ADP
iajs-3311	90	17	the	the	DET
iajs-3311	90	18	autoimmune	autoimmune	ADJ
iajs-3311	90	19	destruction	destruction	NOUN
iajs-3311	90	20	of	of	ADP
iajs-3311	90	21	pancreatic	pancreatic	ADJ
iajs-3311	90	22	beta	beta	ADJ
iajs-3311	90	23	cells	cell	NOUN
iajs-3311	90	24	.	.	PUNCT
iajs-3311	91	1	due	due	ADP
iajs-3311	91	2	to	to	ADP
iajs-3311	91	3	the	the	DET
iajs-3311	91	4	existence	existence	NOUN
iajs-3311	91	5	of	of	ADP
iajs-3311	91	6	autoantibodies	autoantibody	NOUN
iajs-3311	91	7	,	,	PUNCT
iajs-3311	91	8	particularly	particularly	ADV
iajs-3311	91	9	antibodies	antibodie	VERB
iajs-3311	91	10	against	against	ADP
iajs-3311	91	11	glutamic	glutamic	ADJ
iajs-3311	91	12	acid	acid	NOUN
iajs-3311	91	13	decarboxylase	decarboxylase	NOUN
iajs-3311	91	14	,	,	PUNCT
iajs-3311	91	15	insulin	insulin	NOUN
iajs-3311	91	16	injections	injection	NOUN
iajs-3311	91	17	are	be	AUX
iajs-3311	91	18	necessary	necessary	ADJ
iajs-3311	91	19	(	(	PUNCT
iajs-3311	91	20	gad	gad	PROPN
iajs-3311	91	21	)	)	PUNCT
iajs-3311	91	22	.	.	PUNCT
iajs-3311	92	1	children	child	NOUN
iajs-3311	92	2	,	,	PUNCT
iajs-3311	92	3	teenagers	teenager	NOUN
iajs-3311	92	4	,	,	PUNCT
iajs-3311	92	5	and	and	CCONJ
iajs-3311	92	6	young	young	ADJ
iajs-3311	92	7	adults	adult	NOUN
iajs-3311	92	8	under	under	ADP
iajs-3311	92	9	the	the	DET
iajs-3311	92	10	age	age	NOUN
iajs-3311	92	11	of	of	ADP
iajs-3311	92	12	35	35	NUM
iajs-3311	92	13	are	be	AUX
iajs-3311	92	14	most	most	ADV
iajs-3311	92	15	frequently	frequently	ADV
iajs-3311	92	16	diagnosed	diagnose	VERB
iajs-3311	92	17	with	with	ADP
iajs-3311	92	18	it	it	PRON
iajs-3311	92	19	.	.	PUNCT
iajs-3311	93	1	numerous	numerous	ADJ
iajs-3311	93	2	variables	variable	NOUN
iajs-3311	93	3	,	,	PUNCT
iajs-3311	93	4	such	such	ADJ
iajs-3311	93	5	as	as	ADP
iajs-3311	93	6	geography	geography	NOUN
iajs-3311	93	7	,	,	PUNCT
iajs-3311	93	8	age	age	NOUN
iajs-3311	93	9	,	,	PUNCT
iajs-3311	93	10	gender	gender	NOUN
iajs-3311	93	11	,	,	PUNCT
iajs-3311	93	12	and	and	CCONJ
iajs-3311	93	13	family	family	NOUN
iajs-3311	93	14	history	history	NOUN
iajs-3311	93	15	,	,	PUNCT
iajs-3311	93	16	have	have	VERB
iajs-3311	93	17	an	an	DET
iajs-3311	93	18	impact	impact	NOUN
iajs-3311	93	19	on	on	ADP
iajs-3311	93	20	the	the	DET
iajs-3311	93	21	development	development	NOUN
iajs-3311	93	22	of	of	ADP
iajs-3311	93	23	t1	t1	PROPN
iajs-3311	93	24	dm	dm	PROPN
iajs-3311	94	1	[	[	X
iajs-3311	94	2	12	12	NUM
iajs-3311	94	3	]	]	PUNCT
iajs-3311	94	4	.	.	PUNCT
iajs-3311	95	1	ostrow	ostrow	AUX
iajs-3311	95	2	et	et	PROPN
iajs-3311	95	3	al	al	PROPN
iajs-3311	95	4	.	.	PROPN
iajs-3311	95	5	noted	note	VERB
iajs-3311	95	6	that	that	SCONJ
iajs-3311	95	7	.	.	PUNCT
iajs-3311	96	1	only	only	ADV
iajs-3311	96	2	10	10	NUM
iajs-3311	96	3	%	%	NOUN
iajs-3311	96	4	to	to	PART
iajs-3311	96	5	15	15	NUM
iajs-3311	96	6	%	%	NOUN
iajs-3311	96	7	of	of	ADP
iajs-3311	96	8	people	people	NOUN
iajs-3311	96	9	with	with	ADP
iajs-3311	96	10	new	new	ADJ
iajs-3311	96	11	diagnoses	diagnosis	NOUN
iajs-3311	96	12	had	have	VERB
iajs-3311	96	13	a	a	DET
iajs-3311	96	14	t1	t1	NOUN
iajs-3311	96	15	dm	dm	NOUN
iajs-3311	96	16	relative	relative	NOUN
iajs-3311	96	17	[	[	X
iajs-3311	96	18	13	13	NUM
iajs-3311	96	19	]	]	PUNCT
iajs-3311	96	20	.	.	PUNCT
iajs-3311	97	1	the	the	DET
iajs-3311	97	2	average	average	ADJ
iajs-3311	97	3	prevalence	prevalence	NOUN
iajs-3311	97	4	risk	risk	NOUN
iajs-3311	97	5	for	for	ADP
iajs-3311	97	6	children	child	NOUN
iajs-3311	97	7	without	without	ADP
iajs-3311	97	8	a	a	DET
iajs-3311	97	9	family	family	NOUN
iajs-3311	97	10	history	history	NOUN
iajs-3311	97	11	of	of	ADP
iajs-3311	97	12	t1	t1	PROPN
iajs-3311	97	13	dm	dm	PROPN
iajs-3311	97	14	is	be	AUX
iajs-3311	97	15	0.4	0.4	NUM
iajs-3311	97	16	%	%	NOUN
iajs-3311	97	17	;	;	PUNCT
iajs-3311	97	18	however	however	ADV
iajs-3311	97	19	,	,	PUNCT
iajs-3311	97	20	this	this	DET
iajs-3311	97	21	risk	risk	NOUN
iajs-3311	97	22	increases	increase	VERB
iajs-3311	97	23	to	to	ADP
iajs-3311	97	24	6	6	NUM
iajs-3311	97	25	%	%	NOUN
iajs-3311	97	26	and	and	CCONJ
iajs-3311	97	27	>	>	SYM
iajs-3311	97	28	30	30	NUM
iajs-3311	97	29	%	%	NOUN
iajs-3311	97	30	when	when	SCONJ
iajs-3311	97	31	both	both	DET
iajs-3311	97	32	parents	parent	NOUN
iajs-3311	97	33	are	be	AUX
iajs-3311	97	34	affected	affect	VERB
iajs-3311	97	35	,	,	PUNCT
iajs-3311	97	36	respectively	respectively	ADV
iajs-3311	97	37	.	.	PUNCT
iajs-3311	98	1	while	while	SCONJ
iajs-3311	98	2	dizygotic	dizygotic	ADJ
iajs-3311	98	3	twins	twin	NOUN
iajs-3311	98	4	had	have	VERB
iajs-3311	98	5	an	an	DET
iajs-3311	98	6	8	8	NUM
iajs-3311	98	7	%	%	NOUN
iajs-3311	98	8	recurrence	recurrence	NOUN
iajs-3311	98	9	risk	risk	NOUN
iajs-3311	98	10	,	,	PUNCT
iajs-3311	98	11	monozygotic	monozygotic	ADJ
iajs-3311	98	12	twins	twin	NOUN
iajs-3311	98	13	had	have	VERB
iajs-3311	98	14	a	a	DET
iajs-3311	98	15	50	50	NUM
iajs-3311	98	16	%	%	NOUN
iajs-3311	98	17	recurrence	recurrence	NOUN
iajs-3311	98	18	risk	risk	NOUN
iajs-3311	98	19	with	with	ADP
iajs-3311	98	20	a	a	DET
iajs-3311	98	21	10	10	NUM
iajs-3311	98	22	%	%	NOUN
iajs-3311	98	23	possibility	possibility	NOUN
iajs-3311	98	24	within	within	ADP
iajs-3311	98	25	10	10	NUM
iajs-3311	98	26	years	year	NOUN
iajs-3311	98	27	after	after	ADP
iajs-3311	98	28	the	the	DET
iajs-3311	98	29	first	first	ADJ
iajs-3311	98	30	twin	twin	NOUN
iajs-3311	98	31	's	's	PART
iajs-3311	98	32	diagnosis	diagnosis	NOUN
iajs-3311	98	33	[	[	X
iajs-3311	98	34	14,15	14,15	NUM
iajs-3311	98	35	]	]	PUNCT
iajs-3311	98	36	.	.	PUNCT
iajs-3311	99	1	mody	mody	NOUN
iajs-3311	99	2	's	's	PART
iajs-3311	99	3	diagnosis	diagnosis	NOUN
iajs-3311	99	4	is	be	AUX
iajs-3311	99	5	crucial	crucial	ADJ
iajs-3311	99	6	for	for	ADP
iajs-3311	99	7	both	both	CCONJ
iajs-3311	99	8	the	the	DET
iajs-3311	99	9	patient	patient	NOUN
iajs-3311	99	10	and	and	CCONJ
iajs-3311	99	11	the	the	DET
iajs-3311	99	12	family	family	NOUN
iajs-3311	99	13	.	.	PUNCT
iajs-3311	100	1	the	the	DET
iajs-3311	100	2	study	study	NOUN
iajs-3311	100	3	estimates	estimate	VERB
iajs-3311	100	4	that	that	SCONJ
iajs-3311	100	5	the	the	DET
iajs-3311	100	6	risk	risk	NOUN
iajs-3311	100	7	is	be	AUX
iajs-3311	100	8	just	just	ADV
iajs-3311	100	9	about	about	ADV
iajs-3311	100	10	2%–4	2%–4	NUM
iajs-3311	100	11	%	%	NOUN
iajs-3311	100	12	for	for	ADP
iajs-3311	100	13	children	child	NOUN
iajs-3311	100	14	of	of	ADP
iajs-3311	100	15	afflicted	afflict	VERB
iajs-3311	100	16	mothers	mother	NOUN
iajs-3311	100	17	and	and	CCONJ
iajs-3311	100	18	as	as	ADV
iajs-3311	100	19	high	high	ADJ
iajs-3311	100	20	as	as	ADP
iajs-3311	100	21	5%–8	5%–8	NUM
iajs-3311	100	22	%	%	NOUN
iajs-3311	100	23	for	for	ADP
iajs-3311	100	24	children	child	NOUN
iajs-3311	100	25	of	of	ADP
iajs-3311	100	26	affected	affect	VERB
iajs-3311	100	27	fathers	father	NOUN
iajs-3311	100	28	[	[	X
iajs-3311	100	29	19–20	19–20	NUM
iajs-3311	100	30	]	]	PUNCT
iajs-3311	100	31	.	.	PUNCT
iajs-3311	101	1	siblings	sibling	NOUN
iajs-3311	101	2	are	be	AUX
iajs-3311	101	3	expected	expect	VERB
iajs-3311	101	4	to	to	PART
iajs-3311	101	5	have	have	VERB
iajs-3311	101	6	a	a	DET
iajs-3311	101	7	15	15	NUM
iajs-3311	101	8	percent	percent	NOUN
iajs-3311	101	9	relative	relative	ADJ
iajs-3311	101	10	risk	risk	NOUN
iajs-3311	101	11	of	of	ADP
iajs-3311	101	12	t1	t1	PROPN
iajs-3311	101	13	dm	dm	PROPN
iajs-3311	101	14	.	.	PUNCT
iajs-3311	102	1	increasing	increase	VERB
iajs-3311	102	2	evidence	evidence	NOUN
iajs-3311	102	3	suggests	suggest	VERB
iajs-3311	102	4	that	that	SCONJ
iajs-3311	102	5	genetic	genetic	ADJ
iajs-3311	102	6	,	,	PUNCT
iajs-3311	102	7	epigenetic	epigenetic	ADJ
iajs-3311	102	8	,	,	PUNCT
iajs-3311	102	9	and	and	CCONJ
iajs-3311	102	10	environmental	environmental	ADJ
iajs-3311	102	11	variables	variable	NOUN
iajs-3311	102	12	might	might	AUX
iajs-3311	102	13	play	play	VERB
iajs-3311	102	14	a	a	DET
iajs-3311	102	15	critical	critical	ADJ
iajs-3311	102	16	role	role	NOUN
iajs-3311	102	17	in	in	ADP
iajs-3311	102	18	the	the	DET
iajs-3311	102	19	t1	t1	PROPN
iajs-3311	102	20	dm	dm	PROPN
iajs-3311	102	21	disease	disease	NOUN
iajs-3311	102	22	process	process	NOUN
iajs-3311	102	23	[	[	X
iajs-3311	102	24	16	16	NUM
iajs-3311	102	25	]	]	PUNCT
iajs-3311	102	26	.	.	PUNCT
iajs-3311	103	1	the	the	DET
iajs-3311	103	2	heritability	heritability	NOUN
iajs-3311	103	3	of	of	ADP
iajs-3311	103	4	t1	t1	PROPN
iajs-3311	103	5	dm	dm	PROPN
iajs-3311	103	6	can	can	AUX
iajs-3311	103	7	be	be	AUX
iajs-3311	103	8	attributed	attribute	VERB
iajs-3311	103	9	to	to	ADP
iajs-3311	103	10	genetic	genetic	ADJ
iajs-3311	103	11	studies	study	NOUN
iajs-3311	103	12	in	in	ADP
iajs-3311	103	13	80	80	NUM
iajs-3311	103	14	%	%	NOUN
iajs-3311	103	15	of	of	ADP
iajs-3311	103	16	cases	case	NOUN
iajs-3311	103	17	[	[	X
iajs-3311	103	18	17	17	NUM
iajs-3311	103	19	]	]	PUNCT
iajs-3311	103	20	.	.	PUNCT
iajs-3311	104	1	the	the	DET
iajs-3311	104	2	class	class	PROPN
iajs-3311	104	3	ii	ii	PROPN
iajs-3311	104	4	alleles	allele	NOUN
iajs-3311	104	5	of	of	ADP
iajs-3311	104	6	hla	hla	NOUN
iajs-3311	104	7	account	account	NOUN
iajs-3311	104	8	for	for	ADP
iajs-3311	104	9	over	over	ADP
iajs-3311	104	10	50	50	NUM
iajs-3311	104	11	%	%	NOUN
iajs-3311	104	12	of	of	ADP
iajs-3311	104	13	a	a	DET
iajs-3311	104	14	person	person	NOUN
iajs-3311	104	15	's	's	PART
iajs-3311	104	16	genetic	genetic	ADJ
iajs-3311	104	17	susceptibility	susceptibility	NOUN
iajs-3311	104	18	to	to	ADP
iajs-3311	104	19	the	the	DET
iajs-3311	104	20	condition	condition	NOUN
iajs-3311	104	21	,	,	PUNCT
iajs-3311	104	22	and	and	CCONJ
iajs-3311	104	23	non	non	ADJ
iajs-3311	104	24	-	-	ADJ
iajs-3311	104	25	hla	hla	ADJ
iajs-3311	104	26	loci	locus	NOUN
iajs-3311	104	27	such	such	ADJ
iajs-3311	104	28	as	as	ADP
iajs-3311	104	29	the	the	DET
iajs-3311	104	30	interleukin	interleukin	NOUN
iajs-3311	104	31	2	2	NUM
iajs-3311	104	32	receptor	receptor	NOUN
iajs-3311	104	33	(	(	PUNCT
iajs-3311	104	34	il2ra	il2ra	NUM
iajs-3311	104	35	)	)	PUNCT
iajs-3311	104	36	,	,	PUNCT
iajs-3311	104	37	ctla4	ctla4	NOUN
iajs-3311	104	38	,	,	PUNCT
iajs-3311	104	39	ptpn22	ptpn22	NOUN
iajs-3311	104	40	,	,	PUNCT
iajs-3311	104	41	ihjpas	ihjpas	PROPN
iajs-3311	104	42	.	.	PUNCT
iajs-3311	105	1	2024	2024	NUM
iajs-3311	105	2	,	,	PUNCT
iajs-3311	105	3	37	37	NUM
iajs-3311	105	4	(	(	PUNCT
iajs-3311	105	5	3	3	NUM
iajs-3311	105	6	)	)	PUNCT
iajs-3311	105	7	259	259	NUM
iajs-3311	105	8	the	the	DET
iajs-3311	105	9	insulin	insulin	NOUN
iajs-3311	105	10	gene	gene	NOUN
iajs-3311	105	11	,	,	PUNCT
iajs-3311	105	12	and	and	CCONJ
iajs-3311	105	13	others	other	NOUN
iajs-3311	105	14	are	be	AUX
iajs-3311	105	15	now	now	ADV
iajs-3311	105	16	the	the	DET
iajs-3311	105	17	most	most	ADV
iajs-3311	105	18	significant	significant	ADJ
iajs-3311	105	19	susceptibility	susceptibility	NOUN
iajs-3311	105	20	genes	gene	NOUN
iajs-3311	105	21	for	for	ADP
iajs-3311	105	22	t1	t1	PROPN
iajs-3311	105	23	dm	dm	PROPN
iajs-3311	105	24	[	[	X
iajs-3311	105	25	18	18	NUM
iajs-3311	105	26	]	]	PUNCT
iajs-3311	105	27	.	.	PUNCT
iajs-3311	106	1	viruses	virus	NOUN
iajs-3311	106	2	from	from	ADP
iajs-3311	106	3	the	the	DET
iajs-3311	106	4	picorna	picorna	ADJ
iajs-3311	106	5	family	family	NOUN
iajs-3311	106	6	manifest	manifest	NOUN
iajs-3311	106	7	before	before	ADP
iajs-3311	106	8	autoantibodies	autoantibody	NOUN
iajs-3311	106	9	and	and	CCONJ
iajs-3311	106	10	are	be	AUX
iajs-3311	106	11	more	more	ADV
iajs-3311	106	12	common	common	ADJ
iajs-3311	106	13	in	in	ADP
iajs-3311	106	14	newly	newly	ADV
iajs-3311	106	15	diagnosed	diagnose	VERB
iajs-3311	106	16	t1	t1	NOUN
iajs-3311	106	17	dm	dm	PROPN
iajs-3311	106	18	patients	patient	NOUN
iajs-3311	106	19	than	than	ADP
iajs-3311	106	20	in	in	ADP
iajs-3311	106	21	the	the	DET
iajs-3311	106	22	general	general	ADJ
iajs-3311	106	23	population	population	NOUN
iajs-3311	106	24	.	.	PUNCT
iajs-3311	107	1	environmental	environmental	ADJ
iajs-3311	107	2	contaminants	contaminant	NOUN
iajs-3311	107	3	,	,	PUNCT
iajs-3311	107	4	vitamin	vitamin	NOUN
iajs-3311	107	5	d	d	NOUN
iajs-3311	107	6	exposure	exposure	NOUN
iajs-3311	107	7	,	,	PUNCT
iajs-3311	107	8	and	and	CCONJ
iajs-3311	107	9	disorders	disorder	NOUN
iajs-3311	107	10	in	in	ADP
iajs-3311	107	11	the	the	DET
iajs-3311	107	12	gut	gut	NOUN
iajs-3311	107	13	flora	flora	NOUN
iajs-3311	107	14	have	have	AUX
iajs-3311	107	15	been	be	AUX
iajs-3311	107	16	considered	consider	VERB
iajs-3311	107	17	ecological	ecological	ADJ
iajs-3311	107	18	variables	variable	NOUN
iajs-3311	107	19	in	in	ADP
iajs-3311	107	20	the	the	DET
iajs-3311	107	21	past	past	NOUN
iajs-3311	107	22	[	[	X
iajs-3311	107	23	19	19	NUM
iajs-3311	107	24	-	-	SYM
iajs-3311	107	25	21	21	NUM
iajs-3311	107	26	]	]	PUNCT
iajs-3311	107	27	.	.	PUNCT
iajs-3311	108	1	the	the	DET
iajs-3311	108	2	type	type	NOUN
iajs-3311	108	3	of	of	ADP
iajs-3311	108	4	diabetes	diabete	NOUN
iajs-3311	108	5	known	know	VERB
iajs-3311	108	6	as	as	ADP
iajs-3311	108	7	lada	lada	PROPN
iajs-3311	108	8	(	(	PUNCT
iajs-3311	108	9	latent	latent	NOUN
iajs-3311	108	10	autoimmune	autoimmune	ADJ
iajs-3311	108	11	diabetes	diabetes	NOUN
iajs-3311	108	12	in	in	ADP
iajs-3311	108	13	adults	adult	NOUN
iajs-3311	108	14	)	)	PUNCT
iajs-3311	108	15	affects	affect	VERB
iajs-3311	108	16	about	about	ADV
iajs-3311	108	17	7	7	NUM
iajs-3311	108	18	%	%	NOUN
iajs-3311	108	19	of	of	ADP
iajs-3311	108	20	all	all	DET
iajs-3311	108	21	diabetic	diabetic	ADJ
iajs-3311	108	22	patients	patient	NOUN
iajs-3311	108	23	in	in	ADP
iajs-3311	108	24	europe	europe	PROPN
iajs-3311	108	25	.	.	PUNCT
iajs-3311	109	1	for	for	ADP
iajs-3311	109	2	the	the	DET
iajs-3311	109	3	first	first	ADJ
iajs-3311	109	4	six	six	NUM
iajs-3311	109	5	months	month	NOUN
iajs-3311	109	6	following	follow	VERB
iajs-3311	109	7	diagnosis	diagnosis	NOUN
iajs-3311	109	8	,	,	PUNCT
iajs-3311	109	9	lada	lada	PROPN
iajs-3311	109	10	is	be	AUX
iajs-3311	109	11	often	often	ADV
iajs-3311	109	12	referred	refer	VERB
iajs-3311	109	13	to	to	ADP
iajs-3311	109	14	as	as	ADP
iajs-3311	109	15	diabetes	diabetes	NOUN
iajs-3311	109	16	with	with	ADP
iajs-3311	109	17	gad	gad	NOUN
iajs-3311	109	18	antibody	antibody	NOUN
iajs-3311	109	19	positivity	positivity	NOUN
iajs-3311	109	20	that	that	PRON
iajs-3311	109	21	appears	appear	VERB
iajs-3311	109	22	after	after	ADP
iajs-3311	109	23	the	the	DET
iajs-3311	109	24	age	age	NOUN
iajs-3311	109	25	of	of	ADP
iajs-3311	109	26	35	35	NUM
iajs-3311	109	27	and	and	CCONJ
iajs-3311	109	28	does	do	AUX
iajs-3311	109	29	not	not	PART
iajs-3311	109	30	require	require	VERB
iajs-3311	109	31	insulin	insulin	NOUN
iajs-3311	109	32	[	[	X
iajs-3311	109	33	22–25	22–25	NUM
iajs-3311	109	34	]	]	PUNCT
iajs-3311	109	35	.	.	PUNCT
iajs-3311	110	1	a	a	DET
iajs-3311	110	2	threshold	threshold	NOUN
iajs-3311	110	3	that	that	PRON
iajs-3311	110	4	causes	cause	VERB
iajs-3311	110	5	t1	t1	PROPN
iajs-3311	110	6	dm	dm	PROPN
iajs-3311	110	7	also	also	ADV
iajs-3311	110	8	causes	cause	VERB
iajs-3311	110	9	gad	gad	PROPN
iajs-3311	110	10	-	-	PUNCT
iajs-3311	110	11	ab	ab	PROPN
iajs-3311	110	12	positivity	positivity	NOUN
iajs-3311	110	13	.	.	PUNCT
iajs-3311	111	1	as	as	ADP
iajs-3311	111	2	a	a	DET
iajs-3311	111	3	result	result	NOUN
iajs-3311	111	4	,	,	PUNCT
iajs-3311	111	5	on	on	ADP
iajs-3311	111	6	the	the	DET
iajs-3311	111	7	left	left	ADJ
iajs-3311	111	8	side	side	NOUN
iajs-3311	111	9	of	of	ADP
iajs-3311	111	10	the	the	DET
iajs-3311	111	11	spectrum	spectrum	NOUN
iajs-3311	111	12	,	,	PUNCT
iajs-3311	111	13	high	high	ADJ
iajs-3311	111	14	-	-	PUNCT
iajs-3311	111	15	ab	ab	NOUN
iajs-3311	111	16	titer	titer	NOUN
iajs-3311	111	17	lada	lada	PROPN
iajs-3311	111	18	is	be	AUX
iajs-3311	111	19	comparable	comparable	ADJ
iajs-3311	111	20	to	to	PART
iajs-3311	111	21	type	type	VERB
iajs-3311	111	22	1	1	NUM
iajs-3311	111	23	diabetes	diabete	NOUN
iajs-3311	111	24	,	,	PUNCT
iajs-3311	111	25	while	while	SCONJ
iajs-3311	111	26	lada	lada	PROPN
iajs-3311	111	27	with	with	ADP
iajs-3311	111	28	smaller	small	ADJ
iajs-3311	111	29	titers	titer	NOUN
iajs-3311	111	30	is	be	AUX
iajs-3311	111	31	similar	similar	ADJ
iajs-3311	111	32	to	to	ADP
iajs-3311	111	33	t2	t2	PROPN
iajs-3311	112	1	dm	dm	PROPN
iajs-3311	113	1	[	[	X
iajs-3311	113	2	26	26	NUM
iajs-3311	113	3	]	]	PUNCT
iajs-3311	113	4	.	.	PUNCT
iajs-3311	114	1	however	however	ADV
iajs-3311	114	2	,	,	PUNCT
iajs-3311	114	3	all	all	DET
iajs-3311	114	4	types	type	NOUN
iajs-3311	114	5	of	of	ADP
iajs-3311	114	6	diabetes	diabete	NOUN
iajs-3311	114	7	present	present	VERB
iajs-3311	114	8	a	a	DET
iajs-3311	114	9	significant	significant	ADJ
iajs-3311	114	10	risk	risk	NOUN
iajs-3311	114	11	factor	factor	NOUN
iajs-3311	114	12	for	for	ADP
iajs-3311	114	13	lada	lada	PROPN
iajs-3311	114	14	[	[	X
iajs-3311	114	15	27	27	NUM
iajs-3311	114	16	]	]	PUNCT
iajs-3311	114	17	.	.	PUNCT
iajs-3311	115	1	the	the	DET
iajs-3311	115	2	monogenic	monogenic	ADJ
iajs-3311	115	3	form	form	NOUN
iajs-3311	115	4	of	of	ADP
iajs-3311	115	5	diabetes	diabete	NOUN
iajs-3311	115	6	known	know	VERB
iajs-3311	115	7	as	as	ADP
iajs-3311	115	8	mody	mody	NOUN
iajs-3311	115	9	(	(	PUNCT
iajs-3311	115	10	maturity	maturity	NOUN
iajs-3311	115	11	-	-	PUNCT
iajs-3311	115	12	onset	onset	NOUN
iajs-3311	115	13	-	-	PUNCT
iajs-3311	115	14	diabetes	diabetes	NOUN
iajs-3311	115	15	of	of	ADP
iajs-3311	115	16	the	the	DET
iajs-3311	115	17	young	young	ADJ
iajs-3311	115	18	)	)	PUNCT
iajs-3311	115	19	has	have	VERB
iajs-3311	115	20	more	more	ADJ
iajs-3311	115	21	than	than	ADP
iajs-3311	115	22	10	10	NUM
iajs-3311	115	23	different	different	ADJ
iajs-3311	115	24	genes	gene	NOUN
iajs-3311	115	25	with	with	ADP
iajs-3311	115	26	well	well	ADV
iajs-3311	115	27	-	-	PUNCT
iajs-3311	115	28	detected	detect	VERB
iajs-3311	115	29	mutations	mutation	NOUN
iajs-3311	115	30	,	,	PUNCT
iajs-3311	115	31	and	and	CCONJ
iajs-3311	115	32	this	this	DET
iajs-3311	115	33	number	number	NOUN
iajs-3311	115	34	is	be	AUX
iajs-3311	115	35	steadily	steadily	ADV
iajs-3311	115	36	rising	rise	VERB
iajs-3311	115	37	.	.	PUNCT
iajs-3311	116	1	transmission	transmission	NOUN
iajs-3311	116	2	of	of	ADP
iajs-3311	116	3	early	early	ADJ
iajs-3311	116	4	-	-	PUNCT
iajs-3311	116	5	onset	onset	NOUN
iajs-3311	116	6	autosomal	autosomal	ADJ
iajs-3311	116	7	dominant	dominant	ADJ
iajs-3311	116	8	diseases	disease	NOUN
iajs-3311	116	9	(	(	PUNCT
iajs-3311	116	10	25	25	NUM
iajs-3311	116	11	years	year	NOUN
iajs-3311	116	12	)	)	PUNCT
iajs-3311	116	13	the	the	DET
iajs-3311	116	14	characteristics	characteristic	NOUN
iajs-3311	116	15	of	of	ADP
iajs-3311	116	16	the	the	DET
iajs-3311	116	17	condition	condition	NOUN
iajs-3311	116	18	are	be	AUX
iajs-3311	116	19	hyperglycemia	hyperglycemia	NOUN
iajs-3311	116	20	and	and	CCONJ
iajs-3311	116	21	varying	vary	VERB
iajs-3311	116	22	degrees	degree	NOUN
iajs-3311	116	23	of	of	ADP
iajs-3311	116	24	β	β	NOUN
iajs-3311	116	25	-	-	NOUN
iajs-3311	116	26	cell	cell	NOUN
iajs-3311	116	27	dysfunction	dysfunction	NOUN
iajs-3311	116	28	[	[	X
iajs-3311	116	29	28	28	NUM
iajs-3311	116	30	]	]	PUNCT
iajs-3311	116	31	.	.	PUNCT
iajs-3311	117	1	contrary	contrary	ADJ
iajs-3311	117	2	to	to	ADP
iajs-3311	117	3	widespread	widespread	ADJ
iajs-3311	117	4	assumption	assumption	NOUN
iajs-3311	117	5	,	,	PUNCT
iajs-3311	117	6	the	the	DET
iajs-3311	117	7	mody	mody	NOUN
iajs-3311	117	8	genes	gene	NOUN
iajs-3311	117	9	—	—	PUNCT
iajs-3311	117	10	hnf1a	hnf1a	PROPN
iajs-3311	117	11	,	,	PUNCT
iajs-3311	117	12	hnf4a	hnf4a	PROPN
iajs-3311	117	13	,	,	PUNCT
iajs-3311	117	14	hnf1b	hnf1b	PROPN
iajs-3311	117	15	,	,	PUNCT
iajs-3311	117	16	gck	gck	PROPN
iajs-3311	117	17	,	,	PUNCT
iajs-3311	117	18	and	and	CCONJ
iajs-3311	117	19	pdx1	pdx1	PROPN
iajs-3311	117	20	—	—	PUNCT
iajs-3311	117	21	are	be	AUX
iajs-3311	117	22	not	not	PART
iajs-3311	117	23	associated	associate	VERB
iajs-3311	117	24	with	with	ADP
iajs-3311	117	25	a	a	DET
iajs-3311	117	26	variety	variety	NOUN
iajs-3311	117	27	of	of	ADP
iajs-3311	117	28	diseases	disease	NOUN
iajs-3311	117	29	.	.	PUNCT
iajs-3311	118	1	the	the	DET
iajs-3311	118	2	majority	majority	NOUN
iajs-3311	118	3	of	of	ADP
iajs-3311	118	4	mody	mody	NOUN
iajs-3311	118	5	mutations	mutation	NOUN
iajs-3311	118	6	are	be	AUX
iajs-3311	118	7	different	different	ADJ
iajs-3311	118	8	due	due	ADP
iajs-3311	118	9	to	to	ADP
iajs-3311	118	10	the	the	DET
iajs-3311	118	11	high	high	ADJ
iajs-3311	118	12	allelic	allelic	ADJ
iajs-3311	118	13	diversity	diversity	NOUN
iajs-3311	118	14	of	of	ADP
iajs-3311	118	15	the	the	DET
iajs-3311	118	16	mody	mody	NOUN
iajs-3311	118	17	gene	gene	NOUN
iajs-3311	118	18	;	;	PUNCT
iajs-3311	118	19	so	so	ADV
iajs-3311	118	20	far	far	ADV
iajs-3311	118	21	,	,	PUNCT
iajs-3311	118	22	the	the	DET
iajs-3311	118	23	gck	gck	NOUN
iajs-3311	118	24	(	(	PUNCT
iajs-3311	118	25	mody2	mody2	X
iajs-3311	118	26	)	)	PUNCT
iajs-3311	118	27	and	and	CCONJ
iajs-3311	118	28	hnf1a	hnf1a	PROPN
iajs-3311	118	29	(	(	PUNCT
iajs-3311	118	30	mody3	mody3	NOUN
iajs-3311	118	31	)	)	PUNCT
iajs-3311	118	32	genes	gene	NOUN
iajs-3311	118	33	have	have	VERB
iajs-3311	118	34	more	more	ADJ
iajs-3311	118	35	than	than	ADP
iajs-3311	118	36	200	200	NUM
iajs-3311	118	37	mutations	mutation	NOUN
iajs-3311	118	38	found	find	VERB
iajs-3311	118	39	in	in	ADP
iajs-3311	118	40	them	they	PRON
iajs-3311	118	41	[	[	X
iajs-3311	118	42	29	29	NUM
iajs-3311	118	43	,	,	PUNCT
iajs-3311	118	44	30	30	NUM
iajs-3311	118	45	]	]	PUNCT
iajs-3311	118	46	.	.	PUNCT
iajs-3311	119	1	sequencing	sequence	VERB
iajs-3311	119	2	is	be	AUX
iajs-3311	119	3	necessary	necessary	ADJ
iajs-3311	119	4	for	for	ADP
iajs-3311	119	5	an	an	DET
iajs-3311	119	6	accurate	accurate	ADJ
iajs-3311	119	7	mody	mody	NOUN
iajs-3311	119	8	diagnosis	diagnosis	NOUN
iajs-3311	119	9	.	.	PUNCT
iajs-3311	120	1	the	the	DET
iajs-3311	120	2	development	development	NOUN
iajs-3311	120	3	of	of	ADP
iajs-3311	120	4	next	next	ADJ
iajs-3311	120	5	-	-	PUNCT
iajs-3311	120	6	generation	generation	NOUN
iajs-3311	120	7	sequencing	sequencing	NOUN
iajs-3311	120	8	technologies	technology	NOUN
iajs-3311	120	9	has	have	AUX
iajs-3311	120	10	dramatically	dramatically	ADV
iajs-3311	120	11	increased	increase	VERB
iajs-3311	120	12	the	the	DET
iajs-3311	120	13	likelihood	likelihood	NOUN
iajs-3311	120	14	of	of	ADP
iajs-3311	120	15	a	a	DET
iajs-3311	120	16	correct	correct	ADJ
iajs-3311	120	17	mody	mody	NOUN
iajs-3311	120	18	diagnosis	diagnosis	NOUN
iajs-3311	120	19	.	.	PUNCT
iajs-3311	121	1	maternally	maternally	ADV
iajs-3311	121	2	inherited	inherit	VERB
iajs-3311	121	3	diabetes	diabetes	NOUN
iajs-3311	121	4	and	and	CCONJ
iajs-3311	121	5	deafness	deafness	NOUN
iajs-3311	121	6	(	(	PUNCT
iajs-3311	121	7	midd	midd	NOUN
iajs-3311	121	8	)	)	PUNCT
iajs-3311	121	9	are	be	AUX
iajs-3311	121	10	caused	cause	VERB
iajs-3311	121	11	by	by	ADP
iajs-3311	121	12	the	the	DET
iajs-3311	121	13	a3242	a3242	NOUN
iajs-3311	121	14	g	g	NOUN
iajs-3311	121	15	mutation	mutation	NOUN
iajs-3311	121	16	in	in	ADP
iajs-3311	121	17	mitochondrial	mitochondrial	ADJ
iajs-3311	121	18	dna	dna	NOUN
iajs-3311	121	19	(	(	PUNCT
iajs-3311	121	20	mtdna	mtdna	ADV
iajs-3311	121	21	)	)	PUNCT
iajs-3311	122	1	[	[	X
iajs-3311	122	2	30,31	30,31	NUM
iajs-3311	122	3	]	]	PUNCT
iajs-3311	122	4	.	.	PUNCT
iajs-3311	123	1	because	because	SCONJ
iajs-3311	123	2	mtdna	mtdna	PROPN
iajs-3311	123	3	can	can	AUX
iajs-3311	123	4	only	only	ADV
iajs-3311	123	5	be	be	AUX
iajs-3311	123	6	passed	pass	VERB
iajs-3311	123	7	from	from	ADP
iajs-3311	123	8	mother	mother	NOUN
iajs-3311	123	9	to	to	ADP
iajs-3311	123	10	child	child	NOUN
iajs-3311	123	11	,	,	PUNCT
iajs-3311	123	12	midd	midd	PROPN
iajs-3311	123	13	serves	serve	VERB
iajs-3311	123	14	as	as	ADP
iajs-3311	123	15	an	an	DET
iajs-3311	123	16	example	example	NOUN
iajs-3311	123	17	of	of	ADP
iajs-3311	123	18	maternal	maternal	ADJ
iajs-3311	123	19	transmission	transmission	NOUN
iajs-3311	123	20	.	.	PUNCT
iajs-3311	124	1	melas	mela	NOUN
iajs-3311	124	2	syndrome	syndrome	PROPN
iajs-3311	124	3	,	,	PUNCT
iajs-3311	124	4	which	which	PRON
iajs-3311	124	5	is	be	AUX
iajs-3311	124	6	also	also	ADV
iajs-3311	124	7	brought	bring	VERB
iajs-3311	124	8	on	on	ADP
iajs-3311	124	9	by	by	ADP
iajs-3311	124	10	the	the	DET
iajs-3311	124	11	same	same	ADJ
iajs-3311	124	12	mutation	mutation	NOUN
iajs-3311	124	13	in	in	ADP
iajs-3311	124	14	mtdna	mtdna	PROPN
iajs-3311	124	15	,	,	PUNCT
iajs-3311	124	16	is	be	AUX
iajs-3311	124	17	characterized	characterize	VERB
iajs-3311	124	18	by	by	ADP
iajs-3311	124	19	neurological	neurological	ADJ
iajs-3311	124	20	issues	issue	NOUN
iajs-3311	124	21	along	along	ADV
iajs-3311	124	22	with	with	ADP
iajs-3311	124	23	hearing	hear	VERB
iajs-3311	124	24	loss	loss	NOUN
iajs-3311	124	25	.	.	PUNCT
iajs-3311	125	1	stroke	stroke	NOUN
iajs-3311	125	2	,	,	PUNCT
iajs-3311	125	3	lactic	lactic	ADJ
iajs-3311	125	4	acidosis	acidosis	NOUN
iajs-3311	125	5	,	,	PUNCT
iajs-3311	125	6	mitochondrial	mitochondrial	ADJ
iajs-3311	125	7	myopathy	myopathy	ADJ
iajs-3311	125	8	,	,	PUNCT
iajs-3311	125	9	and	and	CCONJ
iajs-3311	125	10	encephalopathy	encephalopathy	NOUN
iajs-3311	125	11	are	be	AUX
iajs-3311	125	12	other	other	ADJ
iajs-3311	125	13	symptoms	symptom	NOUN
iajs-3311	125	14	of	of	ADP
iajs-3311	125	15	melas	melas	PROPN
iajs-3311	125	16	syndrome	syndrome	PROPN
iajs-3311	125	17	.	.	PUNCT
iajs-3311	126	1	neonatal	neonatal	ADJ
iajs-3311	126	2	diabetes	diabetes	NOUN
iajs-3311	126	3	can	can	AUX
iajs-3311	126	4	manifest	manifest	VERB
iajs-3311	126	5	at	at	ADP
iajs-3311	126	6	birth	birth	NOUN
iajs-3311	126	7	or	or	CCONJ
iajs-3311	126	8	within	within	ADP
iajs-3311	126	9	the	the	DET
iajs-3311	126	10	first	first	ADJ
iajs-3311	126	11	six	six	NUM
iajs-3311	126	12	months	month	NOUN
iajs-3311	126	13	of	of	ADP
iajs-3311	126	14	life	life	NOUN
iajs-3311	126	15	in	in	ADP
iajs-3311	126	16	both	both	CCONJ
iajs-3311	126	17	temporary	temporary	ADJ
iajs-3311	126	18	and	and	CCONJ
iajs-3311	126	19	chronic	chronic	ADJ
iajs-3311	126	20	types	type	NOUN
iajs-3311	126	21	[	[	X
iajs-3311	126	22	32	32	NUM
iajs-3311	126	23	]	]	PUNCT
iajs-3311	126	24	.	.	PUNCT
iajs-3311	127	1	the	the	DET
iajs-3311	127	2	primary	primary	ADJ
iajs-3311	127	3	kind	kind	NOUN
iajs-3311	127	4	of	of	ADP
iajs-3311	127	5	treatment	treatment	NOUN
iajs-3311	127	6	for	for	ADP
iajs-3311	127	7	neonatal	neonatal	ADJ
iajs-3311	127	8	diabetes	diabetes	NOUN
iajs-3311	127	9	has	have	AUX
iajs-3311	127	10	been	be	AUX
iajs-3311	127	11	linked	link	VERB
iajs-3311	127	12	to	to	ADP
iajs-3311	127	13	abnormalities	abnormality	NOUN
iajs-3311	127	14	in	in	ADP
iajs-3311	127	15	a	a	DET
iajs-3311	127	16	range	range	NOUN
iajs-3311	127	17	of	of	ADP
iajs-3311	127	18	genes	gene	NOUN
iajs-3311	127	19	and	and	CCONJ
iajs-3311	127	20	requires	require	VERB
iajs-3311	127	21	an	an	DET
iajs-3311	127	22	accurate	accurate	ADJ
iajs-3311	127	23	genetic	genetic	ADJ
iajs-3311	127	24	diagnosis	diagnosis	NOUN
iajs-3311	127	25	(	(	PUNCT
iajs-3311	127	26	kcjn11	kcjn11	ADV
iajs-3311	127	27	,	,	PUNCT
iajs-3311	127	28	sur1	sur1	PROPN
iajs-3311	127	29	,	,	PUNCT
iajs-3311	127	30	gck	gck	PROPN
iajs-3311	127	31	,	,	PUNCT
iajs-3311	127	32	ins	ins	PROPN
iajs-3311	127	33	,	,	PUNCT
iajs-3311	127	34	etc	etc	X
iajs-3311	127	35	.	.	X
iajs-3311	127	36	)	)	PUNCT
iajs-3311	127	37	.	.	PUNCT
iajs-3311	128	1	in	in	ADP
iajs-3311	128	2	addition	addition	NOUN
iajs-3311	128	3	to	to	ADP
iajs-3311	128	4	severe	severe	ADJ
iajs-3311	128	5	diabetes	diabetes	NOUN
iajs-3311	128	6	,	,	PUNCT
iajs-3311	128	7	people	people	NOUN
iajs-3311	128	8	with	with	ADP
iajs-3311	128	9	kcjn11	kcjn11	ADJ
iajs-3311	128	10	gene	gene	NOUN
iajs-3311	128	11	mutations	mutation	NOUN
iajs-3311	128	12	also	also	ADV
iajs-3311	128	13	have	have	VERB
iajs-3311	128	14	developmental	developmental	ADJ
iajs-3311	128	15	issues	issue	NOUN
iajs-3311	128	16	.	.	PUNCT
iajs-3311	129	1	these	these	DET
iajs-3311	129	2	symptoms	symptom	NOUN
iajs-3311	129	3	appear	appear	VERB
iajs-3311	129	4	to	to	PART
iajs-3311	129	5	be	be	AUX
iajs-3311	129	6	better	well	ADJ
iajs-3311	129	7	when	when	SCONJ
iajs-3311	129	8	high	high	ADJ
iajs-3311	129	9	-	-	PUNCT
iajs-3311	129	10	dose	dose	VERB
iajs-3311	129	11	sulfonylurea	sulfonylurea	NOUN
iajs-3311	129	12	therapy	therapy	NOUN
iajs-3311	129	13	is	be	AUX
iajs-3311	129	14	substituted	substitute	VERB
iajs-3311	129	15	for	for	ADP
iajs-3311	129	16	insulin	insulin	NOUN
iajs-3311	129	17	treatment	treatment	NOUN
iajs-3311	129	18	[	[	X
iajs-3311	129	19	33	33	NUM
iajs-3311	129	20	]	]	PUNCT
iajs-3311	129	21	.	.	PUNCT
iajs-3311	130	1	a	a	DET
iajs-3311	130	2	transient	transient	ADJ
iajs-3311	130	3	type	type	NOUN
iajs-3311	130	4	of	of	ADP
iajs-3311	130	5	diabetes	diabetes	NOUN
iajs-3311	130	6	called	call	VERB
iajs-3311	130	7	gestational	gestational	ADJ
iajs-3311	130	8	diabetes	diabetes	NOUN
iajs-3311	130	9	mellitus	mellitus	NOUN
iajs-3311	130	10	(	(	PUNCT
iajs-3311	130	11	gdm	gdm	NOUN
iajs-3311	130	12	)	)	PUNCT
iajs-3311	130	13	occurs	occur	VERB
iajs-3311	130	14	during	during	ADP
iajs-3311	130	15	pregnancy	pregnancy	NOUN
iajs-3311	130	16	as	as	ADP
iajs-3311	130	17	hyperglycemia	hyperglycemia	NOUN
iajs-3311	130	18	,	,	PUNCT
iajs-3311	130	19	which	which	PRON
iajs-3311	130	20	obviously	obviously	ADV
iajs-3311	130	21	does	do	AUX
iajs-3311	130	22	n't	not	PART
iajs-3311	130	23	have	have	VERB
iajs-3311	130	24	diabetes	diabetes	NOUN
iajs-3311	130	25	and	and	CCONJ
iajs-3311	130	26	disappears	disappear	VERB
iajs-3311	130	27	after	after	ADP
iajs-3311	130	28	delivery	delivery	NOUN
iajs-3311	130	29	.	.	PUNCT
iajs-3311	131	1	an	an	DET
iajs-3311	131	2	estimated	estimate	VERB
iajs-3311	131	3	sibling	sible	VERB
iajs-3311	131	4	risk	risk	NOUN
iajs-3311	131	5	ratio	ratio	NOUN
iajs-3311	131	6	of	of	ADP
iajs-3311	131	7	1.75	1.75	NUM
iajs-3311	131	8	was	be	AUX
iajs-3311	131	9	reported	report	VERB
iajs-3311	131	10	for	for	ADP
iajs-3311	131	11	gdm	gdm	NOUN
iajs-3311	131	12	[	[	X
iajs-3311	131	13	34	34	NUM
iajs-3311	131	14	,	,	PUNCT
iajs-3311	131	15	35	35	NUM
iajs-3311	131	16	]	]	PUNCT
iajs-3311	131	17	,	,	PUNCT
iajs-3311	131	18	despite	despite	SCONJ
iajs-3311	131	19	the	the	DET
iajs-3311	131	20	fact	fact	NOUN
iajs-3311	131	21	that	that	SCONJ
iajs-3311	131	22	changes	change	VERB
iajs-3311	131	23	to	to	ADP
iajs-3311	131	24	the	the	DET
iajs-3311	131	25	diagnostic	diagnostic	ADJ
iajs-3311	131	26	criteria	criterion	NOUN
iajs-3311	131	27	made	make	VERB
iajs-3311	131	28	it	it	PRON
iajs-3311	131	29	more	more	ADV
iajs-3311	131	30	challenging	challenging	ADJ
iajs-3311	131	31	to	to	PART
iajs-3311	131	32	identify	identify	VERB
iajs-3311	131	33	gdm	gdm	NOUN
iajs-3311	131	34	patients	patient	NOUN
iajs-3311	131	35	in	in	ADP
iajs-3311	131	36	the	the	DET
iajs-3311	131	37	past	past	NOUN
iajs-3311	131	38	and	and	CCONJ
iajs-3311	131	39	determine	determine	VERB
iajs-3311	131	40	heredity	heredity	NOUN
iajs-3311	131	41	accurately	accurately	ADV
iajs-3311	131	42	.	.	PUNCT
iajs-3311	132	1	it	it	PRON
iajs-3311	132	2	may	may	AUX
iajs-3311	132	3	help	help	VERB
iajs-3311	132	4	to	to	PART
iajs-3311	132	5	explain	explain	VERB
iajs-3311	132	6	why	why	SCONJ
iajs-3311	132	7	women	woman	NOUN
iajs-3311	132	8	with	with	ADP
iajs-3311	132	9	a	a	DET
iajs-3311	132	10	history	history	NOUN
iajs-3311	132	11	of	of	ADP
iajs-3311	132	12	gdm	gdm	NOUN
iajs-3311	132	13	are	be	AUX
iajs-3311	132	14	more	more	ADV
iajs-3311	132	15	likely	likely	ADJ
iajs-3311	132	16	to	to	PART
iajs-3311	132	17	develop	develop	VERB
iajs-3311	132	18	t2	t2	NOUN
iajs-3311	132	19	dm	dm	NUM
iajs-3311	133	1	[	[	X
iajs-3311	133	2	36	36	NUM
iajs-3311	133	3	,	,	PUNCT
iajs-3311	133	4	37	37	NUM
iajs-3311	133	5	]	]	PUNCT
iajs-3311	133	6	and	and	CCONJ
iajs-3311	133	7	that	that	SCONJ
iajs-3311	133	8	some	some	DET
iajs-3311	133	9	gdmassociated	gdmassociate	VERB
iajs-3311	133	10	polymorphisms	polymorphism	NOUN
iajs-3311	133	11	and	and	CCONJ
iajs-3311	133	12	t2d	t2d	NOUN
iajs-3311	133	13	risk	risk	NOUN
iajs-3311	133	14	variants	variant	NOUN
iajs-3311	133	15	have	have	AUX
iajs-3311	133	16	been	be	AUX
iajs-3311	133	17	found	find	VERB
iajs-3311	133	18	to	to	PART
iajs-3311	133	19	overlap	overlap	VERB
iajs-3311	133	20	[	[	X
iajs-3311	133	21	38,39	38,39	NOUN
iajs-3311	133	22	]	]	X
iajs-3311	133	23	.	.	PUNCT
iajs-3311	134	1	women	woman	NOUN
iajs-3311	134	2	with	with	ADP
iajs-3311	134	3	gdm	gdm	NOUN
iajs-3311	134	4	are	be	AUX
iajs-3311	134	5	more	more	ADV
iajs-3311	134	6	likely	likely	ADJ
iajs-3311	134	7	to	to	PART
iajs-3311	134	8	experience	experience	VERB
iajs-3311	134	9	macrosomia	macrosomia	NOUN
iajs-3311	134	10	in	in	ADP
iajs-3311	134	11	neonates	neonate	NOUN
iajs-3311	134	12	,	,	PUNCT
iajs-3311	134	13	fetal	fetal	ADJ
iajs-3311	134	14	ihjpas	ihjpa	NOUN
iajs-3311	134	15	.	.	PUNCT
iajs-3311	135	1	2024	2024	NUM
iajs-3311	135	2	,	,	PUNCT
iajs-3311	135	3	37	37	NUM
iajs-3311	135	4	(	(	PUNCT
iajs-3311	135	5	3	3	NUM
iajs-3311	135	6	)	)	PUNCT
iajs-3311	135	7	260	260	NUM
iajs-3311	135	8	hyperinsulinism	hyperinsulinism	NOUN
iajs-3311	135	9	,	,	PUNCT
iajs-3311	135	10	and	and	CCONJ
iajs-3311	135	11	unfavorable	unfavorable	ADJ
iajs-3311	135	12	pregnancy	pregnancy	NOUN
iajs-3311	135	13	outcomes	outcome	NOUN
iajs-3311	135	14	despite	despite	SCONJ
iajs-3311	135	15	the	the	DET
iajs-3311	135	16	fact	fact	NOUN
iajs-3311	135	17	that	that	SCONJ
iajs-3311	135	18	these	these	DET
iajs-3311	135	19	conditions	condition	NOUN
iajs-3311	135	20	are	be	AUX
iajs-3311	135	21	temporary	temporary	ADJ
iajs-3311	135	22	[	[	X
iajs-3311	135	23	40	40	NUM
iajs-3311	135	24	,	,	PUNCT
iajs-3311	135	25	41	41	NUM
iajs-3311	135	26	]	]	PUNCT
iajs-3311	135	27	.	.	PUNCT
iajs-3311	136	1	due	due	ADP
iajs-3311	136	2	to	to	ADP
iajs-3311	136	3	the	the	DET
iajs-3311	136	4	recent	recent	ADJ
iajs-3311	136	5	rapid	rapid	ADJ
iajs-3311	136	6	breakthroughs	breakthrough	NOUN
iajs-3311	136	7	in	in	ADP
iajs-3311	136	8	technology	technology	NOUN
iajs-3311	136	9	,	,	PUNCT
iajs-3311	136	10	this	this	PRON
iajs-3311	136	11	will	will	AUX
iajs-3311	136	12	be	be	AUX
iajs-3311	136	13	possible	possible	ADJ
iajs-3311	136	14	in	in	ADP
iajs-3311	136	15	the	the	DET
iajs-3311	136	16	not	not	PART
iajs-3311	136	17	-	-	PUNCT
iajs-3311	136	18	toodistant	toodistant	NOUN
iajs-3311	136	19	future	future	NOUN
iajs-3311	136	20	.	.	PUNCT
iajs-3311	137	1	despite	despite	SCONJ
iajs-3311	137	2	recent	recent	ADJ
iajs-3311	137	3	advancements	advancement	NOUN
iajs-3311	137	4	in	in	ADP
iajs-3311	137	5	genetic	genetic	ADJ
iajs-3311	137	6	discoveries	discovery	NOUN
iajs-3311	137	7	,	,	PUNCT
iajs-3311	137	8	they	they	PRON
iajs-3311	137	9	have	have	AUX
iajs-3311	137	10	n't	not	PART
iajs-3311	137	11	yet	yet	ADV
iajs-3311	137	12	had	have	VERB
iajs-3311	137	13	a	a	DET
iajs-3311	137	14	significant	significant	ADJ
iajs-3311	137	15	impact	impact	NOUN
iajs-3311	137	16	on	on	ADP
iajs-3311	137	17	our	our	PRON
iajs-3311	137	18	understanding	understanding	NOUN
iajs-3311	137	19	of	of	ADP
iajs-3311	137	20	the	the	DET
iajs-3311	137	21	pathogenesis	pathogenesis	NOUN
iajs-3311	137	22	of	of	ADP
iajs-3311	137	23	diabetes	diabetes	NOUN
iajs-3311	137	24	.	.	PUNCT
iajs-3311	138	1	they	they	PRON
iajs-3311	138	2	,	,	PUNCT
iajs-3311	138	3	however	however	ADV
iajs-3311	138	4	,	,	PUNCT
iajs-3311	138	5	have	have	AUX
iajs-3311	138	6	already	already	ADV
iajs-3311	138	7	made	make	VERB
iajs-3311	138	8	a	a	DET
iajs-3311	138	9	substantial	substantial	ADJ
iajs-3311	138	10	contribution	contribution	NOUN
iajs-3311	138	11	by	by	ADP
iajs-3311	138	12	revealing	reveal	VERB
iajs-3311	138	13	pathways	pathway	NOUN
iajs-3311	138	14	that	that	PRON
iajs-3311	138	15	could	could	AUX
iajs-3311	138	16	not	not	PART
iajs-3311	138	17	have	have	AUX
iajs-3311	138	18	been	be	AUX
iajs-3311	138	19	connected	connect	VERB
iajs-3311	138	20	to	to	ADP
iajs-3311	138	21	diabetes	diabetes	NOUN
iajs-3311	138	22	by	by	ADP
iajs-3311	138	23	presumptive	presumptive	ADJ
iajs-3311	138	24	models	model	NOUN
iajs-3311	138	25	that	that	PRON
iajs-3311	138	26	already	already	ADV
iajs-3311	138	27	exist	exist	VERB
iajs-3311	138	28	.	.	PUNCT
iajs-3311	139	1	nevertheless	nevertheless	ADV
iajs-3311	139	2	,	,	PUNCT
iajs-3311	139	3	it	it	PRON
iajs-3311	139	4	's	be	AUX
iajs-3311	139	5	critical	critical	ADJ
iajs-3311	139	6	to	to	PART
iajs-3311	139	7	remember	remember	VERB
iajs-3311	139	8	that	that	SCONJ
iajs-3311	139	9	diabetes	diabetes	NOUN
iajs-3311	139	10	is	be	AUX
iajs-3311	139	11	probably	probably	ADV
iajs-3311	139	12	a	a	DET
iajs-3311	139	13	far	far	ADV
iajs-3311	139	14	more	more	ADV
iajs-3311	139	15	complex	complex	ADJ
iajs-3311	139	16	condition	condition	NOUN
iajs-3311	139	17	than	than	ADP
iajs-3311	139	18	the	the	DET
iajs-3311	139	19	distinction	distinction	NOUN
iajs-3311	139	20	between	between	ADP
iajs-3311	139	21	t1	t1	PROPN
iajs-3311	139	22	dm	dm	NOUN
iajs-3311	139	23	and	and	CCONJ
iajs-3311	139	24	t2	t2	NOUN
iajs-3311	139	25	dm	dm	PROPN
iajs-3311	139	26	suggests	suggest	VERB
iajs-3311	139	27	.	.	PUNCT
iajs-3311	140	1	the	the	DET
iajs-3311	140	2	more	more	ADV
iajs-3311	140	3	exact	exact	ADJ
iajs-3311	140	4	division	division	NOUN
iajs-3311	140	5	into	into	ADP
iajs-3311	140	6	subgroups	subgroup	NOUN
iajs-3311	140	7	might	might	AUX
iajs-3311	140	8	accelerate	accelerate	VERB
iajs-3311	140	9	genetic	genetic	ADJ
iajs-3311	140	10	investigation	investigation	NOUN
iajs-3311	140	11	into	into	ADP
iajs-3311	140	12	t2	t2	PROPN
iajs-3311	140	13	dm	dm	PROPN
iajs-3311	140	14	and	and	CCONJ
iajs-3311	140	15	open	open	VERB
iajs-3311	140	16	the	the	DET
iajs-3311	140	17	door	door	NOUN
iajs-3311	140	18	to	to	ADP
iajs-3311	140	19	more	more	ADV
iajs-3311	140	20	customized	customize	VERB
iajs-3311	140	21	therapy	therapy	NOUN
iajs-3311	140	22	.	.	PUNCT
iajs-3311	141	1	it	it	PRON
iajs-3311	141	2	will	will	AUX
iajs-3311	141	3	also	also	ADV
iajs-3311	141	4	be	be	AUX
iajs-3311	141	5	necessary	necessary	ADJ
iajs-3311	141	6	to	to	PART
iajs-3311	141	7	use	use	VERB
iajs-3311	141	8	a	a	DET
iajs-3311	141	9	thorough	thorough	ADJ
iajs-3311	141	10	systems	system	NOUN
iajs-3311	141	11	biology	biology	NOUN
iajs-3311	141	12	approach	approach	NOUN
iajs-3311	141	13	to	to	PART
iajs-3311	141	14	understand	understand	VERB
iajs-3311	141	15	how	how	SCONJ
iajs-3311	141	16	genetic	genetic	ADJ
iajs-3311	141	17	diversity	diversity	NOUN
iajs-3311	141	18	influences	influence	VERB
iajs-3311	141	19	diabetes	diabetes	NOUN
iajs-3311	141	20	entirely	entirely	ADV
iajs-3311	141	21	.	.	PUNCT
iajs-3311	142	1	this	this	PRON
iajs-3311	142	2	will	will	AUX
iajs-3311	142	3	be	be	AUX
iajs-3311	142	4	attainable	attainable	ADJ
iajs-3311	142	5	in	in	ADP
iajs-3311	142	6	the	the	DET
iajs-3311	142	7	not	not	PART
iajs-3311	142	8	-	-	PUNCT
iajs-3311	142	9	toodistant	toodistant	NOUN
iajs-3311	142	10	future	future	NOUN
iajs-3311	142	11	because	because	SCONJ
iajs-3311	142	12	of	of	ADP
iajs-3311	142	13	the	the	DET
iajs-3311	142	14	recent	recent	ADJ
iajs-3311	142	15	rapid	rapid	ADJ
iajs-3311	142	16	advancements	advancement	NOUN
iajs-3311	142	17	in	in	ADP
iajs-3311	142	18	technology	technology	NOUN
iajs-3311	142	19	[	[	X
iajs-3311	142	20	42	42	NUM
iajs-3311	142	21	]	]	PUNCT
iajs-3311	142	22	.	.	PUNCT
iajs-3311	143	1	5	5	X
iajs-3311	143	2	.	.	X
iajs-3311	143	3	conclusion	conclusion	NOUN
iajs-3311	143	4	numerous	numerous	ADJ
iajs-3311	143	5	genetic	genetic	ADJ
iajs-3311	143	6	variations	variation	NOUN
iajs-3311	143	7	linked	link	VERB
iajs-3311	143	8	to	to	ADP
iajs-3311	143	9	t2	t2	NOUN
iajs-3311	143	10	dm	dm	NUM
iajs-3311	143	11	have	have	AUX
iajs-3311	143	12	made	make	VERB
iajs-3311	143	13	significant	significant	ADJ
iajs-3311	143	14	advances	advance	NOUN
iajs-3311	143	15	in	in	ADP
iajs-3311	143	16	learning	learn	VERB
iajs-3311	143	17	more	more	ADJ
iajs-3311	143	18	about	about	ADP
iajs-3311	143	19	genetic	genetic	ADJ
iajs-3311	143	20	science	science	NOUN
iajs-3311	143	21	.	.	PUNCT
iajs-3311	144	1	the	the	DET
iajs-3311	144	2	total	total	ADJ
iajs-3311	144	3	heritability	heritability	NOUN
iajs-3311	144	4	of	of	ADP
iajs-3311	144	5	diabetes	diabetes	NOUN
iajs-3311	144	6	has	have	AUX
iajs-3311	144	7	so	so	ADV
iajs-3311	144	8	far	far	ADV
iajs-3311	144	9	only	only	ADV
iajs-3311	144	10	partially	partially	ADV
iajs-3311	144	11	been	be	AUX
iajs-3311	144	12	explained	explain	VERB
iajs-3311	144	13	by	by	ADP
iajs-3311	144	14	the	the	DET
iajs-3311	144	15	genetic	genetic	ADJ
iajs-3311	144	16	landscape	landscape	NOUN
iajs-3311	144	17	of	of	ADP
iajs-3311	144	18	t2	t2	NOUN
iajs-3311	144	19	dm	dm	NUM
iajs-3311	144	20	susceptibility	susceptibility	NOUN
iajs-3311	144	21	.	.	PUNCT
iajs-3311	145	1	numerous	numerous	ADJ
iajs-3311	145	2	genetic	genetic	ADJ
iajs-3311	145	3	investigations	investigation	NOUN
iajs-3311	145	4	,	,	PUNCT
iajs-3311	145	5	family	family	NOUN
iajs-3311	145	6	sequencing	sequencing	NOUN
iajs-3311	145	7	,	,	PUNCT
iajs-3311	145	8	and	and	CCONJ
iajs-3311	145	9	meta	meta	NOUN
iajs-3311	145	10	-	-	PUNCT
iajs-3311	145	11	analyses	analysis	NOUN
iajs-3311	145	12	have	have	AUX
iajs-3311	145	13	all	all	PRON
iajs-3311	145	14	become	become	VERB
iajs-3311	145	15	effective	effective	ADJ
iajs-3311	145	16	methods	method	NOUN
iajs-3311	145	17	for	for	ADP
iajs-3311	145	18	comprehending	comprehend	VERB
iajs-3311	145	19	the	the	DET
iajs-3311	145	20	etiological	etiological	ADJ
iajs-3311	145	21	architecture	architecture	NOUN
iajs-3311	145	22	of	of	ADP
iajs-3311	145	23	t2	t2	NOUN
iajs-3311	145	24	dm	dm	NOUN
iajs-3311	145	25	.	.	PUNCT
iajs-3311	146	1	even	even	ADV
iajs-3311	146	2	though	though	SCONJ
iajs-3311	146	3	many	many	ADJ
iajs-3311	146	4	genetic	genetic	ADJ
iajs-3311	146	5	discoveries	discovery	NOUN
iajs-3311	146	6	are	be	AUX
iajs-3311	146	7	relatively	relatively	ADV
iajs-3311	146	8	recent	recent	ADJ
iajs-3311	146	9	and	and	CCONJ
iajs-3311	146	10	have	have	AUX
iajs-3311	146	11	not	not	PART
iajs-3311	146	12	yet	yet	ADV
iajs-3311	146	13	made	make	VERB
iajs-3311	146	14	a	a	DET
iajs-3311	146	15	significant	significant	ADJ
iajs-3311	146	16	impact	impact	NOUN
iajs-3311	146	17	on	on	ADP
iajs-3311	146	18	our	our	PRON
iajs-3311	146	19	comprehension	comprehension	NOUN
iajs-3311	146	20	of	of	ADP
iajs-3311	146	21	the	the	DET
iajs-3311	146	22	pathogenesis	pathogenesis	NOUN
iajs-3311	146	23	of	of	ADP
iajs-3311	146	24	diabetes	diabetes	NOUN
iajs-3311	146	25	,	,	PUNCT
iajs-3311	146	26	they	they	PRON
iajs-3311	146	27	have	have	AUX
iajs-3311	146	28	already	already	ADV
iajs-3311	146	29	contributed	contribute	VERB
iajs-3311	146	30	significantly	significantly	ADV
iajs-3311	146	31	by	by	ADP
iajs-3311	146	32	revealing	reveal	VERB
iajs-3311	146	33	pathways	pathway	NOUN
iajs-3311	146	34	that	that	PRON
iajs-3311	146	35	could	could	AUX
iajs-3311	146	36	not	not	PART
iajs-3311	146	37	have	have	AUX
iajs-3311	146	38	been	be	AUX
iajs-3311	146	39	linked	link	VERB
iajs-3311	146	40	to	to	ADP
iajs-3311	146	41	diabetes	diabetes	NOUN
iajs-3311	146	42	by	by	ADP
iajs-3311	146	43	presumptive	presumptive	ADJ
iajs-3311	146	44	models	model	NOUN
iajs-3311	146	45	that	that	PRON
iajs-3311	146	46	already	already	ADV
iajs-3311	146	47	exist	exist	VERB
iajs-3311	146	48	.	.	PUNCT
iajs-3311	147	1	the	the	DET
iajs-3311	147	2	ability	ability	NOUN
iajs-3311	147	3	to	to	PART
iajs-3311	147	4	classify	classify	VERB
iajs-3311	147	5	patients	patient	NOUN
iajs-3311	147	6	into	into	ADP
iajs-3311	147	7	subgroups	subgroup	NOUN
iajs-3311	147	8	based	base	VERB
iajs-3311	147	9	on	on	ADP
iajs-3311	147	10	the	the	DET
iajs-3311	147	11	genetics	genetic	NOUN
iajs-3311	147	12	of	of	ADP
iajs-3311	147	13	t2	t2	NOUN
iajs-3311	147	14	dm	dm	PROPN
iajs-3311	147	15	could	could	AUX
iajs-3311	147	16	facilitate	facilitate	VERB
iajs-3311	147	17	research	research	NOUN
iajs-3311	147	18	data	datum	NOUN
iajs-3311	147	19	.	.	PUNCT
iajs-3311	148	1	a	a	DET
iajs-3311	148	2	thorough	thorough	ADJ
iajs-3311	148	3	biology	biology	NOUN
iajs-3311	148	4	-	-	PUNCT
iajs-3311	148	5	systems	system	NOUN
iajs-3311	148	6	approach	approach	NOUN
iajs-3311	148	7	is	be	AUX
iajs-3311	148	8	also	also	ADV
iajs-3311	148	9	necessary	necessary	ADJ
iajs-3311	148	10	for	for	ADP
iajs-3311	148	11	developing	develop	VERB
iajs-3311	148	12	clinical	clinical	ADJ
iajs-3311	148	13	guidelines	guideline	NOUN
iajs-3311	148	14	on	on	ADP
iajs-3311	148	15	how	how	SCONJ
iajs-3311	148	16	genetic	genetic	ADJ
iajs-3311	148	17	diversity	diversity	NOUN
iajs-3311	148	18	influences	influence	VERB
iajs-3311	148	19	diabetes	diabetes	NOUN
iajs-3311	148	20	.	.	PUNCT
iajs-3311	149	1	acknowledgment	acknowledgment	NOUN
iajs-3311	149	2	many	many	ADJ
iajs-3311	149	3	thanks	thank	NOUN
iajs-3311	149	4	to	to	ADP
iajs-3311	149	5	the	the	DET
iajs-3311	149	6	department	department	NOUN
iajs-3311	149	7	of	of	ADP
iajs-3311	149	8	chemistry	chemistry	NOUN
iajs-3311	149	9	,	,	PUNCT
iajs-3311	149	10	college	college	NOUN
iajs-3311	149	11	of	of	ADP
iajs-3311	149	12	science	science	NOUN
iajs-3311	149	13	,	,	PUNCT
iajs-3311	149	14	university	university	NOUN
iajs-3311	149	15	of	of	ADP
iajs-3311	149	16	baghdad	baghdad	PROPN
iajs-3311	149	17	for	for	ADP
iajs-3311	149	18	facilitating	facilitate	VERB
iajs-3311	149	19	the	the	DET
iajs-3311	149	20	work	work	NOUN
iajs-3311	149	21	of	of	ADP
iajs-3311	149	22	the	the	DET
iajs-3311	149	23	practice	practice	NOUN
iajs-3311	149	24	parts	part	NOUN
iajs-3311	149	25	in	in	ADP
iajs-3311	149	26	this	this	DET
iajs-3311	149	27	article	article	NOUN
iajs-3311	149	28	.	.	PUNCT
iajs-3311	150	1	conflict	conflict	NOUN
iajs-3311	150	2	of	of	ADP
iajs-3311	150	3	interest	interest	NOUN
iajs-3311	150	4	there	there	PRON
iajs-3311	150	5	is	be	VERB
iajs-3311	150	6	no	no	DET
iajs-3311	150	7	conflict	conflict	NOUN
iajs-3311	150	8	of	of	ADP
iajs-3311	150	9	interest	interest	NOUN
iajs-3311	150	10	.	.	PUNCT
iajs-3311	151	1	funding	funding	NOUN
iajs-3311	151	2	there	there	PRON
iajs-3311	151	3	is	be	VERB
iajs-3311	151	4	no	no	DET
iajs-3311	151	5	funding	funding	NOUN
iajs-3311	151	6	for	for	ADP
iajs-3311	151	7	the	the	DET
iajs-3311	151	8	article	article	NOUN
iajs-3311	151	9	.	.	PUNCT
iajs-3311	152	1	ethical	ethical	ADJ
iajs-3311	152	2	clearance	clearance	NOUN
iajs-3311	152	3	the	the	DET
iajs-3311	152	4	samples	sample	NOUN
iajs-3311	152	5	were	be	AUX
iajs-3311	152	6	gained	gain	VERB
iajs-3311	152	7	according	accord	VERB
iajs-3311	152	8	to	to	ADP
iajs-3311	152	9	local	local	ADJ
iajs-3311	152	10	research	research	NOUN
iajs-3311	152	11	ethics	ethic	NOUN
iajs-3311	152	12	committee	committee	PROPN
iajs-3311	152	13	approval	approval	NOUN
iajs-3311	152	14	in	in	ADP
iajs-3311	152	15	iraqi	iraqi	ADJ
iajs-3311	152	16	ministry	ministry	PROPN
iajs-3311	152	17	of	of	ADP
iajs-3311	152	18	health	health	PROPN
iajs-3311	152	19	no	no	PROPN
iajs-3311	152	20	.	.	PROPN
iajs-3311	152	21	3137	3137	NUM
iajs-3311	152	22	on	on	ADP
iajs-3311	152	23	20/12/2021	20/12/2021	NUM
iajs-3311	152	24	.	.	PUNCT
iajs-3311	153	1	ihjpas	ihjpas	PROPN
iajs-3311	153	2	.	.	PUNCT
iajs-3311	154	1	2024	2024	NUM
iajs-3311	154	2	,	,	PUNCT
iajs-3311	154	3	37	37	NUM
iajs-3311	154	4	(	(	PUNCT
iajs-3311	154	5	3	3	NUM
iajs-3311	154	6	)	)	PUNCT
iajs-3311	154	7	261	261	NUM
iajs-3311	154	8	references	reference	NOUN
iajs-3311	154	9	1	1	NUM
iajs-3311	154	10	.	.	PUNCT
iajs-3311	155	1	farhan	farhan	PROPN
iajs-3311	155	2	,	,	PUNCT
iajs-3311	155	3	l.o	l.o	PROPN
iajs-3311	155	4	.	.	PROPN
iajs-3311	155	5	determanation	determanation	NOUN
iajs-3311	155	6	of	of	ADP
iajs-3311	155	7	several	several	ADJ
iajs-3311	155	8	biochemical	biochemical	ADJ
iajs-3311	155	9	parameters	parameter	NOUN
iajs-3311	155	10	in	in	ADP
iajs-3311	155	11	sera	sera	NOUN
iajs-3311	155	12	of	of	ADP
iajs-3311	155	13	iraqi	iraqi	ADJ
iajs-3311	155	14	patients	patient	NOUN
iajs-3311	155	15	with	with	ADP
iajs-3311	155	16	type	type	NOUN
iajs-3311	155	17	2	2	NUM
iajs-3311	155	18	diabetes	diabetes	NOUN
iajs-3311	155	19	.	.	PUNCT
iajs-3311	156	1	baghdad	baghdad	PROPN
iajs-3311	156	2	science	science	PROPN
iajs-3311	156	3	journal	journal	PROPN
iajs-3311	156	4	2015	2015	NUM
iajs-3311	156	5	,	,	PUNCT
iajs-3311	156	6	12(2	12(2	NUM
iajs-3311	156	7	)	)	PUNCT
iajs-3311	156	8	,	,	PUNCT
iajs-3311	156	9	362	362	NUM
iajs-3311	156	10	-	-	SYM
iajs-3311	156	11	370	370	NUM
iajs-3311	156	12	.	.	PUNCT
iajs-3311	157	1	https://doi.org/10.21123/bsj.2015.12.2.362-370	https://doi.org/10.21123/bsj.2015.12.2.362-370	NOUN
iajs-3311	157	2	.	.	PUNCT
iajs-3311	158	1	2	2	NUM
iajs-3311	158	2	.	.	X
iajs-3311	158	3	hassan	hassan	PROPN
iajs-3311	158	4	,	,	PUNCT
iajs-3311	158	5	h.	h.	PROPN
iajs-3311	158	6	;	;	PUNCT
iajs-3311	158	7	kadhim	kadhim	ADJ
iajs-3311	158	8	,	,	PUNCT
iajs-3311	158	9	n.	n.	NOUN
iajs-3311	158	10	;	;	PUNCT
iajs-3311	158	11	jassim	jassim	PROPN
iajs-3311	158	12	,	,	PUNCT
iajs-3311	158	13	m.	m.	VERB
iajs-3311	158	14	the	the	DET
iajs-3311	158	15	impact	impact	NOUN
iajs-3311	158	16	of	of	ADP
iajs-3311	158	17	oxidative	oxidative	ADJ
iajs-3311	158	18	stress	stress	NOUN
iajs-3311	158	19	on	on	ADP
iajs-3311	158	20	the	the	DET
iajs-3311	158	21	activity	activity	NOUN
iajs-3311	158	22	of	of	ADP
iajs-3311	158	23	adenosine	adenosine	ADJ
iajs-3311	158	24	deaminase	deaminase	NOUN
iajs-3311	158	25	and	and	CCONJ
iajs-3311	158	26	its	its	PRON
iajs-3311	158	27	isoenzymes	isoenzyme	NOUN
iajs-3311	158	28	in	in	ADP
iajs-3311	158	29	nephropathy	nephropathy	ADJ
iajs-3311	158	30	patients	patient	NOUN
iajs-3311	158	31	from	from	ADP
iajs-3311	158	32	wasit	wasit	NOUN
iajs-3311	158	33	-	-	PUNCT
iajs-3311	158	34	iraq	iraq	PROPN
iajs-3311	158	35	.	.	PUNCT
iajs-3311	159	1	international	international	ADJ
iajs-3311	159	2	journal	journal	PROPN
iajs-3311	159	3	of	of	ADP
iajs-3311	159	4	health	health	PROPN
iajs-3311	159	5	sciences	science	NOUN
iajs-3311	159	6	2022	2022	NUM
iajs-3311	159	7	,	,	PUNCT
iajs-3311	159	8	6(s8	6(s8	NUM
iajs-3311	159	9	)	)	PUNCT
iajs-3311	159	10	,	,	PUNCT
iajs-3311	159	11	49684979.https://doi.org/10.53730/ijhs.v6ns8.13342	49684979.https://doi.org/10.53730/ijhs.v6ns8.13342	NUM
iajs-3311	159	12	.	.	PUNCT
iajs-3311	160	1	3	3	NUM
iajs-3311	160	2	.	.	X
iajs-3311	160	3	alaaraji	alaaraji	PROPN
iajs-3311	160	4	,	,	PUNCT
iajs-3311	160	5	s.f	s.f	PROPN
iajs-3311	160	6	.	.	PROPN
iajs-3311	160	7	;	;	PUNCT
iajs-3311	160	8	alrawi	alrawi	PROPN
iajs-3311	160	9	,	,	PUNCT
iajs-3311	160	10	k.f	k.f	PROPN
iajs-3311	160	11	.	.	PROPN
iajs-3311	160	12	;	;	PUNCT
iajs-3311	160	13	allah	allah	PROPN
iajs-3311	160	14	,	,	PUNCT
iajs-3311	160	15	p.h.s	p.h.s	NOUN
iajs-3311	160	16	.	.	PUNCT
iajs-3311	160	17	;	;	PUNCT
iajs-3311	160	18	alkrwi	alkrwi	PROPN
iajs-3311	160	19	,	,	PUNCT
iajs-3311	160	20	e.n	e.n	PROPN
iajs-3311	160	21	.	.	PROPN
iajs-3311	160	22	evaluation	evaluation	NOUN
iajs-3311	160	23	of	of	ADP
iajs-3311	160	24	serum	serum	PROPN
iajs-3311	160	25	malondialdehyde	malondialdehyde	PROPN
iajs-3311	160	26	,	,	PUNCT
iajs-3311	160	27	glutathione	glutathione	NOUN
iajs-3311	160	28	and	and	CCONJ
iajs-3311	160	29	lipid	lipid	NOUN
iajs-3311	160	30	profile	profile	NOUN
iajs-3311	160	31	levels	level	NOUN
iajs-3311	160	32	in	in	ADP
iajs-3311	160	33	iraqi	iraqi	ADJ
iajs-3311	160	34	females	female	NOUN
iajs-3311	160	35	with	with	ADP
iajs-3311	160	36	type	type	NOUN
iajs-3311	160	37	2	2	NUM
iajs-3311	160	38	diabetes	diabetes	NOUN
iajs-3311	160	39	mellitus	mellitus	NOUN
iajs-3311	160	40	.	.	PUNCT
iajs-3311	161	1	baghdad	baghdad	PROPN
iajs-3311	161	2	science	science	PROPN
iajs-3311	161	3	journal	journal	PROPN
iajs-3311	161	4	2016	2016	NUM
iajs-3311	161	5	,	,	PUNCT
iajs-3311	161	6	13(2s	13(2s	NUM
iajs-3311	161	7	)	)	PUNCT
iajs-3311	161	8	,	,	PUNCT
iajs-3311	161	9	383	383	NUM
iajs-3311	161	10	-	-	SYM
iajs-3311	161	11	391	391	NUM
iajs-3311	161	12	.	.	PUNCT
iajs-3311	162	1	https://doi.org/10.21123/bsj.2016.13.2.2ncc.0383	https://doi.org/10.21123/bsj.2016.13.2.2ncc.0383	PROPN
iajs-3311	162	2	.	.	PUNCT
iajs-3311	163	1	4	4	X
iajs-3311	163	2	.	.	X
iajs-3311	163	3	ahmed	ahmed	PROPN
iajs-3311	163	4	,	,	PUNCT
iajs-3311	163	5	m.h	m.h	PROPN
iajs-3311	163	6	.	.	PROPN
iajs-3311	163	7	;	;	PUNCT
iajs-3311	163	8	haddad	haddad	PROPN
iajs-3311	163	9	,	,	PUNCT
iajs-3311	163	10	n.i	n.i	PROPN
iajs-3311	163	11	.	.	PROPN
iajs-3311	163	12	;	;	PUNCT
iajs-3311	163	13	nori	nori	PROPN
iajs-3311	163	14	,	,	PUNCT
iajs-3311	163	15	e.	e.	PROPN
iajs-3311	163	16	correlation	correlation	NOUN
iajs-3311	163	17	between	between	ADP
iajs-3311	163	18	albuminuria	albuminuria	PROPN
iajs-3311	163	19	levels	level	NOUN
iajs-3311	163	20	and	and	CCONJ
iajs-3311	163	21	chitinase	chitinase	VERB
iajs-3311	163	22	3	3	NUM
iajs-3311	163	23	like	like	ADP
iajs-3311	163	24	1	1	NUM
iajs-3311	163	25	protein	protein	NOUN
iajs-3311	163	26	in	in	ADP
iajs-3311	163	27	iraqi	iraqi	ADJ
iajs-3311	163	28	patients	patient	NOUN
iajs-3311	163	29	with	with	ADP
iajs-3311	163	30	type	type	NOUN
iajs-3311	163	31	2	2	NUM
iajs-3311	163	32	diabetes	diabetes	NOUN
iajs-3311	163	33	mellitus	mellitus	NOUN
iajs-3311	163	34	.	.	PUNCT
iajs-3311	164	1	iraqi	iraqi	ADJ
iajs-3311	164	2	journal	journal	PROPN
iajs-3311	164	3	of	of	ADP
iajs-3311	164	4	science	science	NOUN
iajs-3311	164	5	2022	2022	NUM
iajs-3311	164	6	,	,	PUNCT
iajs-3311	164	7	63(1	63(1	NUM
iajs-3311	164	8	)	)	PUNCT
iajs-3311	164	9	,	,	PUNCT
iajs-3311	164	10	21	21	NUM
iajs-3311	164	11	-	-	SYM
iajs-3311	164	12	32	32	NUM
iajs-3311	164	13	.	.	PUNCT
iajs-3311	165	1	https://doi.org/10.24996/ijs.2022.63.1.3	https://doi.org/10.24996/ijs.2022.63.1.3	VERB
iajs-3311	165	2	.	.	PROPN
iajs-3311	166	1	5	5	NUM
iajs-3311	166	2	.	.	X
iajs-3311	166	3	malecki	malecki	PROPN
iajs-3311	166	4	,	,	PUNCT
iajs-3311	166	5	m.t	m.t	PROPN
iajs-3311	166	6	.	.	PROPN
iajs-3311	166	7	genetics	genetic	NOUN
iajs-3311	166	8	of	of	ADP
iajs-3311	166	9	type	type	NOUN
iajs-3311	166	10	2	2	NUM
iajs-3311	166	11	diabetes	diabetes	NOUN
iajs-3311	166	12	mellitus	mellitus	NOUN
iajs-3311	166	13	.	.	PUNCT
iajs-3311	167	1	diabetes	diabetes	NOUN
iajs-3311	167	2	research	research	NOUN
iajs-3311	167	3	and	and	CCONJ
iajs-3311	167	4	clinical	clinical	ADJ
iajs-3311	167	5	practice	practice	NOUN
iajs-3311	167	6	2005	2005	NUM
iajs-3311	167	7	,	,	PUNCT
iajs-3311	167	8	68(suupl	68(suupl	NUM
iajs-3311	167	9	1	1	NUM
iajs-3311	167	10	)	)	PUNCT
iajs-3311	167	11	,	,	PUNCT
iajs-3311	167	12	s10	s10	NOUN
iajs-3311	167	13	-	-	PUNCT
iajs-3311	167	14	s21	s21	NOUN
iajs-3311	167	15	.	.	PUNCT
iajs-3311	168	1	https://doi.org/10.1016/j.diabres.2005.03.003	https://doi.org/10.1016/j.diabres.2005.03.003	PROPN
iajs-3311	168	2	.	.	PUNCT
iajs-3311	169	1	6	6	NUM
iajs-3311	169	2	.	.	X
iajs-3311	169	3	halestrap	halestrap	PROPN
iajs-3311	169	4	,	,	PUNCT
iajs-3311	169	5	a.p	a.p	PROPN
iajs-3311	169	6	.	.	PROPN
iajs-3311	170	1	the	the	DET
iajs-3311	170	2	slc16	slc16	PROPN
iajs-3311	170	3	gene	gene	NOUN
iajs-3311	170	4	family	family	NOUN
iajs-3311	170	5	–	–	PUNCT
iajs-3311	170	6	structure	structure	NOUN
iajs-3311	170	7	,	,	PUNCT
iajs-3311	170	8	role	role	NOUN
iajs-3311	170	9	and	and	CCONJ
iajs-3311	170	10	regulation	regulation	NOUN
iajs-3311	170	11	in	in	ADP
iajs-3311	170	12	health	health	NOUN
iajs-3311	170	13	and	and	CCONJ
iajs-3311	170	14	disease	disease	NOUN
iajs-3311	170	15	.	.	PUNCT
iajs-3311	171	1	molecular	molecular	ADJ
iajs-3311	171	2	aspects	aspect	NOUN
iajs-3311	171	3	of	of	ADP
iajs-3311	171	4	medicine	medicine	NOUN
iajs-3311	171	5	2013	2013	NUM
iajs-3311	171	6	,	,	PUNCT
iajs-3311	171	7	34	34	NUM
iajs-3311	171	8	(	(	PUNCT
iajs-3311	171	9	2	2	NUM
iajs-3311	171	10	-	-	SYM
iajs-3311	171	11	3	3	NUM
iajs-3311	171	12	)	)	PUNCT
iajs-3311	171	13	,	,	PUNCT
iajs-3311	171	14	337	337	NUM
iajs-3311	171	15	-	-	SYM
iajs-3311	171	16	349	349	NUM
iajs-3311	171	17	.	.	PUNCT
iajs-3311	172	1	https://doi.org/10.1016/j.mam.2012.05.003	https://doi.org/10.1016/j.mam.2012.05.003	PROPN
iajs-3311	172	2	.	.	PROPN
iajs-3311	172	3	7	7	NUM
iajs-3311	172	4	.	.	X
iajs-3311	172	5	hara	hara	PROPN
iajs-3311	172	6	,	,	PUNCT
iajs-3311	172	7	k.	k.	PROPN
iajs-3311	172	8	;	;	PUNCT
iajs-3311	172	9	shojima	shojima	PROPN
iajs-3311	172	10	,	,	PUNCT
iajs-3311	172	11	n.	n.	PROPN
iajs-3311	172	12	;	;	PUNCT
iajs-3311	172	13	hosoe	hosoe	PROPN
iajs-3311	172	14	,	,	PUNCT
iajs-3311	172	15	j.	j.	PROPN
iajs-3311	172	16	;	;	PUNCT
iajs-3311	172	17	kadowaki	kadowaki	PROPN
iajs-3311	172	18	,	,	PUNCT
iajs-3311	172	19	t.	t.	NOUN
iajs-3311	172	20	genetic	genetic	ADJ
iajs-3311	172	21	architecture	architecture	NOUN
iajs-3311	172	22	of	of	ADP
iajs-3311	172	23	type	type	NOUN
iajs-3311	172	24	2	2	NUM
iajs-3311	172	25	diabetes	diabetes	NOUN
iajs-3311	172	26	.	.	PUNCT
iajs-3311	173	1	biochemical	biochemical	ADJ
iajs-3311	173	2	and	and	CCONJ
iajs-3311	173	3	biophysical	biophysical	ADJ
iajs-3311	173	4	research	research	NOUN
iajs-3311	173	5	communications	communication	NOUN
iajs-3311	173	6	2014	2014	NUM
iajs-3311	173	7	,	,	PUNCT
iajs-3311	173	8	452	452	NUM
iajs-3311	173	9	(	(	PUNCT
iajs-3311	173	10	2	2	NUM
iajs-3311	173	11	)	)	PUNCT
iajs-3311	173	12	,	,	PUNCT
iajs-3311	173	13	213	213	NUM
iajs-3311	173	14	-	-	SYM
iajs-3311	173	15	220	220	NUM
iajs-3311	173	16	.	.	PUNCT
iajs-3311	173	17	https://doi.org/10.1016/j.bbrc.2014.08.012	https://doi.org/10.1016/j.bbrc.2014.08.012	NOUN
iajs-3311	173	18	.	.	PUNCT
iajs-3311	174	1	8	8	NUM
iajs-3311	174	2	.	.	X
iajs-3311	175	1	zhao	zhao	PROPN
iajs-3311	175	2	,	,	PUNCT
iajs-3311	175	3	y.	y.	PROPN
iajs-3311	175	4	;	;	PUNCT
iajs-3311	175	5	feng	feng	PROPN
iajs-3311	175	6	,	,	PUNCT
iajs-3311	175	7	z.	z.	PROPN
iajs-3311	175	8	;	;	PUNCT
iajs-3311	175	9	ding	ding	NOUN
iajs-3311	175	10	,	,	PUNCT
iajs-3311	175	11	q.	q.	NOUN
iajs-3311	175	12	type	type	NOUN
iajs-3311	175	13	2	2	NUM
iajs-3311	175	14	diabetes	diabetes	NOUN
iajs-3311	175	15	variants	variant	NOUN
iajs-3311	175	16	in	in	ADP
iajs-3311	175	17	the	the	DET
iajs-3311	175	18	slc16a11	slc16a11	NOUN
iajs-3311	175	19	coding	code	VERB
iajs-3311	175	20	region	region	NOUN
iajs-3311	175	21	are	be	AUX
iajs-3311	175	22	not	not	PART
iajs-3311	175	23	loss	loss	NOUN
iajs-3311	175	24	of	of	ADP
iajs-3311	175	25	function	function	NOUN
iajs-3311	175	26	mutations	mutation	NOUN
iajs-3311	175	27	.	.	PUNCT
iajs-3311	176	1	cell	cell	NOUN
iajs-3311	176	2	reports	report	VERB
iajs-3311	176	3	2019	2019	NUM
iajs-3311	176	4	,	,	PUNCT
iajs-3311	176	5	29	29	NUM
iajs-3311	176	6	(	(	PUNCT
iajs-3311	176	7	3	3	NUM
iajs-3311	176	8	)	)	PUNCT
iajs-3311	176	9	,	,	PUNCT
iajs-3311	176	10	781	781	NUM
iajs-3311	176	11	-	-	SYM
iajs-3311	176	12	784	784	NUM
iajs-3311	176	13	.	.	PUNCT
iajs-3311	177	1	https://doi.org/10.1016/j.celrep.2019.09.022	https://doi.org/10.1016/j.celrep.2019.09.022	NOUN
iajs-3311	177	2	.	.	PUNCT
iajs-3311	178	1	9	9	NUM
iajs-3311	178	2	.	.	X
iajs-3311	178	3	kimura	kimura	NOUN
iajs-3311	178	4	,	,	PUNCT
iajs-3311	178	5	y.	y.	PROPN
iajs-3311	178	6	;	;	PUNCT
iajs-3311	178	7	higuchi	higuchi	PROPN
iajs-3311	178	8	,	,	PUNCT
iajs-3311	178	9	i.	i.	PROPN
iajs-3311	178	10	;	;	PUNCT
iajs-3311	178	11	kobayashi	kobayashi	PROPN
iajs-3311	178	12	,	,	PUNCT
iajs-3311	178	13	m.	m.	NOUN
iajs-3311	178	14	;	;	PUNCT
iajs-3311	178	15	furugen	furugen	PROPN
iajs-3311	178	16	,	,	PUNCT
iajs-3311	178	17	a.	a.	PROPN
iajs-3311	178	18	;	;	PUNCT
iajs-3311	178	19	narumi	narumi	PROPN
iajs-3311	178	20	,	,	PUNCT
iajs-3311	178	21	k.	k.	PROPN
iajs-3311	178	22	;	;	PUNCT
iajs-3311	178	23	suzuki	suzuki	PROPN
iajs-3311	178	24	,	,	PUNCT
iajs-3311	178	25	y.	y.	PROPN
iajs-3311	178	26	;	;	PUNCT
iajs-3311	178	27	miyoshi	miyoshi	PROPN
iajs-3311	178	28	,	,	PUNCT
iajs-3311	178	29	h.	h.	PROPN
iajs-3311	178	30	;	;	PUNCT
iajs-3311	178	31	nakamura	nakamura	PROPN
iajs-3311	178	32	,	,	PUNCT
iajs-3311	178	33	a.	a.	NOUN
iajs-3311	178	34	;	;	PUNCT
iajs-3311	178	35	atsumi	atsumi	PROPN
iajs-3311	178	36	,	,	PUNCT
iajs-3311	178	37	t.	t.	PROPN
iajs-3311	178	38	;	;	PUNCT
iajs-3311	178	39	iseki	iseki	PROPN
iajs-3311	178	40	,	,	PUNCT
iajs-3311	178	41	k.	k.	PROPN
iajs-3311	178	42	,	,	PUNCT
iajs-3311	178	43	the	the	DET
iajs-3311	178	44	association	association	NOUN
iajs-3311	178	45	between	between	ADP
iajs-3311	178	46	slc16a11	slc16a11	PROPN
iajs-3311	178	47	haplotype	haplotype	NOUN
iajs-3311	178	48	and	and	CCONJ
iajs-3311	178	49	lipid	lipid	ADJ
iajs-3311	178	50	metabolism	metabolism	NOUN
iajs-3311	178	51	in	in	ADP
iajs-3311	178	52	japanese	japanese	ADJ
iajs-3311	178	53	patients	patient	NOUN
iajs-3311	178	54	with	with	ADP
iajs-3311	178	55	type	type	NOUN
iajs-3311	178	56	2	2	NUM
iajs-3311	178	57	diabetes	diabetes	NOUN
iajs-3311	178	58	.	.	PUNCT
iajs-3311	179	1	drug	drug	NOUN
iajs-3311	179	2	metabolism	metabolism	NOUN
iajs-3311	179	3	and	and	CCONJ
iajs-3311	179	4	pharmacokinetics	pharmacokinetic	NOUN
iajs-3311	179	5	2021	2021	NUM
iajs-3311	179	6	,	,	PUNCT
iajs-3311	179	7	37	37	NUM
iajs-3311	179	8	,	,	PUNCT
iajs-3311	179	9	100376	100376	NUM
iajs-3311	179	10	.	.	PUNCT
iajs-3311	180	1	https://doi.org/10.1016/j.dmpk.2020.100376	https://doi.org/10.1016/j.dmpk.2020.100376	NOUN
iajs-3311	180	2	.	.	PUNCT
iajs-3311	181	1	10	10	NUM
iajs-3311	181	2	.	.	PUNCT
iajs-3311	182	1	american	american	ADJ
iajs-3311	182	2	diabetes	diabetes	PROPN
iajs-3311	182	3	association	association	PROPN
iajs-3311	182	4	.	.	PUNCT
iajs-3311	183	1	diagnosis	diagnosis	NOUN
iajs-3311	183	2	and	and	CCONJ
iajs-3311	183	3	classification	classification	NOUN
iajs-3311	183	4	of	of	ADP
iajs-3311	183	5	diabetes	diabetes	NOUN
iajs-3311	183	6	mellitus	mellitus	NOUN
iajs-3311	183	7	.	.	PUNCT
iajs-3311	184	1	diabetes	diabetes	NOUN
iajs-3311	184	2	care	care	NOUN
iajs-3311	184	3	.	.	PUNCT
iajs-3311	185	1	2010	2010	NUM
iajs-3311	185	2	,	,	PUNCT
iajs-3311	185	3	33(suppl	33(suppl	NUM
iajs-3311	185	4	1	1	NUM
iajs-3311	185	5	)	)	PUNCT
iajs-3311	185	6	,	,	PUNCT
iajs-3311	185	7	s62–69	s62–69	PROPN
iajs-3311	185	8	.	.	PUNCT
iajs-3311	186	1	https://doi.org/10.2337/dc09-1848	https://doi.org/10.2337/dc09-1848	PROPN
iajs-3311	186	2	.	.	PROPN
iajs-3311	187	1	11	11	NUM
iajs-3311	187	2	.	.	X
iajs-3311	188	1	jaid	jaid	PROPN
iajs-3311	188	2	,	,	PUNCT
iajs-3311	188	3	h.k	h.k	PROPN
iajs-3311	188	4	.	.	PROPN
iajs-3311	188	5	;	;	PUNCT
iajs-3311	188	6	khaleel	khaleel	PROPN
iajs-3311	188	7	,	,	PUNCT
iajs-3311	188	8	f.m	f.m	PROPN
iajs-3311	188	9	.	.	PROPN
iajs-3311	188	10	;	;	PUNCT
iajs-3311	188	11	salman	salman	PROPN
iajs-3311	188	12	,	,	PUNCT
iajs-3311	188	13	i.n	i.n	PROPN
iajs-3311	188	14	.	.	PROPN
iajs-3311	188	15	;	;	PUNCT
iajs-3311	188	16	abd	abd	PROPN
iajs-3311	188	17	,	,	PUNCT
iajs-3311	188	18	b.a	b.a	PROPN
iajs-3311	188	19	.	.	PROPN
iajs-3311	188	20	evaluation	evaluation	NOUN
iajs-3311	188	21	of	of	ADP
iajs-3311	188	22	insulin	insulin	NOUN
iajs-3311	188	23	resistance	resistance	NOUN
iajs-3311	188	24	and	and	CCONJ
iajs-3311	188	25	glutathione	glutathione	NOUN
iajs-3311	188	26	-	-	PUNCT
iajs-3311	188	27	s	s	NOUN
iajs-3311	188	28	-	-	NOUN
iajs-3311	188	29	transferase	transferase	NOUN
iajs-3311	188	30	in	in	ADP
iajs-3311	188	31	iraqi	iraqi	ADJ
iajs-3311	188	32	patients	patient	NOUN
iajs-3311	188	33	with	with	ADP
iajs-3311	188	34	type	type	NOUN
iajs-3311	188	35	2	2	NUM
iajs-3311	188	36	diabetes	diabetes	NOUN
iajs-3311	188	37	mellitus	mellitus	NOUN
iajs-3311	188	38	and	and	CCONJ
iajs-3311	188	39	diabetic	diabetic	ADJ
iajs-3311	188	40	peripheral	peripheral	ADJ
iajs-3311	188	41	neuropathy	neuropathy	ADJ
iajs-3311	188	42	.	.	PUNCT
iajs-3311	189	1	ibn	ibn	PROPN
iajs-3311	189	2	al	al	PROPN
iajs-3311	189	3	-	-	PUNCT
iajs-3311	189	4	haitham	haitham	PROPN
iajs-3311	189	5	journal	journal	PROPN
iajs-3311	189	6	for	for	ADP
iajs-3311	189	7	pure	pure	ADJ
iajs-3311	189	8	and	and	CCONJ
iajs-3311	189	9	applied	applied	ADJ
iajs-3311	189	10	sciences	science	NOUN
iajs-3311	189	11	.	.	PUNCT
iajs-3311	189	12	2022	2022	NUM
iajs-3311	189	13	,	,	PUNCT
iajs-3311	189	14	35(4	35(4	NUM
iajs-3311	189	15	)	)	PUNCT
iajs-3311	189	16	,	,	PUNCT
iajs-3311	189	17	194–205	194–205	NUM
iajs-3311	189	18	.	.	PUNCT
iajs-3311	190	1	https://doi.org/10.30526/35.4.2916	https://doi.org/10.30526/35.4.2916	PROPN
iajs-3311	190	2	.	.	PROPN
iajs-3311	191	1	12	12	NUM
iajs-3311	191	2	.	.	PUNCT
iajs-3311	191	3	groop	groop	PROPN
iajs-3311	191	4	,	,	PUNCT
iajs-3311	191	5	l.	l.	PROPN
iajs-3311	191	6	;	;	PUNCT
iajs-3311	191	7	lyssenko	lyssenko	PROPN
iajs-3311	191	8	,	,	PUNCT
iajs-3311	191	9	v.	v.	ADP
iajs-3311	191	10	genetics	genetic	NOUN
iajs-3311	191	11	of	of	ADP
iajs-3311	191	12	type	type	NOUN
iajs-3311	191	13	2	2	NUM
iajs-3311	191	14	diabetes	diabetes	NOUN
iajs-3311	191	15	.	.	PUNCT
iajs-3311	192	1	an	an	DET
iajs-3311	192	2	overview	overview	NOUN
iajs-3311	192	3	.	.	PUNCT
iajs-3311	193	1	endocrinol	endocrinol	NOUN
iajs-3311	193	2	.	.	PUNCT
iajs-3311	194	1	nutr	nutr	PROPN
iajs-3311	194	2	2009	2009	NUM
iajs-3311	194	3	,	,	PUNCT
iajs-3311	194	4	56	56	NUM
iajs-3311	194	5	(	(	PUNCT
iajs-3311	194	6	suppl	suppl	ADJ
iajs-3311	194	7	4	4	NUM
iajs-3311	194	8	)	)	PUNCT
iajs-3311	194	9	,	,	PUNCT
iajs-3311	194	10	34–37	34–37	NOUN
iajs-3311	194	11	.	.	PUNCT
iajs-3311	195	1	https://doi.org/10.3390/genes6010087	https://doi.org/10.3390/genes6010087	PROPN
iajs-3311	195	2	.	.	PUNCT
iajs-3311	196	1	13	13	NUM
iajs-3311	196	2	.	.	X
iajs-3311	197	1	ostrow	ostrow	PROPN
iajs-3311	197	2	,	,	PUNCT
iajs-3311	197	3	b.	b.	PROPN
iajs-3311	197	4	;	;	PUNCT
iajs-3311	197	5	sibbald	sibbald	PROPN
iajs-3311	197	6	,	,	PUNCT
iajs-3311	197	7	r.	r.	PROPN
iajs-3311	197	8	g.	g.	PROPN
iajs-3311	197	9	;	;	PUNCT
iajs-3311	197	10	taha	taha	PROPN
iajs-3311	197	11	,	,	PUNCT
iajs-3311	197	12	n.	n.	PROPN
iajs-3311	197	13	;	;	PUNCT
iajs-3311	197	14	lowe	lowe	PROPN
iajs-3311	197	15	,	,	PUNCT
iajs-3311	197	16	j.	j.	PROPN
iajs-3311	197	17	,	,	PUNCT
iajs-3311	197	18	sex	sex	NOUN
iajs-3311	197	19	disaggregated	disaggregate	VERB
iajs-3311	197	20	diabetes	diabetes	NOUN
iajs-3311	197	21	prevalence	prevalence	NOUN
iajs-3311	197	22	study	study	NOUN
iajs-3311	197	23	in	in	ADP
iajs-3311	197	24	guyana	guyana	PROPN
iajs-3311	197	25	needed	need	VERB
iajs-3311	197	26	.	.	PUNCT
iajs-3311	198	1	diabetes	diabetes	NOUN
iajs-3311	198	2	research	research	NOUN
iajs-3311	198	3	and	and	CCONJ
iajs-3311	198	4	clinical	clinical	ADJ
iajs-3311	198	5	practice	practice	NOUN
iajs-3311	198	6	2014	2014	NUM
iajs-3311	198	7	,	,	PUNCT
iajs-3311	198	8	106	106	NUM
iajs-3311	198	9	(	(	PUNCT
iajs-3311	198	10	2	2	NUM
iajs-3311	198	11	)	)	PUNCT
iajs-3311	198	12	,	,	PUNCT
iajs-3311	198	13	e17	e17	NOUN
iajs-3311	198	14	.	.	PUNCT
iajs-3311	199	1	https://doi.org/10.1016/j.diabres.2014.07.012	https://doi.org/10.1016/j.diabres.2014.07.012	PROPN
iajs-3311	199	2	.	.	PUNCT
iajs-3311	200	1	14	14	NUM
iajs-3311	200	2	.	.	X
iajs-3311	201	1	who.who	who.who	PRON
iajs-3311	201	2	report	report	VERB
iajs-3311	201	3	.	.	PUNCT
iajs-3311	202	1	2014	2014	NUM
iajs-3311	202	2	.	.	PUNCT
iajs-3311	203	1	https://doi.org/10.1590/1413-812320152112.17532016	https://doi.org/10.1590/1413-812320152112.17532016	PROPN
iajs-3311	203	2	.	.	PUNCT
iajs-3311	204	1	15	15	NUM
iajs-3311	204	2	.	.	X
iajs-3311	205	1	lyssenko	lyssenko	PROPN
iajs-3311	205	2	,	,	PUNCT
iajs-3311	205	3	v.	v.	PROPN
iajs-3311	205	4	;	;	PUNCT
iajs-3311	205	5	jonsson	jonsson	PROPN
iajs-3311	205	6	,	,	PUNCT
iajs-3311	205	7	a.	a.	NOUN
iajs-3311	205	8	;	;	PUNCT
iajs-3311	205	9	almgren	almgren	PROPN
iajs-3311	205	10	,	,	PUNCT
iajs-3311	205	11	p.	p.	NOUN
iajs-3311	205	12	;	;	PUNCT
iajs-3311	205	13	pulizzi	pulizzi	NOUN
iajs-3311	205	14	,	,	PUNCT
iajs-3311	205	15	n.	n.	NOUN
iajs-3311	205	16	;	;	PUNCT
iajs-3311	205	17	isomaa	isomaa	NOUN
iajs-3311	205	18	,	,	PUNCT
iajs-3311	205	19	b.	b.	PROPN
iajs-3311	205	20	;	;	PUNCT
iajs-3311	205	21	tuomi	tuomi	NOUN
iajs-3311	205	22	,	,	PUNCT
iajs-3311	205	23	t.	t.	PROPN
iajs-3311	205	24	;	;	PUNCT
iajs-3311	205	25	berglund	berglund	PROPN
iajs-3311	205	26	,	,	PUNCT
iajs-3311	205	27	g.	g.	PROPN
iajs-3311	205	28	;	;	PUNCT
iajs-3311	205	29	altshuler	altshuler	PROPN
iajs-3311	205	30	,	,	PUNCT
iajs-3311	205	31	d.	d.	PROPN
iajs-3311	205	32	;	;	PUNCT
iajs-3311	205	33	nilsson	nilsson	PROPN
iajs-3311	205	34	,	,	PUNCT
iajs-3311	205	35	p.	p.	PROPN
iajs-3311	205	36	;	;	PUNCT
iajs-3311	205	37	groop	groop	PROPN
iajs-3311	205	38	,	,	PUNCT
iajs-3311	205	39	l.	l.	PROPN
iajs-3311	205	40	clinical	clinical	ADJ
iajs-3311	205	41	risk	risk	NOUN
iajs-3311	205	42	factors	factor	NOUN
iajs-3311	205	43	,	,	PUNCT
iajs-3311	205	44	dna	dna	PROPN
iajs-3311	205	45	variants	variant	NOUN
iajs-3311	205	46	,	,	PUNCT
iajs-3311	205	47	and	and	CCONJ
iajs-3311	205	48	the	the	DET
iajs-3311	205	49	development	development	NOUN
iajs-3311	205	50	of	of	ADP
iajs-3311	205	51	type	type	NOUN
iajs-3311	205	52	2	2	NUM
iajs-3311	205	53	diabetes	diabetes	NOUN
iajs-3311	205	54	.	.	PUNCT
iajs-3311	206	1	new	new	PROPN
iajs-3311	206	2	england	england	PROPN
iajs-3311	206	3	journal	journal	PROPN
iajs-3311	206	4	of	of	ADP
iajs-3311	206	5	medicine	medicine	NOUN
iajs-3311	206	6	2008	2008	NUM
iajs-3311	206	7	,	,	PUNCT
iajs-3311	206	8	359	359	NUM
iajs-3311	206	9	(	(	PUNCT
iajs-3311	206	10	21	21	NUM
iajs-3311	206	11	)	)	PUNCT
iajs-3311	206	12	,	,	PUNCT
iajs-3311	206	13	2220	2220	NUM
iajs-3311	206	14	-	-	SYM
iajs-3311	206	15	2232	2232	NUM
iajs-3311	206	16	.	.	PUNCT
iajs-3311	207	1	https://doi%3a%2010.1056	https://doi%3a%2010.1056	NUM
iajs-3311	207	2	/	/	SYM
iajs-3311	207	3	nejmoa0801869	nejmoa0801869	PROPN
iajs-3311	207	4	.	.	PUNCT
iajs-3311	208	1	https://doi.org/10.21123/bsj.2015.12.2.362-370	https://doi.org/10.21123/bsj.2015.12.2.362-370	PROPN
iajs-3311	209	1	https://doi.org/10.53730/ijhs.v6ns8.13342	https://doi.org/10.53730/ijhs.v6ns8.13342	PROPN
iajs-3311	209	2	https://doi.org/10.21123/bsj.2016.13.2.2ncc.0383	https://doi.org/10.21123/bsj.2016.13.2.2ncc.0383	PROPN
iajs-3311	209	3	https://doi.org/10.24996/ijs.2022.63.1.3	https://doi.org/10.24996/ijs.2022.63.1.3	PROPN
iajs-3311	209	4	https://doi.org/10.1016/j.diabres.2005.03.003	https://doi.org/10.1016/j.diabres.2005.03.003	PROPN
iajs-3311	209	5	https://doi.org/10.1016/j.mam.2012.05.003	https://doi.org/10.1016/j.mam.2012.05.003	PROPN
iajs-3311	209	6	https://doi.org/10.1016/j.bbrc.2014.08.012	https://doi.org/10.1016/j.bbrc.2014.08.012	PROPN
iajs-3311	209	7	https://doi.org/10.1016/j.celrep.2019.09.022	https://doi.org/10.1016/j.celrep.2019.09.022	NOUN
iajs-3311	209	8	https://doi.org/10.1016/j.dmpk.2020.100376	https://doi.org/10.1016/j.dmpk.2020.100376	PROPN
iajs-3311	209	9	https://doi.org/10.2337/dc09-1848	https://doi.org/10.2337/dc09-1848	PROPN
iajs-3311	209	10	https://doi.org/10.3390/genes6010087	https://doi.org/10.3390/genes6010087	PROPN
iajs-3311	209	11	https://doi.org/10.1016/j.diabres.2014.07.012	https://doi.org/10.1016/j.diabres.2014.07.012	PROPN
iajs-3311	209	12	https://doi.org/10.1590/1413-812320152112.17532016	https://doi.org/10.1590/1413-812320152112.17532016	PROPN
iajs-3311	209	13	about	about	ADP
iajs-3311	209	14	:	:	PUNCT
iajs-3311	209	15	blank	blank	ADJ
iajs-3311	209	16	ihjpas	ihjpas	PROPN
iajs-3311	209	17	.	.	PUNCT
iajs-3311	210	1	2024	2024	NUM
iajs-3311	210	2	,	,	PUNCT
iajs-3311	210	3	37	37	NUM
iajs-3311	210	4	(	(	PUNCT
iajs-3311	210	5	3	3	NUM
iajs-3311	210	6	)	)	PUNCT
iajs-3311	210	7	262	262	NUM
iajs-3311	210	8	16	16	NUM
iajs-3311	210	9	.	.	PUNCT
iajs-3311	210	10	groop	groop	PROPN
iajs-3311	210	11	,	,	PUNCT
iajs-3311	210	12	l.	l.	PROPN
iajs-3311	210	13	pathogenesis	pathogenesis	PROPN
iajs-3311	210	14	of	of	ADP
iajs-3311	210	15	type	type	NOUN
iajs-3311	210	16	2	2	NUM
iajs-3311	210	17	diabetes	diabetes	NOUN
iajs-3311	210	18	:	:	PUNCT
iajs-3311	210	19	the	the	DET
iajs-3311	210	20	relative	relative	ADJ
iajs-3311	210	21	contribution	contribution	NOUN
iajs-3311	210	22	of	of	ADP
iajs-3311	210	23	insulin	insulin	NOUN
iajs-3311	210	24	resistance	resistance	NOUN
iajs-3311	210	25	and	and	CCONJ
iajs-3311	210	26	impaired	impaired	ADJ
iajs-3311	210	27	insulin	insulin	NOUN
iajs-3311	210	28	secretion	secretion	NOUN
iajs-3311	210	29	.	.	PUNCT
iajs-3311	211	1	international	international	ADJ
iajs-3311	211	2	journal	journal	NOUN
iajs-3311	211	3	of	of	ADP
iajs-3311	211	4	clinical	clinical	ADJ
iajs-3311	211	5	practice	practice	NOUN
iajs-3311	211	6	.	.	PUNCT
iajs-3311	212	1	supplement	supplement	NOUN
iajs-3311	212	2	2000	2000	NUM
iajs-3311	212	3	,	,	PUNCT
iajs-3311	212	4	113	113	NUM
iajs-3311	212	5	,	,	PUNCT
iajs-3311	212	6	3	3	NUM
iajs-3311	212	7	-	-	SYM
iajs-3311	212	8	13	13	NUM
iajs-3311	212	9	.	.	PUNCT
iajs-3311	213	1	https://doi.org/10.1185/030079903125002351	https://doi.org/10.1185/030079903125002351	NOUN
iajs-3311	213	2	.	.	PUNCT
iajs-3311	214	1	17	17	NUM
iajs-3311	214	2	.	.	X
iajs-3311	215	1	steck	steck	PROPN
iajs-3311	215	2	,	,	PUNCT
iajs-3311	215	3	a.k	a.k	PROPN
iajs-3311	215	4	.	.	PROPN
iajs-3311	215	5	;	;	PUNCT
iajs-3311	215	6	rewers	rewer	NOUN
iajs-3311	215	7	,	,	PUNCT
iajs-3311	215	8	m.j	m.j	PROPN
iajs-3311	215	9	.	.	PROPN
iajs-3311	215	10	genetics	genetic	NOUN
iajs-3311	215	11	of	of	ADP
iajs-3311	215	12	type	type	NOUN
iajs-3311	215	13	1	1	NUM
iajs-3311	215	14	diabetes	diabetes	NOUN
iajs-3311	215	15	.	.	PUNCT
iajs-3311	216	1	clinical	clinical	ADJ
iajs-3311	216	2	chemistry	chemistry	NOUN
iajs-3311	216	3	2011	2011	NUM
iajs-3311	216	4	,	,	PUNCT
iajs-3311	216	5	57	57	NUM
iajs-3311	216	6	(	(	PUNCT
iajs-3311	216	7	2	2	NUM
iajs-3311	216	8	)	)	PUNCT
iajs-3311	216	9	,	,	PUNCT
iajs-3311	216	10	176185	176185	NUM
iajs-3311	216	11	.	.	PUNCT
iajs-3311	217	1	https://doi.org/10.1373/clinchem.2010.148221	https://doi.org/10.1373/clinchem.2010.148221	PROPN
iajs-3311	217	2	.	.	PROPN
iajs-3311	217	3	18	18	NUM
iajs-3311	217	4	.	.	PUNCT
iajs-3311	218	1	huber	huber	PROPN
iajs-3311	218	2	,	,	PUNCT
iajs-3311	218	3	a.	a.	NOUN
iajs-3311	218	4	;	;	PUNCT
iajs-3311	218	5	menconi	menconi	PROPN
iajs-3311	218	6	,	,	PUNCT
iajs-3311	218	7	f.	f.	PROPN
iajs-3311	218	8	;	;	PUNCT
iajs-3311	218	9	corathers	corather	NOUN
iajs-3311	218	10	,	,	PUNCT
iajs-3311	218	11	s.	s.	PROPN
iajs-3311	218	12	;	;	PUNCT
iajs-3311	218	13	jacobson	jacobson	PROPN
iajs-3311	218	14	,	,	PUNCT
iajs-3311	218	15	e.	e.	PROPN
iajs-3311	218	16	m.	m.	PROPN
iajs-3311	218	17	;	;	PUNCT
iajs-3311	218	18	tomer	tomer	X
iajs-3311	218	19	,	,	PUNCT
iajs-3311	218	20	y.	y.	NOUN
iajs-3311	218	21	joint	joint	ADJ
iajs-3311	218	22	genetic	genetic	ADJ
iajs-3311	218	23	susceptibility	susceptibility	NOUN
iajs-3311	218	24	to	to	PART
iajs-3311	218	25	type	type	VERB
iajs-3311	218	26	1	1	NUM
iajs-3311	218	27	diabetes	diabetes	NOUN
iajs-3311	218	28	and	and	CCONJ
iajs-3311	218	29	autoimmune	autoimmune	ADJ
iajs-3311	218	30	thyroiditis	thyroiditis	NOUN
iajs-3311	218	31	:	:	PUNCT
iajs-3311	218	32	from	from	ADP
iajs-3311	218	33	epidemiology	epidemiology	NOUN
iajs-3311	218	34	to	to	ADP
iajs-3311	218	35	mechanisms	mechanism	NOUN
iajs-3311	218	36	.	.	PUNCT
iajs-3311	219	1	endocrine	endocrine	ADJ
iajs-3311	219	2	reviews	review	NOUN
iajs-3311	219	3	2008	2008	NUM
iajs-3311	219	4	,	,	PUNCT
iajs-3311	219	5	29	29	NUM
iajs-3311	219	6	(	(	PUNCT
iajs-3311	219	7	6	6	NUM
iajs-3311	219	8	)	)	PUNCT
iajs-3311	219	9	,	,	PUNCT
iajs-3311	219	10	697	697	NUM
iajs-3311	219	11	-	-	SYM
iajs-3311	219	12	725	725	NUM
iajs-3311	219	13	.	.	PUNCT
iajs-3311	220	1	https://doi.org/10.1210/er.2008-0015	https://doi.org/10.1210/er.2008-0015	PROPN
iajs-3311	220	2	.	.	PUNCT
iajs-3311	221	1	19	19	NUM
iajs-3311	221	2	.	.	X
iajs-3311	221	3	cernea	cernea	PROPN
iajs-3311	221	4	,	,	PUNCT
iajs-3311	221	5	s.	s.	PROPN
iajs-3311	221	6	;	;	PUNCT
iajs-3311	221	7	dobreanu	dobreanu	PROPN
iajs-3311	221	8	,	,	PUNCT
iajs-3311	221	9	m.	m.	NOUN
iajs-3311	221	10	;	;	PUNCT
iajs-3311	221	11	raz	raz	PROPN
iajs-3311	221	12	,	,	PUNCT
iajs-3311	221	13	i.	i.	NOUN
iajs-3311	221	14	,	,	PUNCT
iajs-3311	221	15	prevention	prevention	NOUN
iajs-3311	221	16	of	of	ADP
iajs-3311	221	17	type	type	NOUN
iajs-3311	221	18	1	1	NUM
iajs-3311	221	19	diabetes	diabetes	NOUN
iajs-3311	221	20	:	:	PUNCT
iajs-3311	221	21	today	today	NOUN
iajs-3311	221	22	and	and	CCONJ
iajs-3311	221	23	tomorrow	tomorrow	NOUN
iajs-3311	221	24	.	.	PUNCT
iajs-3311	222	1	diabetes	diabetes	NOUN
iajs-3311	222	2	metabolism	metabolism	NOUN
iajs-3311	222	3	research	research	NOUN
iajs-3311	222	4	and	and	CCONJ
iajs-3311	222	5	reviews	review	NOUN
iajs-3311	222	6	2010	2010	NUM
iajs-3311	222	7	,	,	PUNCT
iajs-3311	222	8	26	26	NUM
iajs-3311	222	9	(	(	PUNCT
iajs-3311	222	10	8)	8)	NUM
iajs-3311	222	11	,	,	PUNCT
iajs-3311	222	12	602	602	NUM
iajs-3311	222	13	-	-	SYM
iajs-3311	222	14	605	605	NUM
iajs-3311	222	15	.	.	PUNCT
iajs-3311	222	16	https://doi.org/10.1002/dmrr.1138	https://doi.org/10.1002/dmrr.1138	PROPN
iajs-3311	222	17	.	.	PROPN
iajs-3311	223	1	20	20	NUM
iajs-3311	223	2	.	.	PUNCT
iajs-3311	223	3	kyvik	kyvik	PROPN
iajs-3311	223	4	,	,	PUNCT
iajs-3311	223	5	k.o	k.o	PROPN
iajs-3311	223	6	.	.	PROPN
iajs-3311	223	7	;	;	PUNCT
iajs-3311	223	8	green	green	PROPN
iajs-3311	223	9	,	,	PUNCT
iajs-3311	223	10	a.	a.	NOUN
iajs-3311	223	11	;	;	PUNCT
iajs-3311	223	12	beck	beck	PROPN
iajs-3311	223	13	-	-	PUNCT
iajs-3311	223	14	nielsen	nielsen	PROPN
iajs-3311	223	15	,	,	PUNCT
iajs-3311	223	16	h.	h.	PROPN
iajs-3311	223	17	concordance	concordance	NOUN
iajs-3311	223	18	rates	rate	NOUN
iajs-3311	223	19	of	of	ADP
iajs-3311	223	20	insulin	insulin	NOUN
iajs-3311	223	21	dependent	dependent	ADJ
iajs-3311	223	22	diabetes	diabetes	NOUN
iajs-3311	223	23	mellitus	mellitus	NOUN
iajs-3311	223	24	:	:	PUNCT
iajs-3311	223	25	a	a	DET
iajs-3311	223	26	population	population	NOUN
iajs-3311	223	27	based	base	VERB
iajs-3311	223	28	study	study	NOUN
iajs-3311	223	29	of	of	ADP
iajs-3311	223	30	young	young	ADJ
iajs-3311	223	31	danish	danish	ADJ
iajs-3311	223	32	twins	twin	NOUN
iajs-3311	223	33	.	.	PUNCT
iajs-3311	224	1	bmj	bmj	PROPN
iajs-3311	224	2	.	.	PUNCT
iajs-3311	224	3	1995	1995	NUM
iajs-3311	224	4	,	,	PUNCT
iajs-3311	224	5	311	311	NUM
iajs-3311	224	6	(	(	PUNCT
iajs-3311	224	7	7010	7010	NUM
iajs-3311	224	8	)	)	PUNCT
iajs-3311	224	9	,	,	PUNCT
iajs-3311	224	10	913	913	NUM
iajs-3311	224	11	-	-	SYM
iajs-3311	224	12	917	917	NUM
iajs-3311	224	13	.	.	PUNCT
iajs-3311	225	1	https://doi.org/10.1136/bmj.311.7010.913	https://doi.org/10.1136/bmj.311.7010.913	PROPN
iajs-3311	225	2	.	.	PROPN
iajs-3311	226	1	21	21	NUM
iajs-3311	226	2	.	.	PUNCT
iajs-3311	227	1	al	al	PROPN
iajs-3311	227	2	-	-	PUNCT
iajs-3311	227	3	jowari	jowari	PROPN
iajs-3311	227	4	,	,	PUNCT
iajs-3311	227	5	s.a	s.a	PROPN
iajs-3311	227	6	.	.	PROPN
iajs-3311	227	7	comparative	comparative	ADJ
iajs-3311	227	8	investigation	investigation	NOUN
iajs-3311	227	9	of	of	ADP
iajs-3311	227	10	thyroid	thyroid	NOUN
iajs-3311	227	11	autoantibodies	autoantibody	NOUN
iajs-3311	227	12	between	between	ADP
iajs-3311	227	13	type	type	NOUN
iajs-3311	227	14	1	1	NUM
iajs-3311	227	15	and	and	CCONJ
iajs-3311	227	16	type	type	NOUN
iajs-3311	227	17	2	2	NUM
iajs-3311	227	18	diabetes	diabetes	NOUN
iajs-3311	227	19	mellitus	mellitus	NOUN
iajs-3311	227	20	patients	patient	NOUN
iajs-3311	227	21	in	in	ADP
iajs-3311	227	22	baghdad	baghdad	PROPN
iajs-3311	227	23	city	city	PROPN
iajs-3311	227	24	.	.	PUNCT
iajs-3311	227	25	.	.	PUNCT
iajs-3311	228	1	2017	2017	NUM
iajs-3311	228	2	,	,	PUNCT
iajs-3311	228	3	58(2	58(2	NUM
iajs-3311	228	4	)	)	PUNCT
iajs-3311	228	5	,	,	PUNCT
iajs-3311	228	6	815–819	815–819	NUM
iajs-3311	228	7	.	.	PUNCT
iajs-3311	229	1	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/6024	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/6024	NOUN
iajs-3311	229	2	.	.	PUNCT
iajs-3311	230	1	22	22	NUM
iajs-3311	230	2	.	.	PUNCT
iajs-3311	231	1	polychronakos	polychronakos	ADJ
iajs-3311	231	2	,	,	PUNCT
iajs-3311	231	3	c.	c.	PROPN
iajs-3311	231	4	;	;	PUNCT
iajs-3311	231	5	li	li	PROPN
iajs-3311	231	6	,	,	PUNCT
iajs-3311	231	7	q.	q.	PROPN
iajs-3311	231	8	understanding	understanding	NOUN
iajs-3311	231	9	type	type	NOUN
iajs-3311	231	10	1	1	NUM
iajs-3311	231	11	diabetes	diabetes	NOUN
iajs-3311	231	12	through	through	ADP
iajs-3311	231	13	genetics	genetic	NOUN
iajs-3311	231	14	:	:	PUNCT
iajs-3311	231	15	advances	advance	NOUN
iajs-3311	231	16	and	and	CCONJ
iajs-3311	231	17	prospects	prospect	NOUN
iajs-3311	231	18	.	.	PUNCT
iajs-3311	232	1	nature	nature	NOUN
iajs-3311	232	2	reviews	review	VERB
iajs-3311	232	3	genetics	genetic	NOUN
iajs-3311	232	4	2011	2011	NUM
iajs-3311	232	5	,	,	PUNCT
iajs-3311	232	6	12(11	12(11	NUM
iajs-3311	232	7	)	)	PUNCT
iajs-3311	232	8	,	,	PUNCT
iajs-3311	232	9	781	781	NUM
iajs-3311	232	10	-	-	SYM
iajs-3311	232	11	792	792	NUM
iajs-3311	232	12	.	.	PUNCT
iajs-3311	232	13	https://doi.org/10.1210/clinem/dgab056	https://doi.org/10.1210/clinem/dgab056	PROPN
iajs-3311	232	14	.	.	PUNCT
iajs-3311	233	1	23	23	NUM
iajs-3311	233	2	.	.	PUNCT
iajs-3311	234	1	hakonarson	hakonarson	PROPN
iajs-3311	234	2	,	,	PUNCT
iajs-3311	234	3	h.	h.	PROPN
iajs-3311	234	4	;	;	PUNCT
iajs-3311	234	5	grant	grant	PROPN
iajs-3311	234	6	,	,	PUNCT
iajs-3311	234	7	s.f	s.f	PROPN
iajs-3311	234	8	.	.	PROPN
iajs-3311	234	9	genome‐wide	genome‐wide	PROPN
iajs-3311	234	10	association	association	PROPN
iajs-3311	234	11	studies	study	NOUN
iajs-3311	234	12	(	(	PUNCT
iajs-3311	234	13	gwas	gwas	NOUN
iajs-3311	234	14	):	):	PUNCT
iajs-3311	234	15	impact	impact	NOUN
iajs-3311	234	16	on	on	ADP
iajs-3311	234	17	elucidating	elucidate	VERB
iajs-3311	234	18	the	the	DET
iajs-3311	234	19	aetiology	aetiology	NOUN
iajs-3311	234	20	of	of	ADP
iajs-3311	234	21	diabetes	diabetes	NOUN
iajs-3311	234	22	.	.	PUNCT
iajs-3311	235	1	diabetes	diabetes	NOUN
iajs-3311	235	2	/	/	SYM
iajs-3311	235	3	metabolism	metabolism	NOUN
iajs-3311	235	4	research	research	NOUN
iajs-3311	235	5	and	and	CCONJ
iajs-3311	235	6	reviews	review	NOUN
iajs-3311	235	7	2011	2011	NUM
iajs-3311	235	8	,	,	PUNCT
iajs-3311	235	9	27	27	NUM
iajs-3311	235	10	(	(	PUNCT
iajs-3311	235	11	7	7	NUM
iajs-3311	235	12	)	)	PUNCT
iajs-3311	235	13	,	,	PUNCT
iajs-3311	235	14	685	685	NUM
iajs-3311	235	15	-	-	SYM
iajs-3311	235	16	696	696	NUM
iajs-3311	235	17	.	.	PUNCT
iajs-3311	236	1	https://doi.org/10.1542/peds.2013-1652	https://doi.org/10.1542/peds.2013-1652	PROPN
iajs-3311	236	2	.	.	PROPN
iajs-3311	237	1	24	24	NUM
iajs-3311	237	2	.	.	PUNCT
iajs-3311	237	3	groop	groop	PROPN
iajs-3311	237	4	,	,	PUNCT
iajs-3311	237	5	l.	l.	PROPN
iajs-3311	237	6	;	;	PUNCT
iajs-3311	237	7	pociot	pociot	PROPN
iajs-3311	237	8	,	,	PUNCT
iajs-3311	237	9	f.	f.	PROPN
iajs-3311	237	10	genetics	genetics	PROPN
iajs-3311	237	11	of	of	ADP
iajs-3311	237	12	diabetes	diabetes	NOUN
iajs-3311	237	13	—	—	PUNCT
iajs-3311	237	14	are	be	AUX
iajs-3311	237	15	we	we	PRON
iajs-3311	237	16	missing	miss	VERB
iajs-3311	237	17	the	the	DET
iajs-3311	237	18	genes	gene	NOUN
iajs-3311	237	19	or	or	CCONJ
iajs-3311	237	20	the	the	DET
iajs-3311	237	21	disease	disease	NOUN
iajs-3311	237	22	?	?	PUNCT
iajs-3311	238	1	mol	mol	PROPN
iajs-3311	238	2	.	.	PUNCT
iajs-3311	238	3	cell	cell	NOUN
iajs-3311	238	4	.	.	PUNCT
iajs-3311	239	1	endocrinol	endocrinol	NOUN
iajs-3311	239	2	.	.	PUNCT
iajs-3311	240	1	2014	2014	NUM
iajs-3311	240	2	,	,	PUNCT
iajs-3311	240	3	382(1	382(1	NUM
iajs-3311	240	4	)	)	PUNCT
iajs-3311	240	5	,	,	PUNCT
iajs-3311	240	6	726–739	726–739	NUM
iajs-3311	240	7	.	.	PUNCT
iajs-3311	241	1	https://doi.org/10.3390/genes6010087	https://doi.org/10.3390/genes6010087	PROPN
iajs-3311	241	2	.	.	PUNCT
iajs-3311	242	1	25	25	NUM
iajs-3311	242	2	.	.	PUNCT
iajs-3311	242	3	stankov	stankov	PROPN
iajs-3311	242	4	,	,	PUNCT
iajs-3311	242	5	k.	k.	PROPN
iajs-3311	242	6	;	;	PUNCT
iajs-3311	242	7	benc	benc	PROPN
iajs-3311	242	8	,	,	PUNCT
iajs-3311	242	9	d.	d.	PROPN
iajs-3311	242	10	;	;	PUNCT
iajs-3311	242	11	draskovic	draskovic	PROPN
iajs-3311	242	12	,	,	PUNCT
iajs-3311	242	13	d.	d.	PROPN
iajs-3311	242	14	genetic	genetic	ADJ
iajs-3311	242	15	and	and	CCONJ
iajs-3311	242	16	epigenetic	epigenetic	ADJ
iajs-3311	242	17	factors	factor	NOUN
iajs-3311	242	18	in	in	ADP
iajs-3311	242	19	etiology	etiology	NOUN
iajs-3311	242	20	of	of	ADP
iajs-3311	242	21	diabetes	diabetes	NOUN
iajs-3311	242	22	mellitus	mellitus	NOUN
iajs-3311	242	23	type	type	VERB
iajs-3311	242	24	1	1	NUM
iajs-3311	242	25	.	.	PUNCT
iajs-3311	242	26	pediatrics	pediatric	NOUN
iajs-3311	242	27	2013	2013	NUM
iajs-3311	242	28	,	,	PUNCT
iajs-3311	242	29	132	132	NUM
iajs-3311	242	30	(	(	PUNCT
iajs-3311	242	31	6	6	NUM
iajs-3311	242	32	)	)	PUNCT
iajs-3311	242	33	,	,	PUNCT
iajs-3311	242	34	1112	1112	NUM
iajs-3311	242	35	-	-	SYM
iajs-3311	242	36	1122	1122	NUM
iajs-3311	242	37	.	.	PUNCT
iajs-3311	243	1	https://doi.org/10.1542/peds.2013-1652	https://doi.org/10.1542/peds.2013-1652	PROPN
iajs-3311	243	2	.	.	PROPN
iajs-3311	244	1	26	26	NUM
iajs-3311	244	2	.	.	PUNCT
iajs-3311	245	1	forlenza	forlenza	PROPN
iajs-3311	245	2	,	,	PUNCT
iajs-3311	245	3	g.p	g.p	PROPN
iajs-3311	245	4	.	.	PROPN
iajs-3311	245	5	;	;	PUNCT
iajs-3311	245	6	rewers	rewer	NOUN
iajs-3311	245	7	,	,	PUNCT
iajs-3311	245	8	m.	m.	NOUN
iajs-3311	245	9	the	the	DET
iajs-3311	245	10	epidemic	epidemic	NOUN
iajs-3311	245	11	of	of	ADP
iajs-3311	245	12	type	type	NOUN
iajs-3311	245	13	1	1	NUM
iajs-3311	245	14	diabetes	diabete	NOUN
iajs-3311	245	15	:	:	PUNCT
iajs-3311	245	16	what	what	PRON
iajs-3311	245	17	is	be	AUX
iajs-3311	245	18	it	it	PRON
iajs-3311	245	19	telling	tell	VERB
iajs-3311	245	20	us	we	PRON
iajs-3311	245	21	?	?	PUNCT
iajs-3311	246	1	current	current	ADJ
iajs-3311	246	2	opinion	opinion	NOUN
iajs-3311	246	3	in	in	ADP
iajs-3311	246	4	endocrinology	endocrinology	NOUN
iajs-3311	246	5	,	,	PUNCT
iajs-3311	246	6	diabetes	diabetes	NOUN
iajs-3311	246	7	and	and	CCONJ
iajs-3311	246	8	obesity	obesity	NOUN
iajs-3311	246	9	.	.	PUNCT
iajs-3311	247	1	2011	2011	NUM
iajs-3311	247	2	,	,	PUNCT
iajs-3311	247	3	18	18	NUM
iajs-3311	247	4	(	(	PUNCT
iajs-3311	247	5	4	4	NUM
iajs-3311	247	6	)	)	PUNCT
iajs-3311	247	7	,	,	PUNCT
iajs-3311	247	8	248	248	NUM
iajs-3311	247	9	-	-	SYM
iajs-3311	247	10	251	251	NUM
iajs-3311	247	11	.	.	PUNCT
iajs-3311	248	1	https://doi.org/10.1097/med.0b013e32834872ce	https://doi.org/10.1097/med.0b013e32834872ce	NOUN
iajs-3311	248	2	.	.	PUNCT
iajs-3311	249	1	27	27	NUM
iajs-3311	249	2	.	.	X
iajs-3311	249	3	sugihara	sugihara	NOUN
iajs-3311	249	4	,	,	PUNCT
iajs-3311	249	5	s.	s.	PROPN
iajs-3311	249	6	genetic	genetic	ADJ
iajs-3311	249	7	susceptibility	susceptibility	NOUN
iajs-3311	249	8	of	of	ADP
iajs-3311	249	9	childhood	childhood	NOUN
iajs-3311	249	10	type	type	NOUN
iajs-3311	249	11	1	1	NUM
iajs-3311	249	12	diabetes	diabetes	NOUN
iajs-3311	249	13	mellitus	mellitus	NOUN
iajs-3311	249	14	in	in	ADP
iajs-3311	249	15	japan	japan	PROPN
iajs-3311	249	16	.	.	PUNCT
iajs-3311	250	1	pediatr	pediatr	PROPN
iajs-3311	250	2	endocrinol	endocrinol	NOUN
iajs-3311	250	3	rev	rev	PROPN
iajs-3311	250	4	2012	2012	NUM
iajs-3311	250	5	,	,	PUNCT
iajs-3311	250	6	10	10	NUM
iajs-3311	250	7	(	(	PUNCT
iajs-3311	250	8	suppl	suppl	ADJ
iajs-3311	250	9	1	1	NUM
iajs-3311	250	10	)	)	PUNCT
iajs-3311	250	11	,	,	PUNCT
iajs-3311	250	12	62	62	NUM
iajs-3311	250	13	-	-	SYM
iajs-3311	250	14	71	71	NUM
iajs-3311	250	15	.	.	PUNCT
iajs-3311	251	1	https://doi.org/10.1542/peds.2013-1652	https://doi.org/10.1542/peds.2013-1652	PROPN
iajs-3311	251	2	.	.	PUNCT
iajs-3311	252	1	28	28	NUM
iajs-3311	252	2	.	.	PUNCT
iajs-3311	253	1	thomas	thomas	PROPN
iajs-3311	253	2	,	,	PUNCT
iajs-3311	253	3	i.h	i.h	PROPN
iajs-3311	253	4	.	.	PROPN
iajs-3311	253	5	;	;	PUNCT
iajs-3311	253	6	pietropaolo	pietropaolo	PROPN
iajs-3311	253	7	,	,	PUNCT
iajs-3311	253	8	m.	m.	NOUN
iajs-3311	253	9	type	type	NOUN
iajs-3311	253	10	1	1	NUM
iajs-3311	253	11	diabetes	diabete	NOUN
iajs-3311	253	12	:	:	PUNCT
iajs-3311	253	13	a	a	DET
iajs-3311	253	14	genetic	genetic	ADJ
iajs-3311	253	15	pandora	pandora	NOUN
iajs-3311	253	16	's	's	PART
iajs-3311	253	17	box	box	PROPN
iajs-3311	253	18	2010	2010	NUM
iajs-3311	253	19	,	,	PUNCT
iajs-3311	253	20	11	11	NUM
iajs-3311	253	21	,	,	PUNCT
iajs-3311	253	22	511–512	511–512	NUM
iajs-3311	253	23	.	.	PUNCT
iajs-3311	253	24	https://doi.org/10.1111/j.1399-5448.2010.00742.x	https://doi.org/10.1111/j.1399-5448.2010.00742.x	PROPN
iajs-3311	253	25	29	29	NUM
iajs-3311	253	26	.	.	PUNCT
iajs-3311	254	1	groop	groop	PROPN
iajs-3311	254	2	,	,	PUNCT
iajs-3311	254	3	l.	l.	PROPN
iajs-3311	254	4	;	;	PUNCT
iajs-3311	254	5	tuomi	tuomi	NOUN
iajs-3311	254	6	,	,	PUNCT
iajs-3311	254	7	t.	t.	PROPN
iajs-3311	254	8	;	;	PUNCT
iajs-3311	254	9	rowley	rowley	NOUN
iajs-3311	254	10	,	,	PUNCT
iajs-3311	254	11	m.	m.	NOUN
iajs-3311	254	12	;	;	PUNCT
iajs-3311	254	13	zimmet	zimmet	NOUN
iajs-3311	254	14	,	,	PUNCT
iajs-3311	254	15	p.	p.	NOUN
iajs-3311	254	16	;	;	PUNCT
iajs-3311	254	17	mackay	mackay	PROPN
iajs-3311	254	18	,	,	PUNCT
iajs-3311	254	19	i.	i.	PROPN
iajs-3311	254	20	r.	r.	PROPN
iajs-3311	254	21	,	,	PUNCT
iajs-3311	254	22	latent	latent	ADJ
iajs-3311	254	23	autoimmune	autoimmune	ADJ
iajs-3311	254	24	diabetes	diabetes	NOUN
iajs-3311	254	25	in	in	ADP
iajs-3311	254	26	adults	adult	NOUN
iajs-3311	254	27	(	(	PUNCT
iajs-3311	254	28	lada)—more	lada)—more	ADJ
iajs-3311	254	29	than	than	ADP
iajs-3311	254	30	a	a	DET
iajs-3311	254	31	name	name	NOUN
iajs-3311	254	32	.	.	PUNCT
iajs-3311	255	1	diabetologia	diabetologia	NOUN
iajs-3311	255	2	2006	2006	NUM
iajs-3311	255	3	,	,	PUNCT
iajs-3311	255	4	49	49	NUM
iajs-3311	255	5	,	,	PUNCT
iajs-3311	255	6	1996	1996	NUM
iajs-3311	255	7	-	-	SYM
iajs-3311	255	8	1998	1998	NUM
iajs-3311	255	9	.	.	PUNCT
iajs-3311	256	1	https://doi.org/10.1007/s00125-006-0345-x	https://doi.org/10.1007/s00125-006-0345-x	NOUN
iajs-3311	256	2	.	.	PUNCT
iajs-3311	257	1	30	30	NUM
iajs-3311	257	2	.	.	X
iajs-3311	257	3	tuomi	tuomi	PROPN
iajs-3311	257	4	,	,	PUNCT
iajs-3311	257	5	w.v	w.v	PROPN
iajs-3311	257	6	.	.	PROPN
iajs-3311	257	7	;	;	PUNCT
iajs-3311	257	8	kazlauskas	kazlauskas	PROPN
iajs-3311	257	9	,	,	PUNCT
iajs-3311	257	10	r.j	r.j	PROPN
iajs-3311	257	11	.	.	PROPN
iajs-3311	257	12	molecular	molecular	ADJ
iajs-3311	257	13	basis	basis	NOUN
iajs-3311	257	14	for	for	ADP
iajs-3311	257	15	enantioselectivity	enantioselectivity	NOUN
iajs-3311	257	16	of	of	ADP
iajs-3311	257	17	lipase	lipase	NOUN
iajs-3311	257	18	from	from	ADP
iajs-3311	257	19	pseudomonas	pseudomona	NOUN
iajs-3311	257	20	cepacia	cepacia	NOUN
iajs-3311	257	21	toward	toward	ADP
iajs-3311	257	22	primary	primary	ADJ
iajs-3311	257	23	alcohols	alcohol	NOUN
iajs-3311	257	24	.	.	PUNCT
iajs-3311	258	1	modeling	modeling	NOUN
iajs-3311	258	2	,	,	PUNCT
iajs-3311	258	3	kinetics	kinetic	NOUN
iajs-3311	258	4	,	,	PUNCT
iajs-3311	258	5	and	and	CCONJ
iajs-3311	258	6	chemical	chemical	NOUN
iajs-3311	258	7	modification	modification	NOUN
iajs-3311	258	8	of	of	ADP
iajs-3311	258	9	tyr29	tyr29	NOUN
iajs-3311	258	10	to	to	PART
iajs-3311	258	11	increase	increase	VERB
iajs-3311	258	12	or	or	CCONJ
iajs-3311	258	13	decrease	decrease	VERB
iajs-3311	258	14	enantioselectivity	enantioselectivity	NOUN
iajs-3311	258	15	.	.	PUNCT
iajs-3311	259	1	the	the	DET
iajs-3311	259	2	journal	journal	NOUN
iajs-3311	259	3	of	of	ADP
iajs-3311	259	4	organic	organic	ADJ
iajs-3311	259	5	chemistry	chemistry	NOUN
iajs-3311	259	6	1999	1999	NUM
iajs-3311	259	7	,	,	PUNCT
iajs-3311	259	8	64	64	NUM
iajs-3311	259	9	(	(	PUNCT
iajs-3311	259	10	8)	8)	NUM
iajs-3311	259	11	,	,	PUNCT
iajs-3311	259	12	2638	2638	NUM
iajs-3311	259	13	-	-	SYM
iajs-3311	259	14	2647	2647	NUM
iajs-3311	259	15	.	.	PUNCT
iajs-3311	260	1	https://doi.org/10.1021/jo981783y	https://doi.org/10.1021/jo981783y	PROPN
iajs-3311	260	2	.	.	PUNCT
iajs-3311	261	1	31	31	NUM
iajs-3311	261	2	.	.	PUNCT
iajs-3311	261	3	tuomi	tuomi	NOUN
iajs-3311	261	4	,	,	PUNCT
iajs-3311	262	1	t.	t.	NOUN
iajs-3311	262	2	persisting	persist	VERB
iajs-3311	262	3	antibodies	antibody	NOUN
iajs-3311	262	4	to	to	ADP
iajs-3311	262	5	glutamic	glutamic	ADJ
iajs-3311	262	6	acid	acid	NOUN
iajs-3311	262	7	decarboxylase	decarboxylase	NOUN
iajs-3311	262	8	in	in	ADP
iajs-3311	262	9	type	type	NOUN
iajs-3311	262	10	1	1	NUM
iajs-3311	262	11	(	(	PUNCT
iajs-3311	262	12	insulindependent	insulindependent	NOUN
iajs-3311	262	13	)	)	PUNCT
iajs-3311	262	14	diabetes	diabetes	NOUN
iajs-3311	262	15	mellitus	mellitus	NOUN
iajs-3311	262	16	are	be	AUX
iajs-3311	262	17	not	not	PART
iajs-3311	262	18	associated	associate	VERB
iajs-3311	262	19	with	with	ADP
iajs-3311	262	20	neuropathy	neuropathy	ADJ
iajs-3311	262	21	.	.	PUNCT
iajs-3311	262	22	diabetologia	diabetologia	NOUN
iajs-3311	262	23	1993	1993	NUM
iajs-3311	262	24	,	,	PUNCT
iajs-3311	262	25	36(7	36(7	NUM
iajs-3311	262	26	)	)	PUNCT
iajs-3311	262	27	,	,	PUNCT
iajs-3311	262	28	685	685	NUM
iajs-3311	262	29	-	-	SYM
iajs-3311	262	30	685	685	NUM
iajs-3311	262	31	.	.	PUNCT
iajs-3311	263	1	https://doi.org/10.1007/bf00404084	https://doi.org/10.1007/bf00404084	NOUN
iajs-3311	263	2	.	.	PUNCT
iajs-3311	264	1	32	32	NUM
iajs-3311	264	2	.	.	PUNCT
iajs-3311	264	3	tuomi	tuomi	NOUN
iajs-3311	264	4	,	,	PUNCT
iajs-3311	264	5	t.	t.	PROPN
iajs-3311	264	6	;	;	PUNCT
iajs-3311	264	7	santoro	santoro	PROPN
iajs-3311	264	8	,	,	PUNCT
iajs-3311	264	9	n.	n.	PROPN
iajs-3311	264	10	;	;	PUNCT
iajs-3311	264	11	caprio	caprio	PROPN
iajs-3311	264	12	,	,	PUNCT
iajs-3311	264	13	s.	s.	PROPN
iajs-3311	264	14	;	;	PUNCT
iajs-3311	264	15	cai	cai	X
iajs-3311	264	16	,	,	PUNCT
iajs-3311	264	17	m.	m.	NOUN
iajs-3311	264	18	;	;	PUNCT
iajs-3311	264	19	weng	weng	PROPN
iajs-3311	264	20	,	,	PUNCT
iajs-3311	264	21	j.	j.	PROPN
iajs-3311	264	22	;	;	PUNCT
iajs-3311	264	23	groop	groop	PROPN
iajs-3311	264	24	,	,	PUNCT
iajs-3311	264	25	l.	l.	PROPN
iajs-3311	264	26	the	the	DET
iajs-3311	264	27	many	many	ADJ
iajs-3311	264	28	faces	face	NOUN
iajs-3311	264	29	of	of	ADP
iajs-3311	264	30	diabetes	diabetes	NOUN
iajs-3311	264	31	:	:	PUNCT
iajs-3311	264	32	a	a	DET
iajs-3311	264	33	disease	disease	NOUN
iajs-3311	264	34	with	with	ADP
iajs-3311	264	35	increasing	increase	VERB
iajs-3311	264	36	heterogeneity	heterogeneity	NOUN
iajs-3311	264	37	.	.	PUNCT
iajs-3311	265	1	the	the	DET
iajs-3311	265	2	lancet	lancet	PROPN
iajs-3311	265	3	2014	2014	NUM
iajs-3311	265	4	,	,	PUNCT
iajs-3311	265	5	383	383	NUM
iajs-3311	265	6	(	(	PUNCT
iajs-3311	265	7	9922	9922	NUM
iajs-3311	265	8	)	)	PUNCT
iajs-3311	265	9	,	,	PUNCT
iajs-3311	265	10	1084	1084	NUM
iajs-3311	265	11	-	-	SYM
iajs-3311	265	12	1094	1094	NUM
iajs-3311	265	13	.	.	PUNCT
iajs-3311	266	1	https://doi.org/10.1016/s0140-6736(13)62219-9	https://doi.org/10.1016/s0140-6736(13)62219-9	PROPN
iajs-3311	266	2	.	.	PUNCT
iajs-3311	267	1	https://doi.org/10.1185/030079903125002351	https://doi.org/10.1185/030079903125002351	NOUN
iajs-3311	268	1	https://doi.org/10.1373/clinchem.2010.148221	https://doi.org/10.1373/clinchem.2010.148221	PROPN
iajs-3311	268	2	https://doi.org/10.1210/er.2008-0015	https://doi.org/10.1210/er.2008-0015	NOUN
iajs-3311	268	3	https://doi.org/10.1002/dmrr.1138	https://doi.org/10.1002/dmrr.1138	VERB
iajs-3311	268	4	https://doi.org/10.1136/bmj.311.7010.913	https://doi.org/10.1136/bmj.311.7010.913	PROPN
iajs-3311	269	1	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/6024	https://ijs.uobaghdad.edu.iq/index.php/eijs/article/view/6024	PROPN
iajs-3311	269	2	https://doi.org/10.1542/peds.2013-1652	https://doi.org/10.1542/peds.2013-1652	PROPN
iajs-3311	269	3	https://doi.org/10.3390/genes6010087	https://doi.org/10.3390/genes6010087	PROPN
iajs-3311	269	4	https://doi.org/10.1542/peds.2013-1652	https://doi.org/10.1542/peds.2013-1652	PROPN
iajs-3311	269	5	https://doi.org/10.1097/med.0b013e32834872ce	https://doi.org/10.1097/med.0b013e32834872ce	PROPN
iajs-3311	269	6	https://doi.org/10.1542/peds.2013-1652	https://doi.org/10.1542/peds.2013-1652	PROPN
iajs-3311	269	7	https://doi.org/10.1111/j.1399-5448.2010.00742	https://doi.org/10.1111/j.1399-5448.2010.00742	PROPN
iajs-3311	269	8	https://doi.org/10.1007/s00125-006-0345-x	https://doi.org/10.1007/s00125-006-0345-x	VERB
iajs-3311	269	9	https://doi.org/10.1021/jo981783y	https://doi.org/10.1021/jo981783y	PROPN
iajs-3311	269	10	https://doi.org/10.1007/bf00404084	https://doi.org/10.1007/bf00404084	PROPN
iajs-3311	269	11	https://doi.org/10.1016/s0140-6736(13)62219-9	https://doi.org/10.1016/s0140-6736(13)62219-9	PROPN
iajs-3311	269	12	ihjpas	ihjpas	PROPN
iajs-3311	269	13	.	.	PUNCT
iajs-3311	270	1	2024	2024	NUM
iajs-3311	270	2	,	,	PUNCT
iajs-3311	270	3	37	37	NUM
iajs-3311	270	4	(	(	PUNCT
iajs-3311	270	5	3	3	NUM
iajs-3311	270	6	)	)	PUNCT
iajs-3311	270	7	263	263	NUM
iajs-3311	270	8	33	33	NUM
iajs-3311	270	9	.	.	PUNCT
iajs-3311	271	1	carlsson	carlsson	PROPN
iajs-3311	271	2	,	,	PUNCT
iajs-3311	271	3	s.	s.	PROPN
iajs-3311	271	4	;	;	PUNCT
iajs-3311	271	5	midthjell	midthjell	PROPN
iajs-3311	271	6	,	,	PUNCT
iajs-3311	271	7	k.	k.	PROPN
iajs-3311	271	8	;	;	PUNCT
iajs-3311	271	9	grill	grill	NOUN
iajs-3311	271	10	,	,	PUNCT
iajs-3311	271	11	v.	v.	ADP
iajs-3311	271	12	influence	influence	NOUN
iajs-3311	271	13	of	of	ADP
iajs-3311	271	14	family	family	NOUN
iajs-3311	271	15	history	history	NOUN
iajs-3311	271	16	of	of	ADP
iajs-3311	271	17	diabetes	diabetes	NOUN
iajs-3311	271	18	on	on	ADP
iajs-3311	271	19	incidence	incidence	NOUN
iajs-3311	271	20	and	and	CCONJ
iajs-3311	271	21	prevalence	prevalence	NOUN
iajs-3311	271	22	of	of	ADP
iajs-3311	271	23	latent	latent	NOUN
iajs-3311	271	24	autoimmune	autoimmune	ADJ
iajs-3311	271	25	diabetes	diabetes	NOUN
iajs-3311	271	26	of	of	ADP
iajs-3311	271	27	the	the	DET
iajs-3311	271	28	adult	adult	NOUN
iajs-3311	271	29	:	:	PUNCT
iajs-3311	271	30	results	result	NOUN
iajs-3311	271	31	from	from	ADP
iajs-3311	271	32	the	the	DET
iajs-3311	271	33	nord	nord	PROPN
iajs-3311	271	34	-	-	PUNCT
iajs-3311	271	35	trøndelag	trøndelag	NOUN
iajs-3311	271	36	health	health	NOUN
iajs-3311	271	37	study	study	NOUN
iajs-3311	271	38	.	.	PUNCT
iajs-3311	272	1	diabetes	diabetes	NOUN
iajs-3311	272	2	care	care	VERB
iajs-3311	272	3	2007	2007	NUM
iajs-3311	272	4	,	,	PUNCT
iajs-3311	272	5	30	30	NUM
iajs-3311	272	6	(	(	PUNCT
iajs-3311	272	7	12	12	NUM
iajs-3311	272	8	)	)	PUNCT
iajs-3311	272	9	,	,	PUNCT
iajs-3311	272	10	3040	3040	NUM
iajs-3311	272	11	-	-	SYM
iajs-3311	272	12	3045	3045	NUM
iajs-3311	272	13	.	.	PUNCT
iajs-3311	273	1	https://doi.org/10.2337/dc07-0718	https://doi.org/10.2337/dc07-0718	NOUN
iajs-3311	273	2	.	.	PROPN
iajs-3311	273	3	34	34	NUM
iajs-3311	273	4	.	.	PUNCT
iajs-3311	273	5	atheeb	atheeb	PROPN
iajs-3311	273	6	,	,	PUNCT
iajs-3311	273	7	a.k	a.k	PROPN
iajs-3311	273	8	.	.	PROPN
iajs-3311	273	9	;	;	PUNCT
iajs-3311	273	10	hussein	hussein	PROPN
iajs-3311	273	11	,	,	PUNCT
iajs-3311	273	12	s.z	s.z	PROPN
iajs-3311	273	13	.	.	PROPN
iajs-3311	273	14	;	;	PUNCT
iajs-3311	273	15	al	al	PROPN
iajs-3311	273	16	-	-	PUNCT
iajs-3311	273	17	mudhaffar	mudhaffar	PROPN
iajs-3311	273	18	,	,	PUNCT
iajs-3311	273	19	s.s	s.s	PROPN
iajs-3311	273	20	.	.	PROPN
iajs-3311	273	21	oxidative	oxidative	ADJ
iajs-3311	273	22	stress	stress	NOUN
iajs-3311	273	23	status	status	NOUN
iajs-3311	273	24	in	in	ADP
iajs-3311	273	25	sera	sera	NOUN
iajs-3311	273	26	of	of	ADP
iajs-3311	273	27	type	type	NOUN
iajs-3311	273	28	2	2	NUM
iajs-3311	273	29	diabetic	diabetic	ADJ
iajs-3311	273	30	iraqi	iraqi	ADJ
iajs-3311	273	31	patients	patient	NOUN
iajs-3311	273	32	with	with	ADP
iajs-3311	273	33	coronary	coronary	ADJ
iajs-3311	273	34	artery	artery	NOUN
iajs-3311	273	35	diseases	disease	NOUN
iajs-3311	273	36	.	.	PUNCT
iajs-3311	274	1	international	international	ADJ
iajs-3311	274	2	journal	journal	PROPN
iajs-3311	274	3	of	of	ADP
iajs-3311	274	4	drug	drug	NOUN
iajs-3311	274	5	delivery	delivery	NOUN
iajs-3311	274	6	technology	technology	NOUN
iajs-3311	274	7	.	.	PUNCT
iajs-3311	275	1	2021	2021	NUM
iajs-3311	275	2	,	,	PUNCT
iajs-3311	275	3	11(2	11(2	NUM
iajs-3311	275	4	)	)	PUNCT
iajs-3311	275	5	,	,	PUNCT
iajs-3311	275	6	291–297	291–297	NUM
iajs-3311	275	7	.	.	PUNCT
iajs-3311	276	1	https://doi.org/10.25258/ijddt.11.2.9	https://doi.org/10.25258/ijddt.11.2.9	PROPN
iajs-3311	276	2	.	.	PROPN
iajs-3311	277	1	35	35	NUM
iajs-3311	277	2	.	.	PUNCT
iajs-3311	278	1	mahmoud	mahmoud	PROPN
iajs-3311	278	2	,	,	PUNCT
iajs-3311	278	3	e.a	e.a	PROPN
iajs-3311	278	4	.	.	PROPN
iajs-3311	278	5	;	;	PUNCT
iajs-3311	278	6	al	al	PROPN
iajs-3311	278	7	-	-	PUNCT
iajs-3311	278	8	bakri	bakri	PROPN
iajs-3311	278	9	,	,	PUNCT
iajs-3311	278	10	n.a	n.a	PROPN
iajs-3311	278	11	.	.	PROPN
iajs-3311	278	12	;	;	PUNCT
iajs-3311	278	13	qasim	qasim	PROPN
iajs-3311	278	14	,	,	PUNCT
iajs-3311	278	15	b.j	b.j	PROPN
iajs-3311	278	16	.	.	PROPN
iajs-3311	278	17	histomorphometrical	histomorphometrical	ADJ
iajs-3311	278	18	study	study	NOUN
iajs-3311	278	19	of	of	ADP
iajs-3311	278	20	placental	placental	NOUN
iajs-3311	278	21	from	from	ADP
iajs-3311	278	22	male	male	ADJ
iajs-3311	278	23	and	and	CCONJ
iajs-3311	278	24	female	female	ADJ
iajs-3311	278	25	neonates	neonate	NOUN
iajs-3311	278	26	of	of	ADP
iajs-3311	278	27	diabetic	diabetic	ADJ
iajs-3311	278	28	women	woman	NOUN
iajs-3311	278	29	.	.	PUNCT
iajs-3311	279	1	ibn	ibn	PROPN
iajs-3311	279	2	al	al	PROPN
iajs-3311	279	3	-	-	PUNCT
iajs-3311	279	4	haitham	haitham	PROPN
iajs-3311	279	5	journal	journal	PROPN
iajs-3311	279	6	for	for	ADP
iajs-3311	279	7	pure	pure	ADJ
iajs-3311	279	8	and	and	CCONJ
iajs-3311	279	9	applied	applied	ADJ
iajs-3311	279	10	sciences	science	NOUN
iajs-3311	279	11	.	.	PUNCT
iajs-3311	279	12	2019	2019	NUM
iajs-3311	279	13	,	,	PUNCT
iajs-3311	279	14	32(2	32(2	NUM
iajs-3311	279	15	)	)	PUNCT
iajs-3311	279	16	,	,	PUNCT
iajs-3311	279	17	1–8	1–8	X
iajs-3311	279	18	.	.	PUNCT
iajs-3311	280	1	https://doi.org/10.30526/32.2.2125	https://doi.org/10.30526/32.2.2125	PROPN
iajs-3311	280	2	.	.	PROPN
iajs-3311	281	1	36	36	NUM
iajs-3311	281	2	.	.	X
iajs-3311	282	1	scott	scott	PROPN
iajs-3311	282	2	,	,	PUNCT
iajs-3311	282	3	r.a	r.a	PROPN
iajs-3311	282	4	.	.	PROPN
iajs-3311	282	5	;	;	PUNCT
iajs-3311	282	6	lagou	lagou	PROPN
iajs-3311	282	7	,	,	PUNCT
iajs-3311	282	8	v.	v.	PROPN
iajs-3311	282	9	;	;	PUNCT
iajs-3311	282	10	welch	welch	PROPN
iajs-3311	282	11	,	,	PUNCT
iajs-3311	282	12	r.p	r.p	PROPN
iajs-3311	282	13	.	.	PROPN
iajs-3311	282	14	;	;	PUNCT
iajs-3311	282	15	wheeler	wheeler	NOUN
iajs-3311	282	16	,	,	PUNCT
iajs-3311	282	17	e.	e.	PROPN
iajs-3311	282	18	;	;	PUNCT
iajs-3311	282	19	montasser	montasser	PROPN
iajs-3311	282	20	,	,	PUNCT
iajs-3311	282	21	m.e	m.e	PROPN
iajs-3311	282	22	.	.	PROPN
iajs-3311	282	23	;	;	PUNCT
iajs-3311	282	24	luan	luan	PROPN
iajs-3311	282	25	,	,	PUNCT
iajs-3311	282	26	j.a	j.a	PROPN
iajs-3311	282	27	.	.	PROPN
iajs-3311	282	28	;	;	PUNCT
iajs-3311	282	29	mägi	mägi	PROPN
iajs-3311	282	30	,	,	PUNCT
iajs-3311	282	31	r.	r.	PROPN
iajs-3311	282	32	;	;	PUNCT
iajs-3311	282	33	strawbridge	strawbridge	PROPN
iajs-3311	282	34	,	,	PUNCT
iajs-3311	282	35	r.j	r.j	PROPN
iajs-3311	282	36	.	.	PROPN
iajs-3311	282	37	;	;	PUNCT
iajs-3311	282	38	rehnberg	rehnberg	PROPN
iajs-3311	282	39	,	,	PUNCT
iajs-3311	282	40	e.	e.	PROPN
iajs-3311	282	41	;	;	PUNCT
iajs-3311	282	42	gustafsson	gustafsson	PROPN
iajs-3311	282	43	,	,	PUNCT
iajs-3311	282	44	s.	s.	PROPN
iajs-3311	282	45	large	large	ADJ
iajs-3311	282	46	-	-	PUNCT
iajs-3311	282	47	scale	scale	NOUN
iajs-3311	282	48	association	association	NOUN
iajs-3311	282	49	analyses	analysis	NOUN
iajs-3311	282	50	identify	identify	VERB
iajs-3311	282	51	new	new	ADJ
iajs-3311	282	52	loci	locus	NOUN
iajs-3311	282	53	influencing	influence	VERB
iajs-3311	282	54	glycemic	glycemic	ADJ
iajs-3311	282	55	traits	trait	NOUN
iajs-3311	282	56	and	and	CCONJ
iajs-3311	282	57	provide	provide	VERB
iajs-3311	282	58	insight	insight	NOUN
iajs-3311	282	59	into	into	ADP
iajs-3311	282	60	the	the	DET
iajs-3311	282	61	underlying	underlying	ADJ
iajs-3311	282	62	biological	biological	ADJ
iajs-3311	282	63	pathways	pathway	NOUN
iajs-3311	282	64	.	.	PUNCT
iajs-3311	283	1	nature	nature	NOUN
iajs-3311	283	2	genetics	genetics	PROPN
iajs-3311	283	3	2012	2012	NUM
iajs-3311	283	4	,	,	PUNCT
iajs-3311	283	5	44(9	44(9	NOUN
iajs-3311	283	6	)	)	PUNCT
iajs-3311	283	7	,	,	PUNCT
iajs-3311	283	8	991	991	NUM
iajs-3311	283	9	-	-	SYM
iajs-3311	283	10	1005	1005	NUM
iajs-3311	283	11	.	.	PUNCT
iajs-3311	283	12	https://doi.org/10.1038/ng0411-388b	https://doi.org/10.1038/ng0411-388b	NOUN
iajs-3311	283	13	.	.	PUNCT
iajs-3311	284	1	37	37	NUM
iajs-3311	284	2	.	.	PUNCT
iajs-3311	285	1	steinthorsdottir	steinthorsdottir	PROPN
iajs-3311	285	2	,	,	PUNCT
iajs-3311	285	3	v.	v.	ADV
iajs-3311	285	4	;	;	PUNCT
iajs-3311	285	5	thorleifsson	thorleifsson	NOUN
iajs-3311	285	6	,	,	PUNCT
iajs-3311	285	7	g.	g.	PROPN
iajs-3311	285	8	;	;	PUNCT
iajs-3311	285	9	reynisdottir	reynisdottir	NOUN
iajs-3311	285	10	,	,	PUNCT
iajs-3311	285	11	i.	i.	PROPN
iajs-3311	285	12	;	;	PUNCT
iajs-3311	285	13	benediktsson	benediktsson	PROPN
iajs-3311	285	14	,	,	PUNCT
iajs-3311	285	15	r.	r.	PROPN
iajs-3311	285	16	;	;	PUNCT
iajs-3311	285	17	jonsdottir	jonsdottir	NOUN
iajs-3311	285	18	,	,	PUNCT
iajs-3311	285	19	t.	t.	PROPN
iajs-3311	285	20	;	;	PUNCT
iajs-3311	285	21	walters	walters	PROPN
iajs-3311	285	22	,	,	PUNCT
iajs-3311	285	23	g.b	g.b	PROPN
iajs-3311	285	24	.	.	PROPN
iajs-3311	285	25	;	;	PUNCT
iajs-3311	285	26	styrkarsdottir	styrkarsdottir	PROPN
iajs-3311	285	27	,	,	PUNCT
iajs-3311	285	28	u.	u.	PROPN
iajs-3311	285	29	;	;	PUNCT
iajs-3311	285	30	gretarsdottir	gretarsdottir	ADJ
iajs-3311	285	31	,	,	PUNCT
iajs-3311	285	32	s.	s.	PROPN
iajs-3311	285	33	;	;	PUNCT
iajs-3311	285	34	emilsson	emilsson	PROPN
iajs-3311	285	35	,	,	PUNCT
iajs-3311	285	36	v.	v.	PROPN
iajs-3311	285	37	;	;	PUNCT
iajs-3311	285	38	ghosh	ghosh	PROPN
iajs-3311	285	39	,	,	PUNCT
iajs-3311	285	40	s.	s.	PROPN
iajs-3311	285	41	;	;	PUNCT
iajs-3311	285	42	baker	baker	PROPN
iajs-3311	285	43	,	,	PUNCT
iajs-3311	285	44	a.	a.	NOUN
iajs-3311	285	45	;	;	PUNCT
iajs-3311	285	46	snorradottir	snorradottir	PROPN
iajs-3311	285	47	,	,	PUNCT
iajs-3311	285	48	s.	s.	PROPN
iajs-3311	285	49	;	;	PUNCT
iajs-3311	285	50	bjarnason	bjarnason	PROPN
iajs-3311	285	51	,	,	PUNCT
iajs-3311	285	52	h.	h.	PROPN
iajs-3311	285	53	;	;	PUNCT
iajs-3311	285	54	ng	ng	PROPN
iajs-3311	285	55	,	,	PUNCT
iajs-3311	285	56	m.c.y	m.c.y	PROPN
iajs-3311	285	57	.	.	PUNCT
iajs-3311	285	58	;	;	PUNCT
iajs-3311	285	59	hansen	hansen	PROPN
iajs-3311	285	60	,	,	PUNCT
iajs-3311	285	61	t.	t.	PROPN
iajs-3311	285	62	;	;	PUNCT
iajs-3311	285	63	bagger	bagger	NOUN
iajs-3311	285	64	,	,	PUNCT
iajs-3311	285	65	y.	y.	PROPN
iajs-3311	285	66	;	;	PUNCT
iajs-3311	285	67	wilensky	wilensky	PROPN
iajs-3311	285	68	,	,	PUNCT
iajs-3311	285	69	r.l	r.l	PROPN
iajs-3311	285	70	.	.	PROPN
iajs-3311	285	71	;	;	PUNCT
iajs-3311	285	72	reilly	reilly	ADV
iajs-3311	285	73	,	,	PUNCT
iajs-3311	285	74	m.p	m.p	PROPN
iajs-3311	285	75	.	.	PROPN
iajs-3311	285	76	;	;	PUNCT
iajs-3311	285	77	adeyemo	adeyemo	ADJ
iajs-3311	285	78	,	,	PUNCT
iajs-3311	285	79	a.	a.	NOUN
iajs-3311	285	80	;	;	PUNCT
iajs-3311	285	81	chen	chen	PROPN
iajs-3311	285	82	,	,	PUNCT
iajs-3311	285	83	y.	y.	PROPN
iajs-3311	285	84	;	;	PUNCT
iajs-3311	285	85	zhou	zhou	PROPN
iajs-3311	285	86	,	,	PUNCT
iajs-3311	285	87	j.	j.	PROPN
iajs-3311	285	88	;	;	PUNCT
iajs-3311	285	89	gudnason	gudnason	PROPN
iajs-3311	285	90	,	,	PUNCT
iajs-3311	285	91	v.	v.	PROPN
iajs-3311	285	92	;	;	PUNCT
iajs-3311	285	93	chen	chen	PROPN
iajs-3311	285	94	,	,	PUNCT
iajs-3311	285	95	g.	g.	PROPN
iajs-3311	285	96	;	;	PUNCT
iajs-3311	285	97	huang	huang	PROPN
iajs-3311	285	98	,	,	PUNCT
iajs-3311	285	99	h.	h.	PROPN
iajs-3311	285	100	;	;	PUNCT
iajs-3311	285	101	lashley	lashley	PROPN
iajs-3311	285	102	,	,	PUNCT
iajs-3311	285	103	k.	k.	PROPN
iajs-3311	285	104	;	;	PUNCT
iajs-3311	285	105	doumatey	doumatey	PROPN
iajs-3311	285	106	,	,	PUNCT
iajs-3311	285	107	a.	a.	NOUN
iajs-3311	285	108	;	;	PUNCT
iajs-3311	285	109	so	so	ADV
iajs-3311	285	110	,	,	PUNCT
iajs-3311	285	111	w.y	w.y	PROPN
iajs-3311	285	112	.	.	PROPN
iajs-3311	285	113	;	;	PUNCT
iajs-3311	285	114	ma	ma	PROPN
iajs-3311	285	115	,	,	PUNCT
iajs-3311	285	116	r.c.y	r.c.y	PROPN
iajs-3311	285	117	.	.	PROPN
iajs-3311	285	118	;	;	PUNCT
iajs-3311	285	119	andersen	andersen	PROPN
iajs-3311	285	120	,	,	PUNCT
iajs-3311	285	121	g.	g.	PROPN
iajs-3311	285	122	;	;	PUNCT
iajs-3311	285	123	borch	borch	NOUN
iajs-3311	285	124	-	-	PUNCT
iajs-3311	285	125	johnsen	johnsen	PROPN
iajs-3311	285	126	,	,	PUNCT
iajs-3311	285	127	k.	k.	PROPN
iajs-3311	285	128	;	;	PUNCT
iajs-3311	285	129	jorgensen	jorgensen	PROPN
iajs-3311	285	130	,	,	PUNCT
iajs-3311	285	131	t.	t.	PROPN
iajs-3311	285	132	;	;	PUNCT
iajs-3311	285	133	vliet	vliet	PROPN
iajs-3311	285	134	-	-	PUNCT
iajs-3311	285	135	ostaptchouk	ostaptchouk	NOUN
iajs-3311	285	136	,	,	PUNCT
iajs-3311	285	137	j.v.v	j.v.v	PROPN
iajs-3311	285	138	.	.	PROPN
iajs-3311	285	139	;	;	PUNCT
iajs-3311	285	140	hofker	hofker	PROPN
iajs-3311	285	141	,	,	PUNCT
iajs-3311	285	142	m.h	m.h	PROPN
iajs-3311	285	143	.	.	PROPN
iajs-3311	285	144	;	;	PUNCT
iajs-3311	285	145	wijmenga	wijmenga	PROPN
iajs-3311	285	146	,	,	PUNCT
iajs-3311	285	147	c.	c.	PROPN
iajs-3311	285	148	;	;	PUNCT
iajs-3311	285	149	christiansen	christiansen	PROPN
iajs-3311	285	150	,	,	PUNCT
iajs-3311	285	151	c.	c.	PROPN
iajs-3311	285	152	;	;	PUNCT
iajs-3311	285	153	rader	rader	PROPN
iajs-3311	285	154	,	,	PUNCT
iajs-3311	285	155	d.j	d.j	PROPN
iajs-3311	285	156	.	.	PROPN
iajs-3311	285	157	;	;	PUNCT
iajs-3311	285	158	rotimi	rotimi	PROPN
iajs-3311	285	159	,	,	PUNCT
iajs-3311	285	160	c.	c.	NOUN
iajs-3311	285	161	;	;	PUNCT
iajs-3311	285	162	gurney	gurney	NOUN
iajs-3311	285	163	,	,	PUNCT
iajs-3311	285	164	m.	m.	NOUN
iajs-3311	285	165	;	;	PUNCT
iajs-3311	285	166	chan	chan	PROPN
iajs-3311	285	167	,	,	PUNCT
iajs-3311	285	168	j.c.n	j.c.n	PROPN
iajs-3311	285	169	.	.	PUNCT
iajs-3311	285	170	;	;	PUNCT
iajs-3311	285	171	pedersen	pedersen	PROPN
iajs-3311	285	172	,	,	PUNCT
iajs-3311	285	173	o.	o.	PROPN
iajs-3311	285	174	;	;	PUNCT
iajs-3311	285	175	sigurdsson	sigurdsson	NOUN
iajs-3311	285	176	,	,	PUNCT
iajs-3311	285	177	g.	g.	PROPN
iajs-3311	285	178	;	;	PUNCT
iajs-3311	285	179	gulcher	gulcher	ADV
iajs-3311	285	180	,	,	PUNCT
iajs-3311	285	181	j.r	j.r	PROPN
iajs-3311	285	182	.	.	PROPN
iajs-3311	285	183	;	;	PUNCT
iajs-3311	285	184	thorsteinsdottir	thorsteinsdottir	NOUN
iajs-3311	285	185	,	,	PUNCT
iajs-3311	285	186	u.	u.	PROPN
iajs-3311	285	187	;	;	PUNCT
iajs-3311	285	188	kong	kong	PROPN
iajs-3311	285	189	,	,	PUNCT
iajs-3311	285	190	a.	a.	PROPN
iajs-3311	285	191	;	;	PUNCT
iajs-3311	285	192	stefansson	stefansson	PROPN
iajs-3311	285	193	,	,	PUNCT
iajs-3311	285	194	k.	k.	PROPN
iajs-3311	286	1	a	a	DET
iajs-3311	286	2	variant	variant	NOUN
iajs-3311	286	3	in	in	ADP
iajs-3311	286	4	cdkal1	cdkal1	NOUN
iajs-3311	286	5	influences	influence	VERB
iajs-3311	286	6	insulin	insulin	NOUN
iajs-3311	286	7	response	response	NOUN
iajs-3311	286	8	and	and	CCONJ
iajs-3311	286	9	risk	risk	NOUN
iajs-3311	286	10	of	of	ADP
iajs-3311	286	11	type	type	NOUN
iajs-3311	286	12	2	2	NUM
iajs-3311	286	13	diabetes	diabetes	NOUN
iajs-3311	286	14	.	.	PUNCT
iajs-3311	287	1	nature	nature	NOUN
iajs-3311	287	2	genetics	genetic	NOUN
iajs-3311	287	3	.	.	PUNCT
iajs-3311	288	1	2007	2007	NUM
iajs-3311	288	2	,	,	PUNCT
iajs-3311	288	3	39(6	39(6	NUM
iajs-3311	288	4	)	)	PUNCT
iajs-3311	288	5	,	,	PUNCT
iajs-3311	288	6	770–775	770–775	NUM
iajs-3311	288	7	.	.	PUNCT
iajs-3311	289	1	https://doi.org/10.2337/db07-1785	https://doi.org/10.2337/db07-1785	X
iajs-3311	289	2	.	.	PUNCT
iajs-3311	290	1	38	38	NUM
iajs-3311	290	2	.	.	PUNCT
iajs-3311	291	1	murphy	murphy	PROPN
iajs-3311	291	2	,	,	PUNCT
iajs-3311	291	3	r.	r.	PROPN
iajs-3311	291	4	;	;	PUNCT
iajs-3311	291	5	turnbull	turnbull	PROPN
iajs-3311	291	6	,	,	PUNCT
iajs-3311	291	7	d.m	d.m	PROPN
iajs-3311	291	8	.	.	PROPN
iajs-3311	291	9	;	;	PUNCT
iajs-3311	291	10	walker	walker	PROPN
iajs-3311	291	11	,	,	PUNCT
iajs-3311	291	12	m.	m.	NOUN
iajs-3311	291	13	;	;	PUNCT
iajs-3311	291	14	hattersley	hattersley	PROPN
iajs-3311	291	15	,	,	PUNCT
iajs-3311	291	16	a.t	a.t	PROPN
iajs-3311	291	17	.	.	PROPN
iajs-3311	291	18	clinical	clinical	ADJ
iajs-3311	291	19	features	feature	NOUN
iajs-3311	291	20	,	,	PUNCT
iajs-3311	291	21	diagnosis	diagnosis	NOUN
iajs-3311	291	22	and	and	CCONJ
iajs-3311	291	23	management	management	NOUN
iajs-3311	291	24	of	of	ADP
iajs-3311	291	25	maternally	maternally	ADV
iajs-3311	291	26	inherited	inherit	VERB
iajs-3311	291	27	diabetes	diabetes	NOUN
iajs-3311	291	28	and	and	CCONJ
iajs-3311	291	29	deafness	deafness	NOUN
iajs-3311	291	30	(	(	PUNCT
iajs-3311	291	31	midd	midd	PROPN
iajs-3311	291	32	)	)	PUNCT
iajs-3311	291	33	associated	associate	VERB
iajs-3311	291	34	with	with	ADP
iajs-3311	291	35	the	the	DET
iajs-3311	291	36	3243a	3243a	NUM
iajs-3311	291	37	>	>	X
iajs-3311	291	38	g	g	PROPN
iajs-3311	291	39	mitochondrial	mitochondrial	ADJ
iajs-3311	291	40	point	point	NOUN
iajs-3311	291	41	mutation	mutation	NOUN
iajs-3311	291	42	.	.	PUNCT
iajs-3311	292	1	diabetic	diabetic	ADJ
iajs-3311	292	2	medicine	medicine	NOUN
iajs-3311	292	3	.	.	PUNCT
iajs-3311	293	1	2008	2008	NUM
iajs-3311	293	2	,	,	PUNCT
iajs-3311	293	3	25(4	25(4	NOUN
iajs-3311	293	4	)	)	PUNCT
iajs-3311	293	5	,	,	PUNCT
iajs-3311	293	6	383–399	383–399	NUM
iajs-3311	293	7	.	.	PUNCT
iajs-3311	293	8	https://doi.org/10.1111/j.1464-5491.2008.02359.x	https://doi.org/10.1111/j.1464-5491.2008.02359.x	PROPN
iajs-3311	293	9	.	.	PUNCT
iajs-3311	294	1	39	39	NUM
iajs-3311	294	2	.	.	PUNCT
iajs-3311	295	1	murphy	murphy	PROPN
iajs-3311	295	2	,	,	PUNCT
iajs-3311	295	3	r.	r.	PROPN
iajs-3311	295	4	;	;	PUNCT
iajs-3311	295	5	ellard	ellard	PROPN
iajs-3311	295	6	,	,	PUNCT
iajs-3311	295	7	s.	s.	PROPN
iajs-3311	295	8	;	;	PUNCT
iajs-3311	295	9	hattersley	hattersley	PROPN
iajs-3311	295	10	,	,	PUNCT
iajs-3311	295	11	a.t	a.t	PROPN
iajs-3311	295	12	.	.	PROPN
iajs-3311	295	13	clinical	clinical	ADJ
iajs-3311	295	14	implications	implication	NOUN
iajs-3311	295	15	of	of	ADP
iajs-3311	295	16	a	a	DET
iajs-3311	295	17	molecular	molecular	ADJ
iajs-3311	295	18	genetic	genetic	ADJ
iajs-3311	295	19	classification	classification	NOUN
iajs-3311	295	20	of	of	ADP
iajs-3311	295	21	monogenic	monogenic	ADJ
iajs-3311	295	22	beta	beta	NOUN
iajs-3311	295	23	-	-	PUNCT
iajs-3311	295	24	cell	cell	NOUN
iajs-3311	295	25	diabetes	diabetes	NOUN
iajs-3311	295	26	.	.	PUNCT
iajs-3311	296	1	nature	nature	NOUN
iajs-3311	296	2	clinical	clinical	ADJ
iajs-3311	296	3	practice	practice	NOUN
iajs-3311	296	4	endocrinology	endocrinology	NOUN
iajs-3311	296	5	&	&	CCONJ
iajs-3311	296	6	metabol	metabol	PROPN
iajs-3311	296	7	.	.	PUNCT
iajs-3311	297	1	2008	2008	NUM
iajs-3311	297	2	,	,	PUNCT
iajs-3311	297	3	4(4	4(4	NUM
iajs-3311	297	4	)	)	PUNCT
iajs-3311	297	5	,	,	PUNCT
iajs-3311	297	6	200–213	200–213	NUM
iajs-3311	297	7	.	.	PUNCT
iajs-3311	298	1	https://doi.org/10.1038/ncpendmet0778	https://doi.org/10.1038/ncpendmet0778	PROPN
iajs-3311	298	2	.	.	PUNCT
iajs-3311	299	1	40	40	NUM
iajs-3311	299	2	.	.	PUNCT
iajs-3311	300	1	van	van	PROPN
iajs-3311	300	2	den	den	PROPN
iajs-3311	300	3	ouweland	ouweland	PROPN
iajs-3311	300	4	,	,	PUNCT
iajs-3311	300	5	j.m	j.m	PROPN
iajs-3311	300	6	.	.	PROPN
iajs-3311	300	7	;	;	PUNCT
iajs-3311	300	8	lemkes	lemke	NOUN
iajs-3311	300	9	,	,	PUNCT
iajs-3311	300	10	h.h	h.h	PROPN
iajs-3311	300	11	.	.	PROPN
iajs-3311	300	12	;	;	PUNCT
iajs-3311	300	13	ruitenbeek	ruitenbeek	NOUN
iajs-3311	300	14	,	,	PUNCT
iajs-3311	300	15	w.	w.	PROPN
iajs-3311	300	16	;	;	PUNCT
iajs-3311	300	17	sandkuijl	sandkuijl	PROPN
iajs-3311	300	18	,	,	PUNCT
iajs-3311	300	19	l.a	l.a	PROPN
iajs-3311	300	20	.	.	PROPN
iajs-3311	300	21	;	;	PUNCT
iajs-3311	300	22	de	de	X
iajs-3311	300	23	vijlder	vijlder	NOUN
iajs-3311	300	24	,	,	PUNCT
iajs-3311	300	25	m.f	m.f	PROPN
iajs-3311	300	26	.	.	PUNCT
iajs-3311	300	27	;	;	PUNCT
iajs-3311	300	28	struyvenberg	struyvenberg	PROPN
iajs-3311	300	29	,	,	PUNCT
iajs-3311	300	30	p.a	p.a	PROPN
iajs-3311	300	31	.	.	PROPN
iajs-3311	300	32	;	;	PUNCT
iajs-3311	300	33	van	van	PROPN
iajs-3311	300	34	de	de	X
iajs-3311	300	35	kamp	kamp	PROPN
iajs-3311	300	36	,	,	PUNCT
iajs-3311	300	37	j.j	j.j	PROPN
iajs-3311	300	38	.	.	PROPN
iajs-3311	300	39	;	;	PUNCT
iajs-3311	300	40	maassen	maassen	PROPN
iajs-3311	300	41	,	,	PUNCT
iajs-3311	300	42	j.a	j.a	PROPN
iajs-3311	300	43	.	.	PROPN
iajs-3311	300	44	mutation	mutation	NOUN
iajs-3311	300	45	in	in	ADP
iajs-3311	300	46	mitochondrial	mitochondrial	ADJ
iajs-3311	300	47	trna(leu)(uur	trna(leu)(uur	PROPN
iajs-3311	300	48	)	)	PUNCT
iajs-3311	300	49	gene	gene	NOUN
iajs-3311	300	50	in	in	ADP
iajs-3311	300	51	a	a	DET
iajs-3311	300	52	large	large	ADJ
iajs-3311	300	53	pedigree	pedigree	NOUN
iajs-3311	300	54	with	with	ADP
iajs-3311	300	55	maternally	maternally	ADV
iajs-3311	300	56	transmitted	transmit	VERB
iajs-3311	300	57	type	type	NOUN
iajs-3311	300	58	ii	ii	NOUN
iajs-3311	300	59	diabetes	diabetes	NOUN
iajs-3311	300	60	mellitus	mellitus	NOUN
iajs-3311	300	61	and	and	CCONJ
iajs-3311	300	62	deafness	deafness	NOUN
iajs-3311	300	63	.	.	PUNCT
iajs-3311	301	1	nature	nature	NOUN
iajs-3311	301	2	genetics	genetic	NOUN
iajs-3311	301	3	.	.	PUNCT
iajs-3311	302	1	1992	1992	NUM
iajs-3311	302	2	,	,	PUNCT
iajs-3311	302	3	1(5	1(5	NUM
iajs-3311	302	4	)	)	PUNCT
iajs-3311	302	5	,	,	PUNCT
iajs-3311	302	6	368–371	368–371	NUM
iajs-3311	302	7	.	.	PUNCT
iajs-3311	303	1	https://doi.org/10.2337/diabetes.53.2007.s103	https://doi.org/10.2337/diabetes.53.2007.s103	NOUN
iajs-3311	303	2	.	.	PUNCT
iajs-3311	304	1	41	41	NUM
iajs-3311	304	2	.	.	PUNCT
iajs-3311	305	1	pearson	pearson	PROPN
iajs-3311	305	2	,	,	PUNCT
iajs-3311	305	3	e.	e.	PROPN
iajs-3311	305	4	;	;	PUNCT
iajs-3311	305	5	flechtner	flechtner	PROPN
iajs-3311	305	6	,	,	PUNCT
iajs-3311	305	7	i	i	PRON
iajs-3311	305	8	;	;	PUNCT
iajs-3311	305	9	njolstad	njolstad	PROPN
iajs-3311	305	10	,	,	PUNCT
iajs-3311	305	11	p	p	X
iajs-3311	305	12	;	;	PUNCT
iajs-3311	305	13	malecki	malecki	ADJ
iajs-3311	305	14	,	,	PUNCT
iajs-3311	305	15	m.t.;flanagan	m.t.;flanagan	NOUN
iajs-3311	305	16	,	,	PUNCT
iajs-3311	305	17	s.	s.	PROPN
iajs-3311	305	18	;	;	PUNCT
iajs-3311	305	19	larkin	larkin	PROPN
iajs-3311	305	20	,	,	PUNCT
iajs-3311	305	21	b.	b.	PROPN
iajs-3311	305	22	;	;	PUNCT
iajs-3311	305	23	ashcroft	ashcroft	PROPN
iajs-3311	305	24	,	,	PUNCT
iajs-3311	305	25	f.	f.	PROPN
iajs-3311	305	26	;	;	PUNCT
iajs-3311	305	27	klimes	klimes	PROPN
iajs-3311	305	28	,	,	PUNCT
iajs-3311	305	29	i.	i.	PROPN
iajs-3311	305	30	;	;	PUNCT
iajs-3311	305	31	codner	codner	PROPN
iajs-3311	305	32	,	,	PUNCT
iajs-3311	305	33	e.	e.	PROPN
iajs-3311	305	34	;	;	PUNCT
iajs-3311	305	35	iotova	iotova	X
iajs-3311	305	36	,	,	PUNCT
iajs-3311	305	37	v.	v.	ADV
iajs-3311	305	38	;	;	PUNCT
iajs-3311	305	39	slingerland	slingerland	PROPN
iajs-3311	305	40	,	,	PUNCT
iajs-3311	305	41	a.s	a.s	PROPN
iajs-3311	305	42	.	.	PROPN
iajs-3311	305	43	;	;	PUNCT
iajs-3311	305	44	shield	shield	PROPN
iajs-3311	305	45	,	,	PUNCT
iajs-3311	305	46	j.	j.	PROPN
iajs-3311	305	47	;	;	PUNCT
iajs-3311	305	48	robert	robert	PROPN
iajs-3311	305	49	,	,	PUNCT
iajs-3311	305	50	j	j	PROPN
iajs-3311	305	51	-	-	PUNCT
iajs-3311	305	52	j.	j.	PROPN
iajs-3311	305	53	;	;	PUNCT
iajs-3311	305	54	holst	holst	NOUN
iajs-3311	305	55	,	,	PUNCT
iajs-3311	305	56	j.j	j.j	PROPN
iajs-3311	305	57	.	.	PROPN
iajs-3311	305	58	;	;	PUNCT
iajs-3311	305	59	clark	clark	PROPN
iajs-3311	305	60	,	,	PUNCT
iajs-3311	305	61	p.m.	p.m.	ADV
iajs-3311	305	62	;	;	PUNCT
iajs-3311	305	63	ellard	ellard	NOUN
iajs-3311	305	64	,	,	PUNCT
iajs-3311	305	65	s.	s.	PROPN
iajs-3311	305	66	;	;	PUNCT
iajs-3311	305	67	søvik	søvik	ADV
iajs-3311	305	68	,	,	PUNCT
iajs-3311	305	69	o.	o.	PROPN
iajs-3311	305	70	;	;	PUNCT
iajs-3311	305	71	polak	polak	PROPN
iajs-3311	305	72	,	,	PUNCT
iajs-3311	305	73	m.	m.	NOUN
iajs-3311	305	74	;	;	PUNCT
iajs-3311	305	75	hattersley	hattersley	PROPN
iajs-3311	305	76	,	,	PUNCT
iajs-3311	305	77	a.t	a.t	PROPN
iajs-3311	305	78	.	.	PROPN
iajs-3311	305	79	;	;	PUNCT
iajs-3311	305	80	neonatal	neonatal	ADJ
iajs-3311	305	81	diabetes	diabetes	NOUN
iajs-3311	305	82	international	international	ADJ
iajs-3311	305	83	collaborative	collaborative	ADJ
iajs-3311	305	84	group	group	NOUN
iajs-3311	305	85	.	.	PUNCT
iajs-3311	306	1	switching	switch	VERB
iajs-3311	306	2	from	from	ADP
iajs-3311	306	3	insulin	insulin	NOUN
iajs-3311	306	4	to	to	ADP
iajs-3311	306	5	oral	oral	ADJ
iajs-3311	306	6	sulfonylureas	sulfonylurea	NOUN
iajs-3311	306	7	in	in	ADP
iajs-3311	306	8	patients	patient	NOUN
iajs-3311	306	9	with	with	ADP
iajs-3311	306	10	diabetes	diabetes	NOUN
iajs-3311	306	11	due	due	ADP
iajs-3311	306	12	to	to	ADP
iajs-3311	306	13	kir6.2	kir6.2	PROPN
iajs-3311	306	14	mutations	mutation	NOUN
iajs-3311	306	15	.	.	PUNCT
iajs-3311	307	1	new	new	PROPN
iajs-3311	307	2	england	england	PROPN
iajs-3311	307	3	journal	journal	PROPN
iajs-3311	307	4	of	of	ADP
iajs-3311	307	5	medicine	medicine	NOUN
iajs-3311	307	6	.	.	PUNCT
iajs-3311	308	1	2006	2006	NUM
iajs-3311	308	2	,	,	PUNCT
iajs-3311	308	3	355(5	355(5	NUM
iajs-3311	308	4	)	)	PUNCT
iajs-3311	308	5	,	,	PUNCT
iajs-3311	308	6	467–477	467–477	NUM
iajs-3311	308	7	.	.	PUNCT
iajs-3311	309	1	https://doi.org/10.1056/nejmoa061759	https://doi.org/10.1056/nejmoa061759	PROPN
iajs-3311	309	2	.	.	PUNCT
iajs-3311	310	1	42	42	NUM
iajs-3311	310	2	.	.	PUNCT
iajs-3311	311	1	schneiderman	schneiderman	PROPN
iajs-3311	311	2	,	,	PUNCT
iajs-3311	311	3	n.	n.	PROPN
iajs-3311	311	4	;	;	PUNCT
iajs-3311	311	5	llabre	llabre	PROPN
iajs-3311	311	6	,	,	PUNCT
iajs-3311	311	7	m.	m.	NOUN
iajs-3311	311	8	;	;	PUNCT
iajs-3311	311	9	cowie	cowie	PROPN
iajs-3311	311	10	,	,	PUNCT
iajs-3311	311	11	c.	c.	PROPN
iajs-3311	311	12	;	;	PUNCT
iajs-3311	311	13	barnhart	barnhart	PROPN
iajs-3311	311	14	,	,	PUNCT
iajs-3311	311	15	j.;carnethon	j.;carnethon	PROPN
iajs-3311	311	16	,	,	PUNCT
iajs-3311	311	17	m.	m.	NOUN
iajs-3311	311	18	;	;	PUNCT
iajs-3311	311	19	gallo	gallo	PROPN
iajs-3311	311	20	,	,	PUNCT
iajs-3311	311	21	l.c	l.c	PROPN
iajs-3311	311	22	.	.	PROPN
iajs-3311	311	23	;	;	PUNCT
iajs-3311	311	24	giachello	giachello	PROPN
iajs-3311	311	25	,	,	PUNCT
iajs-3311	311	26	a.l	a.l	PROPN
iajs-3311	311	27	.	.	PROPN
iajs-3311	311	28	;	;	PUNCT
iajs-3311	312	1	heiss	heiss	PROPN
iajs-3311	312	2	,	,	PUNCT
iajs-3311	312	3	g.	g.	PROPN
iajs-3311	312	4	;	;	PUNCT
iajs-3311	312	5	kaplan	kaplan	PROPN
iajs-3311	312	6	,	,	PUNCT
iajs-3311	312	7	r.c	r.c	PROPN
iajs-3311	312	8	.	.	PROPN
iajs-3311	312	9	;	;	PUNCT
iajs-3311	312	10	lavange	lavange	PROPN
iajs-3311	312	11	,	,	PUNCT
iajs-3311	312	12	m.l	m.l	PROPN
iajs-3311	312	13	.	.	PUNCT
iajs-3311	312	14	;	;	PUNCT
iajs-3311	313	1	teng	teng	PROPN
iajs-3311	313	2	,	,	PUNCT
iajs-3311	313	3	y.	y.	PROPN
iajs-3311	313	4	;	;	PUNCT
iajs-3311	313	5	villa	villa	PROPN
iajs-3311	313	6	-	-	PUNCT
iajs-3311	313	7	caballero	caballero	PROPN
iajs-3311	313	8	,	,	PUNCT
iajs-3311	313	9	l.	l.	PROPN
iajs-3311	313	10	;	;	PUNCT
iajs-3311	313	11	avilés	avilés	PROPN
iajs-3311	313	12	-	-	PUNCT
iajs-3311	313	13	santa	santa	PROPN
iajs-3311	313	14	,	,	PUNCT
iajs-3311	313	15	m.l	m.l	PROPN
iajs-3311	313	16	..	..	ADJ
iajs-3311	313	17	prevalence	prevalence	NOUN
iajs-3311	313	18	of	of	ADP
iajs-3311	313	19	diabetes	diabetes	NOUN
iajs-3311	313	20	among	among	ADP
iajs-3311	313	21	hispanics	hispanic	NOUN
iajs-3311	313	22	/	/	SYM
iajs-3311	313	23	latinos	latino	NOUN
iajs-3311	313	24	from	from	ADP
iajs-3311	313	25	diverse	diverse	ADJ
iajs-3311	313	26	backgrounds	background	NOUN
iajs-3311	313	27	:	:	PUNCT
iajs-3311	313	28	the	the	DET
iajs-3311	313	29	hispanic	hispanic	ADJ
iajs-3311	313	30	community	community	NOUN
iajs-3311	313	31	health	health	NOUN
iajs-3311	313	32	study	study	NOUN
iajs-3311	313	33	/	/	SYM
iajs-3311	313	34	study	study	NOUN
iajs-3311	313	35	of	of	ADP
iajs-3311	313	36	latinos	latinos	PROPN
iajs-3311	313	37	(	(	PUNCT
iajs-3311	313	38	hchs	hchs	PROPN
iajs-3311	313	39	/	/	SYM
iajs-3311	313	40	sol	sol	NOUN
iajs-3311	313	41	)	)	PUNCT
iajs-3311	313	42	.	.	PUNCT
iajs-3311	314	1	diabetes	diabetes	NOUN
iajs-3311	314	2	care	care	VERB
iajs-3311	314	3	2014	2014	NUM
iajs-3311	314	4	,	,	PUNCT
iajs-3311	314	5	37(8	37(8	NUM
iajs-3311	314	6	)	)	PUNCT
iajs-3311	314	7	,	,	PUNCT
iajs-3311	314	8	2233–2239	2233–2239	NUM
iajs-3311	314	9	.	.	PUNCT
iajs-3311	314	10	https://doi.org/10.2337/dc13-2939	https://doi.org/10.2337/dc13-2939	NOUN
iajs-3311	314	11	.	.	PUNCT
iajs-3311	315	1	https://doi.org/10.2337/dc07-0718	https://doi.org/10.2337/dc07-0718	AUX
iajs-3311	315	2	https://doi.org/10.25258/ijddt.11.2.9	https://doi.org/10.25258/ijddt.11.2.9	PROPN
iajs-3311	315	3	.	.	PUNCT
iajs-3311	315	4	https://doi.org/	https://doi.org/	VERB
iajs-3311	315	5	http://http	http://http	X
iajs-3311	315	6	/	/	SYM
iajs-3311	315	7	doi:%2010.30526/32.2.2125	doi:%2010.30526/32.2.2125	NOUN
iajs-3311	315	8	.	.	PUNCT
iajs-3311	316	1	https://doi.org/10.1038/ng0411-388b	https://doi.org/10.1038/ng0411-388b	NOUN
iajs-3311	316	2	https://pubmed.ncbi.nlm.nih.gov/?term=baker+a&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=baker+a&cauthor_id=17460697	VERB
iajs-3311	316	3	https://pubmed.ncbi.nlm.nih.gov/?term=snorradottir+s&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=snorradottir+s&cauthor_id=17460697	PROPN
iajs-3311	316	4	https://pubmed.ncbi.nlm.nih.gov/?term=bjarnason+h&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=bjarnason+h&cauthor_id=17460697	PROPN
iajs-3311	316	5	https://pubmed.ncbi.nlm.nih.gov/?term=ng+mc&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=ng+mc&cauthor_id=17460697	VERB
iajs-3311	316	6	https://pubmed.ncbi.nlm.nih.gov/?term=hansen+t&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=hansen+t&cauthor_id=17460697	NOUN
iajs-3311	316	7	https://pubmed.ncbi.nlm.nih.gov/?term=bagger+y&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=bagger+y&cauthor_id=17460697	ADV
iajs-3311	317	1	https://pubmed.ncbi.nlm.nih.gov/?term=wilensky+rl&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=wilensky+rl&cauthor_id=17460697	X
iajs-3311	317	2	https://pubmed.ncbi.nlm.nih.gov/?term=wilensky+rl&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=wilensky+rl&cauthor_id=17460697	X
iajs-3311	317	3	https://pubmed.ncbi.nlm.nih.gov/?term=reilly+mp&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=reilly+mp&cauthor_id=17460697	PROPN
iajs-3311	317	4	https://pubmed.ncbi.nlm.nih.gov/?term=reilly+mp&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=reilly+mp&cauthor_id=17460697	PROPN
iajs-3311	317	5	https://pubmed.ncbi.nlm.nih.gov/?term=adeyemo+a&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=adeyemo+a&cauthor_id=17460697	ADJ
iajs-3311	317	6	https://pubmed.ncbi.nlm.nih.gov/?term=chen+y&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=chen+y&cauthor_id=17460697	NUM
iajs-3311	317	7	https://pubmed.ncbi.nlm.nih.gov/?term=zhou+j&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=zhou+j&cauthor_id=17460697	PRON
iajs-3311	317	8	https://pubmed.ncbi.nlm.nih.gov/?term=gudnason+v&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=gudnason+v&cauthor_id=17460697	ADV
iajs-3311	317	9	https://pubmed.ncbi.nlm.nih.gov/?term=chen+g&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=chen+g&cauthor_id=17460697	NOUN
iajs-3311	317	10	https://pubmed.ncbi.nlm.nih.gov/?term=huang+h&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=huang+h&cauthor_id=17460697	X
iajs-3311	317	11	https://pubmed.ncbi.nlm.nih.gov/?term=lashley+k&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=lashley+k&cauthor_id=17460697	NUM
iajs-3311	317	12	https://pubmed.ncbi.nlm.nih.gov/?term=doumatey+a&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=doumatey+a&cauthor_id=17460697	PRON
iajs-3311	317	13	https://pubmed.ncbi.nlm.nih.gov/?term=so+wy&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=so+wy&cauthor_id=17460697	PROPN
iajs-3311	317	14	https://pubmed.ncbi.nlm.nih.gov/?term=ma+rc&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=ma+rc&cauthor_id=17460697	PROPN
iajs-3311	317	15	https://pubmed.ncbi.nlm.nih.gov/?term=andersen+g&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=andersen+g&cauthor_id=17460697	PROPN
iajs-3311	317	16	https://pubmed.ncbi.nlm.nih.gov/?term=borch-johnsen+k&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=borch-johnsen+k&cauthor_id=17460697	X
iajs-3311	317	17	https://pubmed.ncbi.nlm.nih.gov/?term=jorgensen+t&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=jorgensen+t&cauthor_id=17460697	X
iajs-3311	317	18	https://pubmed.ncbi.nlm.nih.gov/?term=van+vliet-ostaptchouk+jv&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=van+vliet-ostaptchouk+jv&cauthor_id=17460697	NOUN
iajs-3311	317	19	https://pubmed.ncbi.nlm.nih.gov/?term=hofker+mh&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=hofker+mh&cauthor_id=17460697	ADP
iajs-3311	317	20	https://pubmed.ncbi.nlm.nih.gov/?term=wijmenga+c&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=wijmenga+c&cauthor_id=17460697	NOUN
iajs-3311	317	21	https://pubmed.ncbi.nlm.nih.gov/?term=christiansen+c&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=christiansen+c&cauthor_id=17460697	NUM
iajs-3311	317	22	https://pubmed.ncbi.nlm.nih.gov/?term=rader+dj&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=rader+dj&cauthor_id=17460697	CCONJ
iajs-3311	317	23	https://pubmed.ncbi.nlm.nih.gov/?term=rotimi+c&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=rotimi+c&cauthor_id=17460697	ADP
iajs-3311	317	24	https://pubmed.ncbi.nlm.nih.gov/?term=gurney+m&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=gurney+m&cauthor_id=17460697	NOUN
iajs-3311	317	25	https://pubmed.ncbi.nlm.nih.gov/?term=chan+jc&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=chan+jc&cauthor_id=17460697	PROPN
iajs-3311	317	26	https://pubmed.ncbi.nlm.nih.gov/?term=pedersen+o&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=pedersen+o&cauthor_id=17460697	NOUN
iajs-3311	317	27	https://pubmed.ncbi.nlm.nih.gov/?term=sigurdsson+g&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=sigurdsson+g&cauthor_id=17460697	PROPN
iajs-3311	318	1	https://pubmed.ncbi.nlm.nih.gov/?term=gulcher+jr&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=gulcher+jr&cauthor_id=17460697	PROPN
iajs-3311	318	2	https://pubmed.ncbi.nlm.nih.gov/?term=thorsteinsdottir+u&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=thorsteinsdottir+u&cauthor_id=17460697	NOUN
iajs-3311	318	3	https://pubmed.ncbi.nlm.nih.gov/?term=kong+a&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=kong+a&cauthor_id=17460697	X
iajs-3311	318	4	https://pubmed.ncbi.nlm.nih.gov/?term=stefansson+k&cauthor_id=17460697	https://pubmed.ncbi.nlm.nih.gov/?term=stefansson+k&cauthor_id=17460697	X
iajs-3311	318	5	https://doi.org/10.2337/db07-1785	https://doi.org/10.2337/db07-1785	X
iajs-3311	318	6	https://doi.org/10.2337/db07-1785	https://doi.org/10.2337/db07-1785	X
iajs-3311	318	7	https://doi.org/10.1111/j.1464-5491.2008.02359.x	https://doi.org/10.1111/j.1464-5491.2008.02359.x	PROPN
iajs-3311	318	8	https://doi.org/10.1038/ncpendmet0778	https://doi.org/10.1038/ncpendmet0778	NOUN
iajs-3311	318	9	https://doi.org/10.2337/diabetes.53.2007.s103	https://doi.org/10.2337/diabetes.53.2007.s103	VERB
iajs-3311	318	10	https://doi.org/10.2337/diabetes.53.2007.s103	https://doi.org/10.2337/diabetes.53.2007.s103	PROPN
iajs-3311	318	11	https://pubmed.ncbi.nlm.nih.gov/?term=slingerland+as&cauthor_id=16885550	https://pubmed.ncbi.nlm.nih.gov/?term=slingerland+as&cauthor_id=16885550	PROPN
iajs-3311	318	12	https://pubmed.ncbi.nlm.nih.gov/?term=shield+j&cauthor_id=16885550	https://pubmed.ncbi.nlm.nih.gov/?term=shield+j&cauthor_id=16885550	PROPN
iajs-3311	318	13	https://pubmed.ncbi.nlm.nih.gov/?term=robert+jj&cauthor_id=16885550	https://pubmed.ncbi.nlm.nih.gov/?term=robert+jj&cauthor_id=16885550	PROPN
iajs-3311	319	1	https://pubmed.ncbi.nlm.nih.gov/?term=holst+jj&cauthor_id=16885550	https://pubmed.ncbi.nlm.nih.gov/?term=holst+jj&cauthor_id=16885550	PROPN
iajs-3311	319	2	https://pubmed.ncbi.nlm.nih.gov/?term=clark+pm&cauthor_id=16885550	https://pubmed.ncbi.nlm.nih.gov/?term=clark+pm&cauthor_id=16885550	PROPN
iajs-3311	319	3	https://pubmed.ncbi.nlm.nih.gov/?term=ellard+s&cauthor_id=16885550	https://pubmed.ncbi.nlm.nih.gov/?term=ellard+s&cauthor_id=16885550	PROPN
iajs-3311	319	4	https://pubmed.ncbi.nlm.nih.gov/?term=s%c3%b8vik+o&cauthor_id=16885550	https://pubmed.ncbi.nlm.nih.gov/?term=s%c3%b8vik+o&cauthor_id=16885550	PROPN
iajs-3311	319	5	https://pubmed.ncbi.nlm.nih.gov/?term=polak+m&cauthor_id=16885550	https://pubmed.ncbi.nlm.nih.gov/?term=polak+m&cauthor_id=16885550	PROPN
iajs-3311	320	1	https://pubmed.ncbi.nlm.nih.gov/?term=hattersley+at&cauthor_id=16885550	https://pubmed.ncbi.nlm.nih.gov/?term=hattersley+at&cauthor_id=16885550	PROPN
iajs-3311	320	2	https://pubmed.ncbi.nlm.nih.gov/?term=neonatal+diabetes+international+collaborative+group%5bcorporate+author%5d	https://pubmed.ncbi.nlm.nih.gov/?term=neonatal+diabetes+international+collaborative+group%5bcorporate+author%5d	PROPN
iajs-3311	320	3	https://pubmed.ncbi.nlm.nih.gov/?term=neonatal+diabetes+international+collaborative+group%5bcorporate+author%5d	https://pubmed.ncbi.nlm.nih.gov/?term=neonatal+diabetes+international+collaborative+group%5bcorporate+author%5d	PROPN
iajs-3311	320	4	https://doi.org/10.1056/nejmoa061759	https://doi.org/10.1056/nejmoa061759	PROPN
iajs-3311	320	5	https://pubmed.ncbi.nlm.nih.gov/?term=llabre+m&cauthor_id=25061138	https://pubmed.ncbi.nlm.nih.gov/?term=llabre+m&cauthor_id=25061138	PROPN
iajs-3311	320	6	https://pubmed.ncbi.nlm.nih.gov/?term=cowie+cc&cauthor_id=25061138	https://pubmed.ncbi.nlm.nih.gov/?term=cowie+cc&cauthor_id=25061138	PROPN
iajs-3311	320	7	https://pubmed.ncbi.nlm.nih.gov/?term=barnhart+j&cauthor_id=25061138	https://pubmed.ncbi.nlm.nih.gov/?term=barnhart+j&cauthor_id=25061138	PROPN
iajs-3311	320	8	https://pubmed.ncbi.nlm.nih.gov/?term=carnethon+m&cauthor_id=25061138	https://pubmed.ncbi.nlm.nih.gov/?term=carnethon+m&cauthor_id=25061138	PROPN
iajs-3311	321	1	https://pubmed.ncbi.nlm.nih.gov/?term=gallo+lc&cauthor_id=25061138	https://pubmed.ncbi.nlm.nih.gov/?term=gallo+lc&cauthor_id=25061138	PROPN
iajs-3311	321	2	https://pubmed.ncbi.nlm.nih.gov/?term=giachello+al&cauthor_id=25061138	https://pubmed.ncbi.nlm.nih.gov/?term=giachello+al&cauthor_id=25061138	PROPN
iajs-3311	322	1	https://pubmed.ncbi.nlm.nih.gov/?term=giachello+al&cauthor_id=25061138	https://pubmed.ncbi.nlm.nih.gov/?term=giachello+al&cauthor_id=25061138	PROPN
iajs-3311	322	2	https://pubmed.ncbi.nlm.nih.gov/?term=heiss+g&cauthor_id=25061138	https://pubmed.ncbi.nlm.nih.gov/?term=heiss+g&cauthor_id=25061138	PROPN
iajs-3311	323	1	https://pubmed.ncbi.nlm.nih.gov/?term=kaplan+rc&cauthor_id=25061138	https://pubmed.ncbi.nlm.nih.gov/?term=kaplan+rc&cauthor_id=25061138	PROPN
iajs-3311	323	2	https://pubmed.ncbi.nlm.nih.gov/?term=lavange+lm&cauthor_id=25061138	https://pubmed.ncbi.nlm.nih.gov/?term=lavange+lm&cauthor_id=25061138	PROPN
iajs-3311	323	3	https://pubmed.ncbi.nlm.nih.gov/?term=teng+y&cauthor_id=25061138	https://pubmed.ncbi.nlm.nih.gov/?term=teng+y&cauthor_id=25061138	NOUN
iajs-3311	323	4	https://pubmed.ncbi.nlm.nih.gov/?term=villa-caballero+l&cauthor_id=25061138	https://pubmed.ncbi.nlm.nih.gov/?term=villa-caballero+l&cauthor_id=25061138	NOUN
iajs-3311	323	5	https://pubmed.ncbi.nlm.nih.gov/?term=avil%c3%a9s-santa+ml&cauthor_id=25061138	https://pubmed.ncbi.nlm.nih.gov/?term=avil%c3%a9s-santa+ml&cauthor_id=25061138	PROPN
iajs-3311	323	6	https://doi.org/10.2337/dc13-2939	https://doi.org/10.2337/dc13-2939	NOUN